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Summary 
The current Ph.D. dissertation revolves around the components of the body composition and physical 
condition like body fat percentage (BF%), fat mass index (FMI) and muscular strength (normalized 
grip strength [NGS]) respectively, can be used to detect metabolic syndrome (MetS) in collegiate 
students from Colombia. Besides these components are related with the ideal cardiovascular health 
(CVH) in Colombian University Students. For these reasons, the current doctoral thesis is based on 3 
scientific studies that have been published or submitted for publication in scientific international 
journals. 
The first study (chapter 2), has the aim to explore thresholds of body fat percentage (BF%) and fat 
mass index (FMI) for the prediction of MetS among Colombian University students. The second 
study (chapter 3) to determine cut-off of normalized grip strength (NGS) for the detection of MetS in 
a large nonrepresentative sample of a collegiate student population from Colombia. The lastly study 
(chapter 4) has the purpose to investigate the relationship between handgrip strength, muscle mass, 
and ideal cardiovascular health (CVH) among Colombian college students.  
Study 1 
Percentage of Body Fat and Fat Mass Index as a Screening Tool for Metabolic Syndrome 
Prediction in Colombian University Students. 
Ramírez-Vélez R; Correa-Bautista JE; Sanders-Tordecilla A; Ojeda-Pardo ML; Cobo-Mejía EA; 
Castellanos-Vega RDP; García-Hermoso A; González-Jiménez E; Schmidt-RioValle J; González-
Ruíz K. (2017). Percentage of Body Fat and Fat Mass Index as a Screening Tool for Metabolic 
Syndrome Prediction in Colombian University Students. Nutrients 9(9). doi: 10.3390/nu9091009. 
The first study we aimed to explore thresholds of body fat percentage (BF%) and fat mass index 
(FMI) for the prediction of MetS among Colombian University students. A cross-sectional study was 
conducted on 1687 volunteers (63.4% women, mean age=20.6 years). Weight, waist circumference, 
serum lipids indices, blood pressure, and fasting plasma glucose were measured. Body composition 
was measured by bioelectrical impedance analysis (BIA) and FMI was calculated. MetS was defined 
as including more than or equal to three of the metabolic abnormalities according to the International 
Diabetes Federation (IDF) definition. Receiver operating curve (ROC) analysis was used to determine 
optimal cut-off points for BF% and FMI in relation to the area under the curve (AUC), sensitivity, 
and specificity in both sexes. The overall prevalence of Mets was found to be 7.7%, higher in men 
than women (11.1% vs. 5.3%; p<0.001). BF% and FMI were positively correlated to MetS 
components (p<0.05). ROC analysis indicated that BF% and FMMI thresholds of 25.5% and 6.97 
kg/m2 in men, and 38.95% and 11.86 kg/m2 in women, were found to be indicative of high MetS risk. 
Based on the IDF criteria, both indexes´ thresholds seem to be good tools to identify university 
students with unfavorable metabolic profiles. 
Study 2 
Muscle strength cut-off for the detection of metabolic syndrome in a nonrepresentative sample of 
collegiate students from Colombia 
García-Hermoso A; Tordecilla-Sanders A; Correa-Bautista JE; Peterson MD; Izquierdo M; Quino-
Avila AC; Sandoval-Cuellar C; González-Ruíz K; Ramírez-Vélez R. Muscle Strength cut-offs for the 
Detection of Metabolic Syndrome in Non-Representative Sample Collegiate Students from Colombia. 
Journal of Sport and Health Science. 2018 (In press). https://doi.org/10.1016/j.jshs.2018.09.004.  
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The aim of the second study was to determine cut-off of normalized grip strength (NGS) for the 
detection of MetS in a large nonrepresentative sample of a collegiate student population from 
Colombia. A cross-sectional study was conducted on 1795 volunteers (61.4% female, 
age=20.68±3.10 years, mean ±SD). Strength was estimated using a handheld dynamometer and 
normalized to body mass (handgrip strength (kg)/ body mass (kg)). Anthropometrics, serum lipids 
indices, blood pressure, and fasting plasma glucose were measured. Body composition was measured 
by bioelectrical impedance analysis (BIA). MetS was defined as including ≥ 3 of the 5 metabolic 
abnormalities according to the IDF definition. A metabolic risk score was computed from the 
following components: waist circumference, triglycerides, high-denstiy lipoprotein cholesterol, 
glucose, and systolic and diastolic blood pressure.  
Receiver operating curve analysis showed significant discriminatory accuracy of NGS in identifying 
the thresholds and risk categories. Lower strength was associated with increased prevalence of MetS. 
In males, weak, intermediate, and strong NGS values at these points were <0.466, 0.466-0.615, 
>0.615, respectively. In females, these cut-offs points were <0.332, 0.332-0.437, >0.437, 
respectively. Our sex-specific cut-off of NGS could be incorporated into a clinical setting for 
identifying college students at cardiometabolic disease risk. 
Study 3 
Ideal Cardiovascular Health, Handgrip Strength and muscle mass among college students: The 
FUPRECOL Adults study 
Garcia-Hermoso A; Correa-Bautista JE; Izquierdo M; Tordecilla-Sanders A; Prieto-Benavides D; 
Sandoval-Cuellar C; González-Ruíz K; Ramírez-Vélez R. Ideal Cardiovascular Health, Handgrip 
Strength, and Muscle Mass Among College Students: Results from the cross-sectional The 
FUPRECOL Adult Study. J Strength Cond Res. 2019 Jan 17. doi: 10.1519/JSC.0000000000003052. 
[Epub ahead of print].  
The last study of the current Ph.D. dissertation has the purpose to investigate the relationship between 
handgrip strength, muscle mass, and ideal cardiovascular health (CVH) among Colombian college 
students. Data from 1835 college students were analyzed (1128 female). Muscular strength was 
estimated using a hand-hold dynamometer and normalized to body mass (normalized grip strength 
[NGS]). The percentage of body fat was determined for bioelectrical impedance analysis (BIA) using 
tetrapolar whole-body impedance. Ideal CVH was defined as meeting the ideal levels of 4 behaviors 
(smoking, body mass index, physical activity, and diet adherence) and 3 factors (total cholesterol, 
fasting glucose, and blood pressure). Higher levels of NGS and muscle mass (relative to body mass) 
were associated with a higher number of ideal CVH metrics scored on a continuous scale from 0 (all 
7 poor) to 7 (all 7 ideal), a 1-metric increase was associated with reduced odds of weak NGS (33 and 
36%) and low-medium muscle mass (28 and 34%) mass in men and women, respectively (all 
p<0.001). This study indicates that in Colombian college students, both handgrip strength and muscle 
mass are positively associated with the ideal CVH metrics. To reduce the possible future public health 
burden of muscular weakness, health professionals need to encourage the public to optimize lifestyle-
related risk factors during the young adult stage. 
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Resumen 
La actual disertación doctoral gira en torno a como los componentes de la composición corporal y la 
condición física, como el porcentaje de tejido graso (BF%- Siglas en inglés body fat percentage), el 
índice de masa grasa (FMI- Siglas en inglés fat mass index) y la fuerza muscular (fuerza prensil 
ajustada- NGS- Siglas en ingles normalized grip strength) respectivamente, pueden utilizarse para 
detectar síndrome metabólico (MetS- Siglas en inglés metabolic syndrome) en estudiantes 
universitarios de Colombia. Además, estos componentes están relacionados con el índice de salud 
cardiovascular (CVH- siglas en inglés cardiovascular health) en estudiantes universitarios 
colombianos. Por estas razones, la presente tesis doctoral se basa en 3 estudios científicos que se han 
sido publicado o enviados para su publicación en revistas científicas internacionales.  
El primer estudio (capítulo 2) tuvo como objetivo, fue explorar los valores de referencia del BF% y 
el FMI para la predicción de MetS en los estudiantes universitarios de Colombia. El objetivo del 
segundo estudio (capítulo 3) fue determinar los puntos de referencia de la NGS para la detección de 
MetS en una gran muestra no representativa de una población de estudiantes universitarios de 
Colombia. El último estudio (capítulo4) tuvo el propósito de investigar la relación entre la fuerza 
prensil, masa muscular y el índice de CVH en estudiantes universitarios de Colombia 
Estudio 1 
Porcentaje de grasa corporal y el índice de masa grasa como herramienta de detección para la 
predicción de síndrome metabólico en estudiantes universitarios colombianos. 
Referencia: 
Ramírez-Vélez R; Correa-Bautista JE; Sanders-Tordecilla A; Ojeda-Pardo ML; Cobo-Mejía EA; 
Castellanos-Vega RDP; García-Hermoso A; González-Jiménez E; Schmidt-RioValle J; González-
Ruíz K. (2017). Percentage of Body Fat and Fat Mass Index as a Screening Tool for Metabolic 
Syndrome Prediction in Colombian University Students. Nutrients 9(9). doi: 10.3390/nu9091009.  
El primer estudio tuvo como objetivo, fue explorar los valores de referencia del porcentaje de tejido 
graso (BF%- Siglas en inglés Body fat percentage) y el índice de masa grasa (FMI- Siglas en inglés 
Fat mass index) para la predicción de Síndrome metabólico (MetS- Siglas en inglés Metabolic 
Syndrome) en los estudiantes universitarios de Colombia. Se realizó un estudio transversal en 1687 
voluntarios (63.4% mujeres, edad promedio=20.6 años). Se midió el peso, la circunferencia de 
cintura, los índices lipídicos, la presión arterial y la glucosa en plasma en ayunas. La composición 
corporal se midió a través de un analizador de impedancia bioeléctrica (BIA- Siglas en inglés 
Bioelectrical impedance análisis) y el FMI se calculó. El MetS se definió como la inclusión de más 
o equivalente a tres de las anomalías metabólicas según la definición de la Federación Internacional 
de Diabetes (IDF- Siglas en inglés de International Diabetes Federation). El análisis de la Curva 
operativa del receptor (ROC- Siglas en inglés de Receiver Operating Characteristic) se utilizó para 
determinar los puntos de referencia óptimos para establecer el % de tejido graso y el FMI en relación 
al área bajo la curva (AUC-Siglas en inglés Area Under the Curve), la sensibilidad y especificidad en 
ambos sexos, para la detección de síndrome metabólico. En toda la población evaluada se encontró 
una prevalencia del 7.7% se MetS, mayor en hombres que en mujeres (11.1% vs 5.3%, p<0.001). Se 
encontró una correlación positiva entre el % tejido graso y el FMI frente a los componentes de SM 
(p<0.05). Los análisis de la curva ROC indican que los puntos de referencia de %tejido graso y FMI 
de 25.55% y 6.97 kg/m2 en hombres y 38.95% y 11.86 kg/m2 en mujer, son indicativos de alto riesgo 
de SM. Teniendo en cuenta los criterios de la IDF, los puntos de referencia de los dos índices parecen 
10 
ser buenas herramientas para identificar perfiles metabólicos poco saludables en estudiantes 
universitarios.  
Estudio 2 
Puntos de corte de fuerza muscular para la detección de síndrome metabólico en una muestra no 
representativa de estudiantes universitarios de Colombia. 
Referencia: 
García-Hermoso A; Tordecilla-Sanders A; Correa-Bautista JE; Peterson MD; Izquierdo M; Quino-
Avila AC; Sandoval-Cuellar C; González-Ruíz K; Ramírez-Vélez R. Muscle Strength cut-offs for the 
Detection of Metabolic Syndrome in Non-Representative Sample Collegiate Students from Colombia. 
Journal of Sport and Health Science. 2018 (In press). https://doi.org/10.1016/j.jshs.2018.09.004. 
El objetivo del segundo estudio fue determinar los puntos de referencia de la fuerza prensil ajustada 
(NGS- Siglas en ingles Normalized grip strength) para la detección de síndrome metabólico (MetS- 
Siglas en inglés Metabolic Syndrome) en una gran muestra no representativa de una población de 
estudiantes universitarios de Colombia. Se realizó un estudio transversal en 1795 voluntarios (61.4% 
mujeres, edad= 20.68 ± 3.10 años, media ± DE). Se estimó la fuerza usando un dinamómetro manual 
y se ajustó por el peso de cada sujeto (fuerza prensil (kg)/ peso corporal (kg)). Se tomaron medidas 
antropométricas, índices del perfil lipídico, presión arterial, glucosa plasmática en ayunas. La 
composición corporal se midió a través de un analizador de impedancia bioeléctrica (BIA- Siglas en 
inglés Bioelectrical impedance análisis). El MetS se definió como la inclusión de ≥ 3 de las 5 
anomalías metabólicas según la definición de la Federación Internacional de Diabetes (IDF- Siglas 
en inglés de International Diabetes Federation). Se calculó una puntuación de riesgo metabólico a 
partir de los siguientes componentes: circunferencia de cintura, triglicéridos, lipoproteínas de alta 
densidad (HDL-C: Siglas en ingles de High density lipoprotein colesterol), glucosa y, presión arterial 
sistólica y diastólica. 
Los análisis de la curva Operativa del receptor (ROC- Siglas en inglés de Receiver Operating 
Characteristic) evidenciaron como la fuerza ajustada identifica los puntos de referencia y las 
categorías de riesgo de forma precisa y significativa. Menor fuerza se asoció con mayor prevalencia 
de SM. En hombres, los valores de la fuerza ajustada categorizada en débil, intermedia y fuerte fue 
de <0.466, 0.466-0.615, >0.615, respectivamente. En mujeres estos puntos de corte fueron de >0.332, 
0.332-0.437, >0.437, respectivamente. Los puntos de corte de la fuerza prensil ajustada pueden ser 
incorporadas en un entorno clínico para identificar riesgo cardiovascular en estudiantes universitarios. 
Estudio 3 
Salud Cardiovascular Ideal, fuerza muscular y masa muscular en estudiantes universitarios: 
Estudio FUPRECOL adultos. 
Referencia: 
Garcia-Hermoso A; Correa-Bautista JE; Izquierdo M; Tordecilla-Sanders A; Prieto-Benavides D; 
Sandoval-Cuellar C; González-Ruíz K; Ramírez-Vélez R. Ideal Cardiovascular Health, Handgrip 
Strength, and Muscle Mass Among College Students: Results from the cross-sectional The 
FUPRECOL Adult Study. J Strength Cond Res. 2019;33(3):747-754. doi: 
10.1519/JSC.0000000000003052. 
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El último trabajo tuvo el propósito de investigar la relación entre la fuerza prensil, masa muscular y 
el índice de Salud Cardiovascular (CVH- siglas en inglés Cardiovascular health) en estudiantes 
universitarios de Colombia. Se analizaron datos de 1835 estudiantes universitarios (1128 mujeres). 
La fuerza muscular se estimó utilizando un dinamómetro manual y se ajustó por el peso del sujeto 
(NGS- siglas en inglés Normalized grip strength). El porcentaje de grasa corporal se determinó por 
el análisis de impedancia bioeléctrica (BIA-siglas en ingles Bioelectrical impedance análisis) usando 
una impedancia tetrapolar. El índice de CVH se definió como el cumplimiento de los niveles ideales 
de 4 comportamientos (tabaquismo, índice de masa corporal [IMC], actividad física y adherencia a la 
dieta) y 3 factores (colesterol total, glucosa en ayunas y presión arterial). Los niveles más altos de 
NGS y masa muscular (ajustada al peso corporal) se asociaron con un mayor cumplimiento de 
métricas del índice de CVH, puntuadas en una escala continua de 0 (los 7 parámetros deficientes) a 7 
(los 7 parámetros saludables). un aumento de 1 métrica se asoció con una reducción de las 
probabilidades de presentar FPA débil (33 y 36%) y una masa muscular media-baja (28 y 34%) en 
hombres y mujeres respectivamente (todos valores p<0.001). Este estudio indica que, en estudiantes 
Universitarios de Colombia, tanto la fuerza prensil como la masa muscular son asociados 
positivamente con el índice de Salud Cardiovascular. Para reducir la posible futura carga de debilidad 
muscular en la salud pública, los profesionales de la salud deben alentar al público a mejorar los 
factores de riesgo relacionados con el estadio de vida durante la etapa de adulto joven. 
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Background 
 
Cardiovascular disease (CVD) have been listed as the leading cause of death worldwide [1]. 
According to the American Heart Association (AHA) during the 2013 to 2016, more than 40% of the 
Hispanic population older than 20 years had CVD [2]. Several studies have stablished that in young 
adults who present risk factors for CVD, have a higher risk of developing coronary heart disease in 
later years and with atherosclerotic changes that persist into adulthood [3-5]. In this sense, the 
Metabolic Syndrome (MetS), defined by International Diabetes Federation (IDF) as a cluster of the 
most dangerous heart attack risk factors: diabetes and raised fasting plasma glucose, abdominal 
obesity, high cholesterol and high blood pressure [6], is referred to as grouping of atherosclerotic 
CVD risk factor, that probably has more than one cause [7, 8].  
It is estimate that 20-25% of the world´s adult population have the MetS and the prevalence is often 
more in the urban population of developing countries [6, 7]. The people, who has MetS are twice as 
likely to die form and three times as likely to have a heart attack or stroke compared with people 
without the syndrome [6]. Many experts have establishing that genetics, unhealthy lifestyle (physical 
inactivity and inadequate diet) [9], ageing, proinflammatory state and hormonal changes may also 
have a causal effect on the MetS and CVD develop, highlighting the insulin resistance and central 
obesity as significant factors [6, 9, 10, 11]. 
The excess of adiposity tissue is a risk factor for develop MetS and CVD [8]. Many studies have 
examined the role of body composition in health assessment and monitoring [11], using different 
methods like Bioelectric Impedance Analysis (BIA) and Fat Mass Index (FMI) as a predictive method 
of MetS by having a high correlation with the components of the MetS [12]. Likewise, the predictive 
role of other fitness components such as muscle strength [16,17] and cardiorespiratory fitness [18] 
have been described as independent and inverse association in the appearance of CVD and MetS in 
adolescents and adults [14-16].  
Against this background, the AHA has designed new strategies with a global impact to reduce the 
occurrence of CVD, based on the new concept of Cardiovascular Health (CVH). This concept 
includes the adoption of 7 metrics comprise 4 healthy behaviors (current smoking, body mass index 
[BMI], physical activity and healthy diet score) and 3 physiological health factors (total cholesterol, 
blood pressure, and fasting plasma glucose levels). [2] 
Several studies have established that young adults who reach middle age with favorable levels of 
cardiovascular risk factors (cholesterol, blood pressure and no cigarette consumption), have lower 
incidence of developing CVD and greater longevity [13-15], which highlights the importance of 
identifying and treating CVD risk factors at an early age. Recently works such as those made by 
Agostinis-Sobrinho C et al. [19] and Ramírez-Velez [20] describe how having high levels of CVH is 
associated with high levels of muscle strength in children and adolescents. 
Based on the above, this thesis is an evidence on the determination of CVH in Colombian University 
students and its relationship with the muscular strength and body composition components. 
Therefore, this work describes the associations of physical fitness components such as muscular 
strength and body composition in university students with cardiovascular health. For these reasons, 
three cross-sectional design studies have been carried out that describe the muscular strength and 
body fat percentage reference value for the detection of metabolic syndrome (study 1 and 2) and the 
association of muscle strength and muscle mass with parameters of the CVH in collegiate students 
from Colombia. 
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Chapter 1: Theoretical background  
Cardiovascular Disease (CVD) and Cardiovascular Health (CVH) 
Cardiovascular disease (CVD) refers to the group of heterogeneous disorders of the heart and blood 
vessels, such as hypertension, coronary heart disease, cerebrovascular disease, heart failure, 
rheumatic heart disease, arrhythmia, congenital heart disease and cardiomyopathies; these include 
numerous problems that are most often related to a process called atherosclerosis, which is a condition 
that develops when plaque builds up in the walls of the arteries [1,2] This set of pathologies are 
chronic asymptomatic diseases that gradually evolve throughout life and advanced usually disease 
causes symptoms or sudden death. [3] 
The number of deaths from CVD has increased globally during the past decade by 12.5%, and is now 
considered the number one cause of death worldwide. In 2015, 50% of deaths were attributed to 
ischemic heart disease and 35% to cerebrovascular disease [4]; it is estimated by 2030 that almost 
23.6 million people will die of CVD, mainly from heart disease and stroke [1]. 
CVDs are caused by multiple factors that are invariable (age, gender, genetic heritage) and others that 
can be modifiable, like smoking tobacco, high blood pressure (HBP), dyslipidaemia, type 2 diabetes 
mellitus (T2DM), obesity, physical inactivity (PI) and poor eating habits [5]. Clinical studies, such as 
those by Framingham [6], INTERHEART [7] and the Multiple Risk Factor Intervention Trial [8], 
have shown that modifiable risk factors multiply CVD risk and myocardial infarction progressively. 
In this sense, different organisations and associations have established the importance of reducing 
CVD mortality, and managing modifiable risk factors in its diagnosis, monitoring and treatment [3]. 
Many studies have established an association between modifiable risk factors and the development 
of CVD, trying to explain the effect of certain factors on the heart and blood vessels [6-8]. One of 
these factors is smoking tobacco, which has demonstrated a dose effect and unfavourable interactions 
with other risk factors (total serum cholesterol, very-low density lipoprotein (VLDL), low density 
lipoprotein (LDL), and triglyceride serum concentrations) in the generation of atherosclerosis in 
narrowed vessels, thereby increasing the risk of thrombosis [9]. This has been shown for the effect of 
smoking in the reduction of flow-mediated dilatation (FMD) in systemic arteries, considering that 
altered FMD is a marker for vascular (endothelial) dysfunction [10]. 
The review by Messner and Bernhard determined the proatherogenic effect of smoking cigarettes, 
which generates reactive oxygen species (ROS), thereby inducing oxidative stress (OX), and is 
implicated in the increased expression of intracellular adhesion, vascular cell adhesion molecule, 
platelets and macrophages, reduced nitric oxide (NO) bioavailability within the cells and the 
subsequent loss of function of smooth muscle cells (SMC) in the vessel media from the activated 
endothelium. Endothelial cells release inflammatory and proatherogenic cytokines that cause 
endothelial cell loss by apoptosis or necrosis. Likewise, macrophages are activated by the expression 
of adhesion molecule receptors, which take up oxidised lipids produced by oxidative modification for 
increased ROS production and induce the formation of foam cells within the aortic wall; the death of 
foam cells induces the release of these lipids and the formation of lipid-rich aortic plaques (Figure 1) 
[10]. 
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Figure 1. Schematic representation of smoking-induced signaling pathways in the vessel wall.  
 
Figure modified from: Messner B, Bernhard D. Smoking and cardiovascular disease: mechanisms of 
endothelial dysfunction and early atherogenesis. Arterioscler Thromb Vasc Biol. 201;34(3):509-15. Doi: 
10-1161/ATVBAHA.113.300156. 
 
In conclusion, smoking can cause direct physical damage to endothelial cells, resulting in remodelling 
and prothrombotic processes with the activation of systemic inflammatory signals that contribute to 
atherogenic vessel wall changes and subsequent cardiovascular disease [10].  
HBP is commonly defined as persistent blood pressure (≥140/90 mm Hg) and is considered a 
modifiable CVD risk factor that affects more than 1 billion people worldwide; it is responsible for 
more than 10 million preventable deaths globally each year [11]. Numerous investigations have 
establishing that many interrelated factors contribute to raised blood pressure, like cardiac output, 
peripheral resistance, salt intake, obesity, insulin resistance, the renin-angiotensin system, the 
sympathetic nervous system and endothelial dysfunction [12]. 
The maintenance of normal blood pressure is dependent on the balance between cardiac output and 
peripheral vascular resistance, which is raised in patients with essential hypertension, specifically in 
the walls of the arterioles which contain SMC. The prolonged smooth muscle constriction increases 
the intracellular calcium concentration and induces structural changes like thickening of the arteriolar 
vessel walls mediated by angiotensin, which leads to an irreversible rise in peripheral resistance [12]. 
The most recent explanation for the pathophysiologic genesis of hypertension is based on the 
endothelial dysfunction associated with the overexpression of the vasoconstrictor peptide endothelin, 
the increased production of angiotensin II (Ang II) and aldosterone, and the reduced generation of 
vasodilators such as NO and prostacyclin, all increasing oxidative stress. Other factors associated 
with endothelial dysfunction are alterations in the expression of the kallikrein-kinin system that 
affects vascular tone, increased activity of the sympathetic nervous system, inappropriate renin 
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secretion with the resultant deficiencies of vasodilators such as prostacyclin, and renal salt handling 
(Figure 2) [13,14]. 
      
 
 
Figure 2. Pathophysiology factors for high blood pressure  
Figure modified from: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG. Pharmacotherapy: a 
pathophysiologic approach. 9th ed. New York, USA: McGraw-Hill Education; 2014. 2586 pag. 
Other modifiable risk factors corresponding to the higher lipid burden associated with atherosclerosis 
and consequently CVD events [15] are the triad of high triglycerides, high low-density lipoprotein 
cholesterol (LDL-C) and low high-density lipoprotein cholesterol (HDL-C) levels, which are strongly 
associated with type 2 diabetes and metabolic syndrome (MetS) [16]. Disturbed lipid metabolism can 
also be the result of a genetic predisposition (hereditary dyslipidaemia), can be an integral part of 
other diseases (secondary dyslipidaemia) or can be the result of external factors (such as a diet rich 
in saturated fats and carbohydrates, reduced body activity, smoking, etc.) [3]. In this case, it is 
believed that dyslipidaemia, specifically high LDL-C levels (calculated using Friedewald´s formula 
≥100 mg/dL), induces the formation of atherosclerotic lesions triggered by a local inflammation in 
the vascular wall [17,18]. Berneis and Krauss [19] suggested that the increased atherogenic potential 
of small dense LDL-C leads to the greater propensity for transport into the subendothelial space, 
increased binding to arterial proteoglycans, susceptibility to oxidative modification, increased levels 
of triglyceride rich lipoprotein remnants and reduced levels of HDL-C. 
The process of the development of atherosclerotic lesions was described in six steps by Katakami 
[20]; this consists of the expression of adhesion molecules for OX as a result of vascular endothelial 
cell injury, which generates the release of cytokines and chemokines. These chemokines attract 
monocytes from the circulation to the injured area, which attach to the endothelium through 
interactions with adhesion molecules. Then, the monocytes penetrate into the subendothelial space 
and mature into macrophages that release cytokines. LDL-C is oxidised and infiltrates the 
subendothelial space (when the levels are high), before being retained in the intima. In this space, the 
macrophages take up and accumulate oxidised LDL-C, leading to foam cell formation and 
atherogenesis. Also, the oxidised lipids trigger the secretion of various growth factors by the 
endothelium. In this point, the vascular SMC of the media transform and migrate into the intima, 
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increasing the extracellular matrix, developing intimal thickening and sclerosis from the death of 
foam cells; this induces the release of these lipids and the formation of lipid-rich aortic plaques 
(atheroma) (Figure 3). 
 
Figure 3. Process of the formation of atherosclerotic lesions 
Figure modified from: Katakami N. Mechanism of Development of Atherosclerosis and Cardiovascular 
Disease in Diabetes Mellitus. J Atheroscler Thromb. 2018; 25(1):27-39. Doi: 10.5551/jat.RV17014. 
 
As described previously, atherosclerotic lesions are formed for different and complex interactions of 
various factors that are accelerated in the presence of T2DM [20].  
T2DM is defined by the International Diabetes Federation (IDF) as a chronic disease characterised 
by insulin resistance, because insulin cannot work properly, meaning that blood glucose levels keep 
rising and releasing more insulin, which triggers hyperglycaemia [21]. According to the World Health 
Organisation (WHO) and the American Diabetes Association (ADA) the diagnostic criteria of T2DM 
is glycated haemoglobin (HbA1c) ≥6.5% and fasting plasma glucose 2-hour post-load plasma glucose 
≥126 mg/dL [22]. Around 281,000 men and 317,000 women worldwide died with T2DM in 2011, so 
this is considered the sixth leading cause of disability worldwide [4, 22]. According to Rydén et al. 
[22], the increase in HbA1c is associated with an increased CVD risk, and the relative risk of the 
occurrence of coronary artery disease (CAD) mortality is higher in patients with T2DM.  
The pathophysiology of T2DM is initiated by β-cell dysfunction to regulate blood glucose 
concentrations, which results in fewer insulin effects on glucose disposal in the skeletal muscle and 
the suppression of endogenous glucose production in the liver. This change in insulin action is 
accompanied by the up-regulation of insulin secretion, which triggers increased compensation of the 
β-cell function and elevated concentrations of blood glucose. The increase in blood glucose 
concentration over time generates glucose toxicity, leading the production of ROS, which are known 
to enhance Nuclear Factor kB (NFkB) activity, which potentially induces β-cell apoptosis [23]. 
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The association between T2DM and CVD can be explained by cumulative glucose exposure and non-
enzymatic reactions with the amino groups of proteins; this is defined as protein glycation, which 
generates early-stage protein glycation products like haemoglobin A1c and glycoalbumin [20, 24, 
25]. These products are submitted to complex reactions such as oxidation, dehydration and 
condensation creating advanced glycation end products (AGEs) that are involved in each step of 
atherosclerosis [20].  
AGEs, through the interaction with cell surface receptors for AGEs (RAGE), evoke OX, and 
inflammatory, thrombotic and fibrotic reactions in vascular wall cells, which are involved in 
atherosclerotic CVD, as AGEs inhibit endothelial cell-derived NO production via suppression of 
endothelial NO synthase expression and increase the formation of peroxynitrite [24]. Likewise, AGEs 
have many functions, like eliciting the activation of NF-kB by promoting vascular inflammation, 
accelerating the migration of monocytes to the subendothelial space and its transformation to 
macrophages, leading macrophages to develop into foam cells, release cytokines, enhance 
vasoconstriction by increasing endothelin-1 levels and induce pathological neovascularisation in 
plaques (Figure 4) [24,25]. 
 
Figure 4. Role of AGEs in the vascular damage 
Figure modified from: Katakami N. Mechanism of Development of Atherosclerosis and Cardiovascular 
Disease in Diabetes Mellitus. J Atheroscler Thromb. 2018; 25(1):27-39. Doi: 10.5551/jat.RV17014. 
 
The fifth most important CVD risk factor for monitoring is obesity, which is defined as excessive fat 
accumulation, and is considered the most important preventable factor; it is associated with 
comorbidities (hypertension, T2DM, dyslipidaemia, obstructive sleep apnoea and certain cancers) 
and CVD mortality, which has been increasing in epidemic proportions in adults and children [3,26]. 
According to the WHO [27], almost 13% of the world´s adults aged 18 years and over were obese in 
2016. 
Obesity occurs when there is increased energy storage in the form of adipose tissue (AT), resulting 
from an imbalance between energy intake and energy expenditure over time [14]. This AT acts as an 
endocrine organ, which plays a substantial role in the chronic inflammatory cell infiltration processes, 
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cytokine production, and cell death that consequently induce insulin resistance, endothelial 
dysfunction, hypercoagulability and systemic inflammation, all of which are atherosclerosis 
promoters [26, 27]. This suggests that the adipokines released by AT interact and influence metabolic 
and immunologic cascades, such as vascular reactivity (leptin, TNF-α and adiponectin), inflammation 
(monocyte chemotactic protein 1 and IL-8) and coagulation (plasminogen activator inhibitor) [28,29]. 
The pathophysiology of obesity described by Rocha and Libby [28] involves the fatty acids and 
triglycerides that accumulate in the liver, muscle and adipose tissue. Excessive amounts of these lipids 
overload the oxidation and storage pathways in the hepatocytes or myocytes, leading to the 
accumulation of fatty acid intermediates (diacylglycerol and ceramide), which inhibit insulin function 
via the activation of serine kinase pathways, in particular the most potent proinflammatory cascades 
IkB kinase (IKK) and c-Jun N- terminal kinase (JNK) [28]. Likewise, free fatty acids might also bind 
toll-like receptors 4 or 13 (TLR4 or TLR13), which are present in adipocytes and macrophages, to 
activate the mitogen-activated protein kinase-activator protein 1 and nuclear factor kB (NF-kB) 
signalling pathways which are responsible for initiating an inflammatory gene response that generates 
insulin resistance (Figure 5) [28]. 
 
Figure 5. Effects of free fatty acids on various organs. 
Figure modified from: Rocha VZ, Libby P. Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. 
2009;6(6):399-409. doi: 10.1038/nrcardio.2009.55. 
 
Another CVD risk factor corresponds to physical inactivity (PI), which is defined as <30 minutes of 
moderate-intensity physical activity on at least 5 days each week, or <20 minutes of vigorous-
intensity physical activity on at least 3 days each week [4]. This factor causes 2 million deaths per 
year and 22% of all ischemic heart disease [3].  
The review by Thijssen, Green and Hopman [30] suggests that PI leads to a rapid and dose-dependent 
inward remodelling of resistance arteries and to a thickening of the arterial walls, which is 
representative of endothelial dysfunction and favours atherosclerotic progression, for the up-
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regulation of vasoconstrictor pathways, rather than the down-regulation of vasodilator pathways as 
an adaptation to PI.  
Different studies have demonstrated that a 2 weeks reduction in daily activity level can generate 
changes in the expression of different genes involved in mitochondrial function, increasing insulin 
resistance in health subjects, in the same way as 9 days of strict bed rest [31,32]. Likewise, 
experimental evidence indicates that PI increases the production of vascular ROS, which contributes 
to endothelial dysfunction, the accumulation of visceral fat mass and impaired glucose and lipid 
metabolism [33,34]. This leads to the inflammation of ectopic fat, which is considered an important 
source of chronic systemic inflammation, promoting the development of insulin resistance, 
atherosclerosis, neurodegeneration and tumour growth and a rise in vascular lipid peroxidation as a 
global marker of OX, which implicates increased superoxide production for the activity of vascular 
NADPH oxidase [33,34]. 
The seventh most important CVD risk factor is poor eating habits (food rich in saturated fats and 
sucrose), related to traditional risk factors such as plasma lipids, blood pressure, or plasma glucose 
levels [4,35,36]. The review by Mozaffarian et al. [37] established that the increase in energy intake 
from trans fatty acids (TFA) (from hydrogenated oils) is associated with a 23% higher incidence of 
coronary heart disease.  
The explanation for this has been established as the effect of TFA on fatty acid metabolism and the 
inflammatory responses of adipocytes, increased levels of soluble vascular-cell adhesion molecule 1 
(sVCAM-1) and soluble intercellular adhesion molecule 1 (sICAM-1) identified on the nitric oxide-
dependent endothelial dysfunction, the regulation of gene transcription, the activation of the kinase 
pathway (Jun N-terminal kinase; JNK), the generation of ROS, and the modulation of monocyte and 
macrophage activity by the increased production of inflammatory mediators; all of these increase the 
risk of atherosclerosis, plaque rupture, sudden death (from cardiac causes) and diabetes (Figure 6) 
[37]. 
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Figure 6: Potential physiological Effects of Trans Fatty Acids. 
 
Figure modified from: Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ, Willett WC. Trans Fatty Acids 
and Cardiovascular Disease. N Engl J Med. 2006;354(15):1601-13. Doi: 10.1056/NEJMra054035. 
 
With this background of the development of CVD risk factors, the American Heart Association 
(AHA) [38], establishing a new strategic impact goal, focused on reducing cardiac heart disease and 
stroke death rates and the prevalence of risk factors by 20%, as well as the improvement of 
cardiovascular health (CVH), which is determined as the factors needed to enhance general health. 
This uses the concept of Ideal Cardiovascular Health, which is defined as the adoption of seven 
metrics comprised of four healthy behaviours (abstinence from smoking, ideal body mass index 
[BMI], physical activity at goal and consumption of a healthy diet that promotes CVH) and three 
physiological health factors (untreated total cholesterol <200mg/dL, untreated blood pressure 
<120/<80 mm Hg, and absence of T2DM). 
Several studies have established that young adults who reach middle age with some health behaviours 
and factors (cholesterol, blood pressure and no cigarette consumption), have a lower incidence of 
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developing CVD and greater longevity, which highlights the importance of identifying and treating 
CVD risk factors at an early age [39-41]. These results may be supported by the Ramirez-Vélez et al. 
[42] systematic review and meta-analysis which established that the incident CVD was lower 
(HR=0.28, 95%CI: 0.23-0.33, p<0.001, I2=72.0%) in individuals who had an ideal CVH profile 
(achieve 5-7 metrics) compared with individuals with a poor ideal CVH profile (meeting only 1-2 
metrics). 
Other studies, like those reported by Guo et al. [43] and Fernández-Alvira et al. [44], determined that 
adherence to ideal CVH may be a useful index in lowering the risk of atherosclerosis. In the same 
line, a prospective study of over 4000 participants has established that the number of ideal CVH 
metrics (accomplishment of 5-6 metrics) is inversely associated with the risk of developing 
subclinical atherosclerosis (represented by carotid plaques (OR: 0.29, 95%CI: 0.18-0.49), increased 
carotid intima-media thickness (OR: 0.44, 95%CI: 0.32-0.61), increased brachial-ankle pulse wave 
velocity (OR: 0.20, 95%CI: 0.13-0.31) and microalbuminuria (OR:0.38, 95%CI: 0.17-0.87)) and 
evaluated in the middle aged population [45]. The results can be explained by the fact that behaviours 
like moderate physical activity, smoking cessation and healthy diets had many beneficial effects on 
blood pressure, glucose homeostasis and dyslipidaemia, and consequently on the prevention of CVD 
events [35,46,47].  
According to the systematic review by Calabrese et al. [35], changes in nutrient composition 
specifically replacing saturated fat, reducing salt intake, and implementing dietary patterns similar to 
the Mediterranean diet (MD) have been shown to be associated with a lower risk of CVD events. The 
results of randomised controlled trials (RCTs) and other systematic reviews have established that the 
replacement of saturated fatty acid with polyunsaturated fatty acid induces a 19% reduction of 
coronary heart disease (RR= 0.81, 95CI: 0.70-0.95, p=0.008) and CVD mortality of 27% (HR: 0.73, 
95CI:0.70-0.77), accompanied by a small reduction in serum total and LDL cholesterol. Likewise, 
this study concludes that the salt reduction generates a significant reduction of CVD incidence by 
20% (p<0.05). 
With respect to the implementation of MD patterns, an umbrella review comprised 13 meta-analyses 
of observational studies and 16 meta-analyses of RCTs, with a total population of over 12,800,000 
subjects; this established that a greater adherence to the MD determines a reduction of CVD risk 
(p<0.01), for the beneficial effects of MD patterns on atherosclerotic risk factors like reduced weight, 
BMI and waist circumference, generating an anti-inflammatory effect in the vascular wall, inducing 
lower total cholesterol levels and blood pressure, and increasing HDL-cholesterol levels [48].  
On the other hand, physical activity, especially exercise training (ET), has been considered a non-
pharmacological therapy that improves arterial function, particularly the endothelium-dependent 
vasodilation for increased NO bioavailability and reduces OX in the microcirculation [49]. According 
to the Physical Activity Guidelines for Americans, adults should undertake at least 150 to 300 minutes 
a week of moderate-intensity or 75 to 150 minutes a week of vigorous-intensity aerobic physical 
activity, and include muscle-strengthening activities of moderate or greater intensity that involve all 
major muscle groups on 2 or more days a week for substantial health benefits [50]. 
From these recommendations, the protective effect of ET against the health risks factors associated 
with obesity is clearly established, independent of changes in body weight or composition [49]. In 
many systematic reviews and meta-analyses of intervention studies, there is a beneficial chronic effect 
(after 12 weeks) of ET on cardiovascular health due to an improved lipid profile, glycaemic control 
and cardiorespiratory fitness [51-54]. The evidence suggests that new modalities of ET like High-
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Intensity Interval Training (HIIT) significantly improved maximal oxygen uptake (VO2 max, SMD: 
1.20, 95%CI: 0.57 to 0.83, p<0.001), systolic and diastolic blood pressure (SBP, SMD: -0.35, 95%CI: 
-0.60 to -0.09, p<0.01; DBP, SMD:-0.38, 95%CI: -0.65 to -0.10, p<0.01), fasting glucose (SMD:-
0.35, 95%CI: -0.62to -0.09, p<0.01), waist circumference (SMD: -0.20, 95%CI: -0.38 to -0.01, 
p<0.05) and % body fat (SMD: -0.40, 95% CI: -0.74 to -0.06, p<0.05) in overweight/obese 
populations [53].  
These beneficial effects of ET on CVH could be explained by the physiological pathway of the ET 
effect on vascular function, which implicates the increased shear stress in the vascular lumen, 
generating the activation of acetylcholine (Ach) signalling and phospholipase activity in endothelial 
cells, due to an increase in the intracellular release of Ca2 and prostaglandin I2 (PGI2), and the 
relaxation of smooth muscle cells via the action of cyclic adenosine monophosphate (cAMP); also, it 
activates phosphoinositide 3-kinase (PI3K) for the vascular endothelial growth factor receptor 2 
(VEGFR2) activity, which induces the phosphorylation of protein kinase B (AKT)-mediated nitric 
oxide synthase endothelium (eNOS) phosphorylation, leading to the increased production of NO 
(Figure 7) [55] 
 
Figure 7. The effect of exercise training on the vascular endothelium. 
 
Figure modified from: Fernandes T, Gomes-Gatto CV, Pereira NP, Alayafi YR, das Neves VJ, Oliveira EM. 
NO signaling in the Cardiovascular System and Exercise. Adv Exp Med Biol.2017;1000:211-245. Doi: 
10.1007/978-981-10-4304-8_13. 
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Metabolic Syndrome (MetS) and Cardiovascular Disease (CVD) 
In the last 3 decades, a new concept has emerged that refers to metabolic disorder (specifically insulin 
resistance) which increases the risk of developing CVD (three times) and diabetes (five times), known 
as metabolic syndrome (MetS) [56,59]. MetS is defined as a cluster of interconnected factors (central 
obesity, elevated blood pressure, impaired glucose tolerance and atherogenic dyslipidaemia) that 
increase the risk of coronary heart disease, stroke and type 2 diabetes [57,58].  
According to the International Diabetes Federation (IDF) [60], the diagnosis of MetS occurs when a 
person has three or more of the following risk factors: a) Central obesity: defined as waist 
circumference for Latin American ethnic ≥90 cm for males and ≥80 cm for females, b) raised 
triglycerides ≥150 mg/dL (1.7 mmol/L), c) reduced HDL-cholesterol: <40 mg/dL (1.03 mmol/L) in 
males and <50 mg/dL (1.28 mmol/L) in females, d) raised blood pressure: systolic BP ≥130 mm Hg 
or diastolic BP ≥85 mm Hg, and e) raised fasting plasma glucose: ≥100 mg/dL (5.6 mmol/L); it is 
estimated that over a billion people in the world had MetS, one-quarter to one-third of which are 
adults [57,61]. 
The relationship between MetS and the development of CVD, understanding CVD as the heart and 
blood vessel disorders that include hypertension, coronary heart disease, cerebrovascular and other 
pathologies associated with it, which are most often related to an atherosclerosis process [1,2], is the 
multiple risk factors referred to its appearance, like atherogenic dyslipidaemia, high blood pressure 
(HBP), obesity, diabetes and physical inactivity [5, 61].  
The predominant underlying risk factors of MetS appear to be insulin resistance and obesity as a 
result of behavioural factors like physical inactivity and excess food fat intake, which generates 
excess energy and is stored as subcutaneous or visceral fat [57,59]. The visceral adipose tissue, 
specifically comprised of white adipose tissue, is metabolically active and secretes dozens of 
hormones, free fat acids (FFA), adipocytokines and inflammatory factors (TNF-α, interleukin 6, 
angiotensinogen, PAI-1, resistin) [61,62,63]. In this sense, the excess of fat accumulation generates a 
destructive effect on glucose metabolism, like insulin resistance and pancreatic beta cell dysfunction, 
defined lipotoxicity, characterised by impaired glucose oxidation, glycogen synthesis and decreased 
glucose transport-phosphorylation as result of the fat accumulation of intracellular toxic metabolites 
of FFA such as triacylglycerol (TAG) [57,64,65].  
Increased plasma FFA concentrations can lead to insulin resistance in the muscle and liver, inhibiting 
insulin signalling, and stimulating an increase in hepatic gluconeogenesis and decreased glucose 
myocellular disposal; over time, this generates decompensation of pancreatic β-cells due to the 
increased need for insulin to overcome myocellular and hepatic insulin resistance [14,57]. The 
pathophysiological explanation of these effects has been determined in many investigations such as 
those by Yazici et al. [64] and Van Pelt et al. [65]; these groups established that FFA promotes insulin 
resistance by activating inflammatory pathways like toll-like receptor 4 (TRL-4) signalling from the 
protein kinase C and JNK-1 pathways in adipocytes, macrophages and skeletal cells. These signalling 
pathways stimulate levels of diacylglycerol, ceramide, LCFA-CoA (long-chain fatty acyl COAs), 
acylcarnitines and oxidative radicals, which reduce GLUT4 translocation to the muscle membrane 
(Figure 8). 
As previously described, insulin resistance also leads to a change in the balance between the 
phosphoinositide 3-kinase (PI3K) and mitogen-activated protein (MAP) kinase pathways. As PI3k 
leads to a reduction in endothelial NO production, resulting in endothelial dysfunction and a reduction 
in GLUT 4 translocation, causing decreased skeletal muscle and fat glucose uptake, and continued 
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ET-1 (endothelin-1) production for the expression of vascular cell adhesion molecules and mitogen 
stimulus to vascular smooth muscle cells [66, 67] 
 
Figure 8. Clustering of MetS characters and the increased risk of T2DM and CVD. 
Figure modified from: Samson SL, Garber AJ. Metabolic Syndrome. Endocrinol Metab Clin North Am. 
2014;43(1):1-23. Doi: 10.1016/j.ecl.2013.09.009. 
 
According to the above, MetS is a major health risk of CVD and T2DM; therefore, its management 
is recommended as a primary intervention, especially in a healthy lifestyle, including moderated 
calorie restriction (CR) to achieve a 5-10% loss of body weight in the first year, moderate increase in 
physical activity and change in dietary composition [60,68].  
CR is a non-pharmacological dietary intervention known to reduce metabolic rate and oxidative 
damage, improve markers of age-related disease, and alter neuroendocrine activities from the weight 
loss effect [69]. The significant decrease in whole-body adiposity and central adiposity measures 
indicate a potential reduction of fat stores and delays the development of age-associated diseases 
(such as type 2 diabetes) for the improvement in β-cell responsiveness to glucose and insulin 
sensitivity, as well as reducing LDL-C and triacylglycerol levels, suggesting a beneficial effect of CR 
in chronic disease risk reduction [69,71]. 
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Some interventional studies such as the CALERIE study [70,71] established that 2 years of 13% 
calorie restriction (reduction in calorie intake from 2467 kcal to 2170 kcal, based on energy 
requirements estimated from doubly-labelled water) significantly reduced multiple cardiometabolic 
risk factors in young, non-obese adults, such as LDL-cholesterol (-0.23 ± 0.04 mmol/L, p<0.0001), 
triglycerides (-0.27±0.04, p=0.0002), systolic (-2.20 ± 0.82 mm Hg, p<0.0011) and diastolic (-3.40 
± 0.62 mm Hg, p<0.0001) blood pressure, and an improvement in C-reactive protein (-0.068±0.018 
mmol/L, p=0.012), insulin sensitivity index (0.099 ± 0.015, p<0.0001), and metabolic syndrome 
score (-2.669 ± 0.193, p<0.0001), and body composition components like weight (-7.6±0.3 kg, 
p<0.001), waist circumference (-6.2±0.4 cm p<0.001), fat mass (-5.4±0.3 kg, p<0.001) and fat free 
mass (-2.0±0.2 kg, p<0.001). 
Combined interventions of CR and exercise have been shown to generate healthy effects on 
cardiovascular risk factors when 3 to 6 months of treatment were reached, by reducing triacylglycerol 
(-22 ± 8 mg/dL, p<0.01), LDL-C (-16.0±5.1 mg/dL, p<0.05) and diastolic blood pressure (-4.0±2.1 
mm Hg, p<0.05) levels and decreasing the estimated 10-year CVD risk by 38% (p<0.001) [72]. Also, 
modest weight loss (3.0% to 4.9%) achieved with exercise is known to enhance insulin activity, 
improve carotid vascular function and atherosclerosis risk factors, and reduce inflammatory 
biomarkers and lipids [73-75].  
The beneficial effect of exercise and CR on health has been determined by the induced reduction in 
fatty acid availability and decrease in the activation of the inflammatory JNK and IKK-NFkB 
pathways, decrease in plasminogen activator inhibitor-1 (PAI-1), tumour necrosis factor receptor-II 
(TNFRII) and HOMA-IR, and increase plasma levels of adiponectin, resistin and sex hormone 
binging globulin (SHBG); these later generate increases in vascular function and regression of the 
burden of atherosclerosis [65,75]. These healthy effects are a result of the training in muscle fibre 
composition to increase the muscle insulin receptor expression, GLUT 4 expression and capacity for 
muscle mitochondria to oxidise fatty acids, which might reduce the accumulation of cytosolic lipid 
molecules and stimulate the mitochondrial biogenesis improving the insulin sensitivity. [74,76,77] 
Muscular strength (MS), MetS and CVH 
 
Physical fitness is catalogued as one of the strongest predictors of individual future health status, 
characterised by the ability to perform daily activities with vigour, through capacities that are 
associated with a low risk for the development of chronic diseases and premature death, especially 
cardiorespiratory fitness and muscular strength (MS) [78,79]. The MS is defined by Artero EG et al. 
[78] as the ability of a specific muscle or muscle group to generate force, for resist repeated 
contractions over time and/or to maintain the contraction of muscle fibres over a short period of time.  
Based on the meta-analysis of Kodoma et al. [80], achieving better cardiorespiratory fitness is 
associated with a lower risk of all-cause mortality and CVD in healthy men and women. In the same 
way, it has been established that reduced muscular strength (MS) increases the risk of mortality for 
all-cause, cardiovascular death and CVD for its association with insulin resistance and β-cell 
dysfunction, independent of cardiorespiratory fitness and adiposity [81-83]. Against this, different 
researchers have suggesting the importance of increasing MS through exercise from childhood for 
which the MS is considered capable of predicting adult MetS outcomes independent of childhood 
cardiorespiratory fitness [82]. As mentioned previously, it has been recognised that handgrip strength 
(HGS) is a simple inexpensive measure of overall MS and useful prognostic indicator of mortality; 
when corrected by body mass, this is associated with a higher prevalence of MetS in adults, 
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independent of age and body size, and is considered to reflect muscle mass as an important health 
indicator [84,85].  
The study by Peterson et al. study [86] established that low normalised handgrip strength (NHS) was 
associated with cardiometabolic disease and physical disabilities in middle-age to older men and 
women; for the loss of every 0.05 kg of MS, the odds of diabetes increases by 49%, of hyperglycaemia 
by 46%, of hypertriglyceridemia by 15%, of low HDL-cholesterol by 22%, of hypertension by 19%, 
and the odds of disability status in American adults by 36% (all p<0.01). Similar works as those 
presented by Ramírez-Vélez et al. [87], who determined the association between the new ratio of 
NHS and increased visceral fat level mass (MVF), and the prevalence of MetS and Ideal CVH, found 
that subjects with lower MVF ratio (Q1) is associated with worse CVH metrics (accomplishment 0-
2 metrics) and a higher prevalence of MetS (32.2%, p<0.0001) in early Colombian adults. 
In this sense, resistance training has been determined as part of the physical activity recommendations 
for the primary and secondary prevention of MetS and associated chronic diseases in adults, with a 
role of skeletal muscle in the metabolism of glucose and triglycerides [78,88].  
Several studies have elucidated the health impact of the physical activity and exercise to increase 
mitochondrial oxidative capacity and skeletal muscle capillarisation, while generating anti-
inflammatory effects, which contribute to improved insulin signalling, glucose uptake and metabolic 
flexibility [89]. The interventional study Tomeleri et al. [90] has shown that 12 weeks of resistance 
training reduce MetS components (glucose: -20.4%, waist circumference: -1.5% and systolic blood 
pressure: -6.2%, all p<0.05) and inflammatory biomarkers (CRP: -28.6%, TNF-α: -21.6%, all 
p<0.05), can generate different body composition and physical fitness parameters, like reduced body 
fat (-6.0%, p<0.01), increased skeletal muscle mass (+6.1 kg, p<0.01) and MS (+14.0, p <0.001) in 
older women. 
In this sense, the mechanism responsible for the improvement in MetS parameters is speculated, 
identifying multiple factors, such as the IL-6 released by muscle contraction, which has anti-
inflammatory properties and stimulates the production of anti-inflammatory cytokines such as IL-1ra 
and IL-10; together, these lead to the reduction of FFA, suppress TNF-α expression, down-regulate 
TLR 4 expression and reduce the activation of NF-kB signalling and cytokine production, 
consequently improving glucose homeostasis [90, 91]. IL-6 is a myokine produced by skeletal muscle 
during physical activity in the muscle which is activated through the gp130 receptor, AMP-kinase (in 
charge of stimulates fatty acid oxidation) and PI3-kinase to increase glucose uptake and fat oxidation, 
besides when the IL-6 is released peripherally with different effects in organs like the liver and 
adipose tissue, thus increasing hepatic glucose output and lipolysis during exercise, respectively 
(Figure 9) [92-94]. 
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Figure 9. Biological role of contraction-induced IL-6. 
Figure modified from: Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived 
interleukin-6. Physiol Rev. 2008;88(4):1379-406. Doi: 10.1152/physrev.90100.2007. 
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Aims and layouts of the thesis 
 
Study 1 (Chapter 2) 
Tittle: Percentage of body fat and fat mass index as a screening tool for metabolic syndrome (MetS) 
prediction in Colombian university students 
Research aim: To explore thresholds of body fat percentage (BF%) and fat mass index (FMI) for the 
prediction of MetS among Colombian University students. 
Hypothesis: thresholds of BF% and FMI predict of MetS among Colombian University students. 
 
Study 2 (Chapter 3) 
Tittle: Muscle strength cut-off for the detection of metabolic syndrome in a nonrepresentative sample 
of collegiate students from Colombia 
Research aim: to determine cut-offs of normalized grip strength (NGS) for the detection of MetS in 
a large nonrepresentative sample of a collegiate student population from Colombia. 
Hypothesis: thresholds of normalized grip strength predict of MetS in a sample of a collegiate student 
population from Colombia 
 
Study 3 (Chapter 4) 
Tittle: Ideal cardiovascular health, handgrip strength, and muscle mass among college students: The 
FUPRECOL Adults Study. 
Research aim: To determinate the relationship between handgrip strength, muscle mass, and ideal 
Cardiovascular Health among Colombian college students. 
Hypothesis: Higher scores on 7 metrics for ideal CVH, indicating better CVH, are associated with 
higher levels of handgrip strength and muscle mass in Colombian college students. 
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Chapter 2: Percentage of body fat and Fat Mass Index as a screening tool for Metabolic 
Syndrome prediction in Colombian University Students. 
 
1. Introduction 
 
With increasing prevalence worldwide, obesity has become a significant public health issue [1]. 
Obesity has been linked to a number of cardiovascular disease (CVD) risk factors including metabolic 
syndrome (MetS) [2]. In Colombia, it is estimated that over 50% of adults are overweight or obese 
and the obesity epidemic has been associated with obesogenic factors, such as an intake of energy-
dense diets, a sedentary lifestyle, and low levels of physical activity [3,4]. 
In this context, there is growing evidence that suggests that the way in which fat is distributed 
contributes different effects on the cardiometabolic risk associated with obesity [3-5]. In addition, 
measures of central body obesity, such as waist circumference and waist-hip ratio, have been 
suggested as being more strongly related to MetS risk compared to body mass index (BMI) [4,5]. 
Aside from age or sex, excess body fat is the strongest determinant of an individual´s risk of 
developing countries such as Colombia [2,11]. Recently, more research has examined the potential 
role of body composition measurements in health monitoring [12,13]. Bioelectrical impedance 
analysis (BIA) is the method that is most frequently used to assess body composition and calculate 
BF% in clinical practice, given its accuracy, simplicity, low cost, and excellent correlation with DCA, 
CT, or magnetic resonance image (MRI) [14,15]. 
Alternative simple and inexpensive approaches for assessing body adiposity have been suggested. A 
recen study highlighted the usefulness of the fat mass index (FMI), measured as kg/m2, as an indicator 
of the function of adipose tissue as a surrogate marker of cardiovascular risk in young adults [16]. 
However, BF% and FFM are known to change with height, weight, sex and age. Along this line, 
Valitallie et al. [16] proposed an FMI that considers an individual´s height. FMI, like BMI except that 
it uses a two-compartment model, merits reappraisal and appears to be of interest in the classification 
of overweight, obese and underweight patients [17]. Previous research has evaluated the applicability 
of FMI in the prediction of MetS and has highlighted its close relation with the components of MetS 
[17]. However, only a few studies have focused on the differential impact adiposity levels [18-24] in 
young adults when examining the link between fat and the risk of MetS. 
Understanding the specific fat distribution associated with MetS risk is important to improve the 
interventions that are currently more focused on overall weight loss [5,6]. Our study proposes a 
gender-specific fat index based on BIA as a way of estimating the fat mass and body adiposity 
dysfunction associated with MetS. Apart from the study of Liu et al. [17], this is the first study in 
Colombian young adults (university students) to investigate the association between fat mass by BIA 
and MetS components. Based on the IDF definition of MetS [2], the aim of the study was to explore 
thresholds of BF% and FMI for the prediction of MetS among Colombian university students.  
2. Methods 
2.1 Study Design and Sample Population 
During the 2014-2017 academic years, we reviewed a cross-sectional component of the FUPRECOL 
study that investigated the association between muscular strength and metabolic risk factors in 
Colombian collegiate students. The FUPRECOL study aimed to establish the general prevalence of 
cardiovascular risk factors, including anthropometric and metabolic markers, in the study population 
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and to examine the relationships between physical fitness levels, body compositions, and 
cardiometabolic risk factors. We recently published a complete description of the FUPRECOL study 
design, methods, and primary outcomes for our current cohort [2]. The sample consisted of adults 
(men: n=107; women: n=1128). We removed cases due to missing (n=37, 2.0%) or erroneous data 
entry (n=83, 4.5%) and those which had neither age nor a valid date of birth recorded (n= 28, 1.5%), 
limiting the analytical sample to 1687 volunteers, which was 63.4% women and a mean age of 20.6 
years. The subjects, whose ages ranged from 18 to 35 years, were all of low to middle socioeconomic 
status (SISBEN levels: 1-4 on a scale of 1-6 as defined by “The System of Identifying Potential 
Beneficiaries of Social Programs”, called SISBEN). The system takes into account sociodemographic 
characteristics including family composition, employment status, family income, and educational 
level; living conditions, including construction type and materials; and access to public utilities, 
which involves sewers, electricity, potable water, and garbage collection. They were enrolled in 
public or private universities in the capital district of Bogota, Boyacá, and Cali, Colombia. 
Exclusion criteria included the following: medical or clinical diagnosis of a major systemic disease 
including malignant conditions such as cancer, type 1 or 2 diabetes, high blood pressure, 
hypothyroidism or hyperthyroidism; a history of drug or alcohol abuse; regular use of multivitamins; 
chronic inflammatory conditions including rheumatoid arthritis, systemic lupus erythematosus, 
multiple sclerosis; infectious conditions; and a BMI ≥ 35kg/m2. Volunteers received no 
compensations for their participation. 
2.2 Data collection 
Subjects were screened for inclusion in the study via personal interviews. Interview questions 
collected consisted of health status, medical history, CVD risk factors, and lifestyle. After completing 
another general information questionnaire, participants were instructed to wear shorts and a T-shirt 
to the physical exam. They were also required to remove all worn jewelry and metal objects. Once 
the subjects were barefoot and in their underwear, their body weight (kg) was measured using an 
electric scale (Model Tanita® BC- 418®, Tokyo, Japan) with a range of 0-200 kg and with an 
accuracy of within 100 g. Height was measured with a portable stadiometer with a precision of 0.1 
cm and a range of 0-2.5 m (Seca ® 274, Hamburg, Germany). BMI was calculated by using the 
formula proposed by the Quetelet where BMI= body mass (kg)/ height (m2). Body mass index status 
was evaluated according to the World Health Organization (WHO) criteria [24]. The waist 
circumference (WC) (cm) was measured as the narrowest point between the lower costal border and 
the iliac crest. When this point was not evident, it was measured at the midpoint between the last rib 
and the iliac crest, using a metal tape measures (Lufkin W606PM®, Parsippany, NJ, USA), in 
accordance with the International Society for the Advancement of Kinanthropometry guidelines [25]. 
The evaluation process was carried out by a team of professionals (four physical therapy professors) 
with extensive experience in anthropometric measurement. Two percent of the sample was measured 
twice in order to ensure quality of measures. The technical error of measurement (TEM) values was 
less than 2% for all anthropometric variables. 
BF% and FMI were determined for Bia by a tetrapolar whole body impedance (Tanita Model BC-
418®, Tokyo, Japan). A detailed description of the BIA technique can be found in a previous study 
[2]. For the calculation of intra-inter observer TEM, at least 50 subjects needed to be measured (30 
men, 20 women, aged 22.3 ± 2.1 years). The corresponding intra-observer technical error (% 
reliability) of the measurements was 95%. FMI was then calculated by dividing each subject´s fat 
mass (kg) by the square of his or her height (m), as previously described [17]. In a sub-sample (48 
adults, 54% women, range mean age = 20 to 40 years old), we verified the validity of BIA for 
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predicting BF% in Colombian adults using DXA as a reference. Our analysis showed a strong 
agreement between the two methods, as reflected in the range of BF% (Lin´s concordance correlation 
coefficient= 0.943 (95%CI= 0.775 to 0.950, p= 0.041) and bias- 0.6 (SD 2.2; 95% CI= -5.0 to 3.7). 
In line with our findings, a previously study has shown a high correlation between fat mass 
determined by BIA and that obtained by a CT scan and DXA [14,15,26]. Thus, these results show 
that BIA and DXA are comparable methods for measuring body composition with lower/higher body 
fat percentage. 
2.3 Metabolic Syndrome diagnosis 
After the subjects had fasted for 10-12 h, blood samples were obtained from capillary sampling 
between 6:00 a.m. and 9:00 a.m. Participants were asked not to engage in prolonged exercise in the 
24 h prior to testing. The biochemical profile included the following: (i) high-density lipoprotein 
cholesterol (HCL-C); (ii) triglycerides; (iii) low-density lipoprotein cholesterol (LDL-C); (iv) total 
cholesterol; (v) glucose fasting by enzymatic colorimetric methods (CardioChek PA®, Polymer 
Technology Systems, PTS, Indianapolis, IN, USA). The inter-assay reproducibility (coefficient of 
variation) was determined from 16 replicate analyses of 8 capillary blood pools over a period of 15 
days. The percentages obtained were 2.6% for triglycerides; 2.0% for total cholesterol, 3.2% for 
HDL-C, 3.6% for LDL-C, and 1.5% for fasting glucose.  
Blood pressure was taken on the left arm at the heart level with an automatic device Omron M6 
Comfort (Omron® Healthcare Europe B.B., Hoofddorp, The Netherlands) while the participants were 
sitting still. The Blood pressure monitor cuff was placed two to three fingers-widths above the bend 
of the arm and a two-minute pause was allowed between the first and second measurements with a 
standard cuff for an arm circumference of 22-32 cm. 
MetS was defined in accordance with the updated harmonized criteria of the IDF [2]. Participants 
were considered to have MetS if they showed three or more of the following: (1) abdominal obesity 
for individuals (WC ≥ 80 cm in women and ≥ 90cm in men) [27]; (2) hypertriglyceridemia (≥ 150 
mg/dL); (3) low HDL-C (<50 mg/dL in women and <40 mg/dL in men): (4) high blood pressure 
(systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85mmHg); (5) high fasting glucose 
(≥100 mg/dL). 
2.4 Lifestyle co-variables 
A standardized questionnaire, FANTASTIC lifestyle, was used to collect comprehensive information 
about substance use via a personal interview with participants [28]. Alcohol consumption and 
smoking status were defined as subjects how had consumed any alcoholic beverage ≥ 1 times per 
week, and those who had smoked ≥ 10 cigarettes per week, for at least six months, as previously 
described by Ramírez-Vélez et al. [28]. Participants who exercised three or more times a week for > 
30 min were categorized as physical active (PA), and those who exercised less than three times a 
week were considered insufficiently physically active. The accuracy of information about lifestyle 
co-variables obtained from the FANTASTIC questionnaire has been validated by different cross-
sectional studies and described in detail elsewhere [28,29]. 
2.5 Ethics statement 
Informed consent was obtained from each participant. The protocol was based on the Helsinki 
Declaration Accord (World Medical Association for Human Subjects). Moreover, ethical approval 
was obtained from the Universidad Manuela Beltrán (UMB N° 01-1802-2013). 
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2.6 Statistical Analysis 
Participants´ characteristics obtained were given as mean values and standard deviation (SD). 
Histograms and Q-Q plots were used to verify the normality of the selected variables. Independent 
two-tailed t-test for continuous variables, and chi-square (x2) test for categorical variables, were used 
to examine sex differences or MetS grouping. The relationships between BF%, FMI and MetS 
components were tested by means of partial correlation coefficients. This analysis was adjusted by 
age, sex, tobacco, and alcohol consumption, and PA levels. To predict MetS with BF% and FMI, we 
used area under the curve (AUC), ranging between 0 and 1 ( a Worthless and a perfect test, 
respectively), which is a global indicator of diagnostic performance, and represents the ability of the 
test to correctly classify participants with high risk MetS by p-values <0.01 and an AUC >0.80. The 
positive likelihood ratio LR (+) and the negative likelihood ratio LR (-) were also determined. Cutoff 
points were chosen based on the highest Youden index, i.e., the point on the receiver operating 
characteristic curve (RPC) that is farthest from the line of equality [30]. Data analysis was performed 
using the Statistical Package for the Social Sciences for Windows SPSS, version 21.0 (SPSS Inc., 
Chicago, IL, USA). Statistical significance was set at p <0.05. 
3. Results 
3.1 Descriptive characteristics 
Descriptive characteristics of the participants are presented in Table 1. The final sample had a mean 
age of 20.6 years (SD 3.0; range 19-24 years) with 63.4% of participants being women. Women were 
found to have significantly lower height, WC, blood pressure, triglycerides, and PA than men 
(p<0.05). The prevalence of MetS was higher in men than in women at 11.2% vs 5.3% (p<0.001). 
Table 1. Characteristics among a sample of college students from Colombia (mean ± SD) or 
frequency (%) 
Characteristic Mean (n=617) Women (n=1070) P Value 
Anthropometric 
Age (years) 20.6 ± 2.2 20.6 ± 2.0 0.843 
Weight (kg) 58.9 ± 10.0 69.9 ± 12.4 <0.001 
Height (cm) 159.8 ± 6.1 172.5 ± 6.7 <0.001 
WC (cm) 78.4 ± 9.5 71.5 ± 7.9 <0.001 
BMI (Kg/m2) 23.2 ± 3.7 23.2 ± 3.7 0.356 
Body fat (%) 15.7 ± 6.7 27.0 ± 7.2 0.028 
FMI (kg/m2) 3.9 ± 2.3 6.5 ± 2.7 <0.001 
Body mass index status n (%) * 
Underweight 34 (5.5) 71 (6.7) <0.001 
Normal weight 425 (68.8) 725 (57.8) <0.001 
Overweight 128 (20.8) 220 (20.5) <0.001 
Obese 31 (5.0) 54 (5.0) <0.001 
Blood pressure 
Systolic blood pressure (mmHg) 120.83 ± 13.0 111.28 ± 11.1 <0.001 
Diastolic blood pressure (mmHg) 74.83 ± 11.4 71.78 ± 9.3 <0.001 
Mean arteria pressure (mmHg) 97.83 ± 10.8 91.53 ± 8.9 <0.001 
Metabolic biomarkers 
Total cholesterol (mg/dL) 132.26 ± 30.8 146.27 ± 33.3 0.212 
Triglycerides (mg/dL) 93.01 ± 8.7 88.10 ± 43.7 0.011 
LDL-C (mg/dL) 38.92 ± 10.4 43.98 ± 12.8 <0.001 
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HDL-C (mg/dL) 81.89 ± 26.5 87.85 ± 26.2 0.589 
Glucose (mg/dL) 84.36 ± 12.2 85.99 ± 11.6 0.002 
Metabolic Syndrome n (%) * Yes 73 (11.2) 59 (5.3) 0.001 
Life-style n (%) * 
Tobacco (≥10 cigarettes per week) 183 (29.7) 213 (19.9) 0.289 
Alcohol (≥ 1 times per week) 294 (47.6) 381 (35.6) 0.358 
PA (Three or more times a week for 
> 30 min) 213 (34.5) 228 (21.3) 0.011 
Continuous variables are reported as mean values (standard deviations) and categorical variables are 
reported as numbers and percentages in brackets. Signiﬁcant between-sex differences (t-tests or * chi-
square test χ2). WC: waist circumference; BMI: body mass index; FMI: fat mass index; LDL-C: low-
density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; PA: physical activity. 
 
 
At least one MetS component was found in 818 participants (48.5%), two MetS components were 
present in 341 participants (20.2%), three MetS components were found in 126 participants (7.7%), 
and four or more components of MetS were present in 80 participants (4.7%) (Figure 1) 
 
Figure 10. Distribution of the prevalence of metabolic syndrome components 
according to sex. 
 
3.2 Clinical characteristics and distribution by MetS status 
Independent of sex, participants with MetS had significantly higher weight, body mass index, WC, 
BF%, FMI, and total cholesterol and triglyceride levels (p<0.01) (Table 2). Furthermore, participants 
without MetS were more active (34.5% vs. 17.8% for men, and 21.1% vs. 6.8% for women, p<0.01) 
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Table 2. The descriptive characteristics of participants with and without MetS in both 
sexes. 
Variable 
Men (n= 617) Women (n= 1070) 
MetS 
(n = 73) 
Non-MetS 
(n = 544) 
P 
Value 
MetS 
(n = 59) 
Non-MetS 
(n = 1011) 
P 
Value 
Anthropometric 
Age (years) 21.7 ±3.4 20.4±3.1 0.229 22.3±3.8 20.5±2.8 <0.001 
Weight (kg) 80.8±15.8 67.3±10.7 <0.001 76.4±13.8 57.4±8.8 <0.001 
Height (cm) 172.7±7.5 172.1± 6.6 0.129 161.1±5.6 158.9±5.8 0.902 
WC (cm) 89.5±11.6 76.7±8.0 <0.001 84.9±8.8 70.5±7.1 0.145 
BMI (Kg/m2) 27.0±4.7 22.6±3.1 <0.001 29.3±4.7 22.7±3.3 <0.001 
Body fat (%) 23.5±7.5 14.5±5.7 0.005 37.3±6.0 26.2±6.8 0.234 
FMI (kg/m2) 6.6±3.1 3.4±1.8 <0.001 11.2±3.4 6.1±2.4 <0.001 
Body mass index status n (%) * 
Underweight 4 (0.6) 30 (5.0) <0.001 0.00 (0.0) 71 (6.6) <0.001 
Normal weight 16 (2.6) 408 (66.1) <0.001 8 (0.8) 717 (67.0) <0.001 
Overweight 37 (6.0) 91 (14.8) <0.001 23 (2.1) 197 (18.4) <0.001 
Obese 16 (2.6) 15 (2.4) <0.001 28 (2.6) 26 (2.4) <0.001 
Blood pressure       
Systolic blood pressure 
(mmHg) 131.0±11.9 119.3±12.4 0.461 123.5±11.0 110.3±10.6 0.809 
Diastolic blood pressure 
(mmHg) 83.6±10.8 73.5±10.1 0.160 81.6±13.8 71.1±8.6 0.237 
Mean arteria pressure 
(mmHg) 107.3±10.2 96.4±10.1 0.176 102.6± 9.2 90.7±8.4 0.518 
Metabolic biomarkers 
Total cholesterol 
(mg/dL) 146.0±39.6 130.2±29.1 <0.001 153.4±33.7 145.7±33.3 0.955 
Triglycerides (mg/dL) 163.0±75.9 83.0±33.7 <0.001 139.8±66.6 84.9±40.2 <0.001 
LDL-C (mg/dL) 31.3±5.9 40.1±10.6 <0.001 36.5±9.04 44.5±12.8 0.002 
HDL-C (mg/dL) 86.0±30.8 81.3±26.1 0.077 89.6±28.4 87.6±26.2 0.571 
Glucose (mg/dL) 92.4±13.4 83.1±11.6 0.063 92.6±14.4 85.5±11.4 0.142 
Life-style n (%) * 
Tobacco (≥10 cigarettes 
per week) 19 (26.0) 155 (28.5) 0.769 5 (8.5) 198 )19.6) 0.088 
Alcohol (≥ 1 times per 
week) 36 (49.3) 294 (54.0) 0.563 22 (37.3) 394 (38.7) 0.378 
PA (Three or more times 
a week for > 30 min) 13 (17.81) 188 (34.5) 0.005 4 (6.8) 213 (21.0) 0.018 
Continuous variables are reported as mean values ± standard deviations and categorical 
variables are reported as numbers(percentages). Signiﬁcant between-sex differences (t-tests 
or*chi-square test χ2). WC: waist circumference; BMI: body mass index; FMI: fat mass 
index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein 
cholesterol; PA: physical activity. The mean blood pressure was calculated using the 
following formula: (systolic blood pressure + (2×diastolic blood pressure))/3. 
 
 
Table 3 shows the partial correlation between BF%, FMI and MetS components. Overall, BF% and 
FMI were weakly positively correlated with all MetS parameters (all p<0.05), except HDL, which 
was negatively correlated. 
Table 3. Results of the partial correlation analysis between body fat percentage (BF%), 
fat mass index (FMI), and MetS components. 
Variable Glucose (mg/dL) 
HDL-C 
(mg/dL) 
Triglycerides 
(mg/dL) 
Total 
Cholesterol 
(mg/dL) 
MAP 
(mmHg) 
WC 
(cm) 
FMI 
(kg/m2) 
Body fat (%) 0.188* -0.239** 0.230** 0.279** 0.276** 0.827** 0.960** 
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FMI (kg/m2) 0.113** -0.256** 0.230** 0.162* 0.272** 0.860** 1 
WC (cm) 0.106* -0.219 0.248 0.858** 0.271** 1  
Mean blood 
pressure 
(mmHg) 
0.004 -0.022** 0.179** 0.259** 1   
Total 
cholesterol 
(mg/dL) 
-0.008 -0.341** 0.241** 1    
Triglycerides 
(mg/dL) 0.125** -0.170** 1     
HDL-C 
(mg/dL) -0.158** 1      
Glucose 
(mg/dL) 1       
Analysis adjusted by co-variables: age, sex, tobacco, alcohol, and physical activity. *p< 0.05; **p<0.01. 
WC: waist circumference; FMI: fat mass index; HDL-C: high-density lipoprotein cholesterol; MAP: mean 
arterial pressure. The mean blood pressure was calculated using the following formula (Systolic blood 
pressure + (2 x diastolic blood pressure))/3 
 
3.3 Optimal cut-off values in the screening of MetS 
The ROC analysis showed that BF% and FMI parameters could be used to detect MetS according to 
the IDF criteria among Colombian university students (Table 4; Figure 2). Since multiple levels of 
risk were desired, the selection of the resulting cut-off values was based on multiple combinations of 
sensitivity. The focus was on higher sensitivity for the BF% and FMI thresholds in an effort to identify 
the majority of cases of MetS according to the IDF criteria. In men, the cut-off point values of 25.5% 
for BF% provided a sensitivity of 96.1%, an LR (+) value of 2.3, a specificity of 57.5%, and an LR 
(-) value of 0.06. For FMI, the cut-off value of 6.9 kg/m2 provided a sensitivity of 95-8%, an LR (+) 
value of 2.2, a specificity of 56.2%, and an LR (-) value of 0.07. With respect to BF% among the 
women in the study population, the cut-off point value of 38.9% provided a sensitivity of 97.4%, an 
LR (+) value of 2.2, a specificity of 55.9%, and an LR (-) value of 0.04. The ROC curve for FMI was 
also obtained, using a cut-off value of 11.8 kg/m2, a sensitivity of 97.6%, an LR (+) of 2.2, a 
specificity of 56.9%, and an LR (-) of 0.04. 
 
Figure 11. ROC curves for BF% and FMI for prediction of the prevalence of MetS 
according to IDF criteria in men and women. 
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Table 4. Parameters of the ROC curves analysis for the diagnostic performance of body fat 
percentage (BF%) and fat mass index (kg/m2) in identifying high risk of MetS according to the 
IDF criteria in men and women. 
Parameter BF% FMI 
High risk of 
MetS 
Men 
AUC 0.835 0.838 
95% CI 0.779-0.891 0.779-0.892 
P Value <0.001 <0.001 
Cut-off 25.5 6.9 
Sensitivity (%) 96.1 95.8 
Specificity (%) 57.5 56.2 
LR (+) 2.3 2.2 
LR (-) 0.06 0.07 
Women 
AUC 0.887 0.889 
95% CI 0.842-0.932 0.844-0.933 
P Value <0.001 <0.001 
Cut-off 38.9 11.9 
Sensitivity (%) 97.4 97.6 
Specificity (%) 55.9 56.9 
LR (+) 2.2 2.2 
LR (-) 0.04 0.04 
AUC: area under the curve; CI: confidence interval; LR (+): positive likelihood ratio; LR (-): negative 
likelihood ratio. 
 
 
4. Discussion 
In our study, we found that the MetS prevalence was higher in men than in women (11,2% vs 5.3%, 
p<0.001), which is an intermediate value compared to those reported in local and international studies, 
ranging from 2 to 13% [31-33], that BF% and FMI were positively correlated to MetS components 
(p<0.05), and that the ROC analysis showed that both the BF% and FMI had a moderate 
discriminatory power in the identification of MetS among Colombian university students. 
The higher prevalence of MetS, at 11.2%, seen in male subjects in our results does not coincide with 
Ruano-Nieto et al. [34] who found that the estimated prevalence of MetS was 8.4% for women and 
6.1% for men in a population of Ecuadorian university students. The overall prevalence of MetS in 
our study, at 7.7%, was also greater than that in other Latin American countries such as Chile at 4.9% 
and Argentina at 4.1% [35,36]. Clearly, the prevalence of MetS could differ between studies 
depending on the MetS cluster used, the design method, and the target population. In this study, we 
used the IDF and AHA/NHLBI [2] joint statement, as it was an international attempt to harmonize 
the definition of MetS; central obesity is not an obligatory component of this definition and it is 
ethnic-specific. 
Of those components, abdominal obesity, the most prevalent manifestation of MetS, is a marker of 
dysfunctional adipose tissue, and is of central importance in clinical diagnosis [37-41]. Our results 
show correlation between BF%, FMI and all of the cardiometabolic biomarkers analyzed, including 
mena arterial pressure, glucose, HDL-C, LDL.C, triglycerides, and total cholesterol (p<0.05 for all). 
These findings agree with Knowles et al. [19], who studied a population of young Peruvian adults 
and found significant correlations between the fat parameters and the above-mentioned 
cardiometabolic biomarkesr. Blood lipid disorders and adipose tissue are the key etiologic defects 
that define MetS; we found all fat indices used in this study were associated with BF%. In contrast, 
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other researchers such as Schuster et al. [40], who studied a sample of 444 young adults in Brazil, 
only found correlations between the BF% and glucose, HDL-C, and triglycerides. Our result may be 
different due to degree and the prevalence varying on the basis of ethnicity, genetic susceptibility, 
lifestyle, and geographic location. In addition, our results showed lower values of weight, height, and 
WC in women compared to men. This aligns with Liu et al. [17], who studied a population of 1698 
adults in China. In all likelihood, these differences in body composition were due to sexual 
dimorphism [31] and diet [34]. Sex-specific hormones are another possible explanation. For example, 
the triglyceride levels and blood pressure were also lower among women in comparison to men. In 
this context, much of the risk of MetS associated with sex can be explained by the change is steroid 
hormone levels and the metabolism of carbohydrates and lipids [39]. An increase in total fat and the 
distribution of central fat, resulting from alterations in biomarker-disease, such as fasting glucose 
triglycerides, and ferritin, which are mediators of MetS, has been reported in female Hispanic/Latino 
adults [40]. This coincides with previous research, in which this finding was correlated with lower 
cardiovascular morbidity and dysfunctional adipose tissue in women [39,41]. Furthermore, the 
observation of ongoing changes in body composition by sex and its relationship with obesity has 
demonstrated that obesity affects individuals no matter their muscle mass, fat mass, height, and 
weight [41]. 
The AUC values for the MetS ROC analysis, at 0.835 for men and 0.838 for women, indicate that 
BF% has moderate diagnostic capabilities to identify subjects with MetS (≥3 risk factors). 
Interestingly, when considering MetS in our study, FMI showed the greatest AUC to predict MetS 
risk in women compared to men. Results show that metabolic disorders are present in young adult 
independent of age, smoking, physical activity, or fitness levels [42]. There is a growing interest in 
suggesting cut-off points for body fat levels for the early detection of CVD risk. Future longitudinal 
studies should be carried out to understand the role of different levels of adiposity on CVD risk 
stratification within a college population. 
In contrast, another study carried out by Mohammadreza et al. [43] among Iranian adults found that 
BF% was not as effective a parameter for predicting MetS as other anthropometric indexes such as 
BMI, waisto-to height ratio, and waist-to hip ratio. In this same line, Mousa et al. [44] studied a 
population of young adults and found that the predictive power of BF% and BMI for screening Mets 
was limited. This discrepancy in result could be explained by the heterogeneity of the sample 
population. Consequently, the applicability and usefulness of BF% and FMI in the prediction of MetS 
require further studies of different populations and ethnic groups. These results are partially consistent 
with previous studies that showed BF% was positively correlated with single metabolic risk factors, 
such as BMI and triglycerides, and negatively correlated with HDL cholesterol in men, but not in 
women [45,46].  
To our knowledge, few studies have explored the use of FMI as a proxy of obesity. In a study of 538 
Mexican American college students (373 women and 165 men), the validity of FMI and BMI against 
BF% with BIA as the reference method was evaluated [47]. Correlations between FMI and BF% 
resulted in correlation coefficients of 0.976 in men (p<0.001) and 0.992 in women (p<0.001). 
However, similar to our findings, the correlations between FMI and PBF were higher (r= 0.960, 
p<0.01). In a study of 2986 healthy white men and 2649 white women, age 15 to 98 years in 
Switzerland, the men FMI in the overall age group was 4.9 (1.) kg/m2 in men and 6.6 (2.4) kg/m2 in 
women [48], compared to our results, of 6.6(3.1)kg/m2 in men and 11.2 (3.4)kg/m2 in women without 
MetS. This difference can be explained by the fact that FMI cutoffs in the Swiss group were derived 
from BMI and not from MetS cutoff. On the other hand, in the Petz et al. study [47], the median FMI 
51 
 
in the overall age group was 7.3 (interquartile range 4.5) kg/m2 in men and 9.0 (interquartile range 
5.9) kg/m2 in in women. Our FMI means fell within the lower range of the Mexican American normal 
FMI ranges in both men and women. This was expected, as South Americans have a lower percentage 
of body fat across all age groups when compared to non-Hispanic whites, Mexican American, and 
non-Hispanic blacks [49]. In a subsequent study from the same group (5635 apparently healthy adults 
from a mixed non-randomly selected Caucasian population) in Switzerland, obesity was defined as 
an FMI greater than 8.2 kg/m2 in men and 11.8 kg/m2 in women [50], which are similar than our FMI 
cutoffs of ≥6.9 kg/m2 in men and ≥11.8 kg/m2 in women in our study. These findings, although 
limited, show an interesting agreement with our results, which collectively contribute to the concepts 
of developing one set of recommended ranges that are not affected by height. 
Our results have public health and clinical implications as college populations have been reported as 
a period in life when several behavioral and metabolic changes occur. These changes, in addition to 
the adoption of a Western lifestyle and diet, have led to a rise in the prevalence of overweight and 
obese Colombians, particularly among university students [32,51]. Further studies are needed to 
identify clinical characteristics in young adults that could be used in screening tests to predict MetS 
risk in adulthood. 
Th principal limitation of this study was the use of cross-sectional data. Furthermore, it is also true 
that the hydration status of the participants could have modified the results of the BF% measured with 
BIA. Most BIA prediction equations assume that the fat mass and fat-free mass consist of 73% water 
[52]. These major limitations of the BIA method remain unresolved. Secondly, the assessment of 
other biomarkers, such as insulin, adiponectin, and c-reactive protein levels, which could have shown 
additional information about prognostic assessment, was not performed. These and other questions 
deserver further investigations by future well-designed longitudinal studies. 
The main strength of our study is the fact that our study compared the predictive power of both BF% 
and FMI while providing cut-off values for the prediction of MetS in university students from 
Colombia. Considering the wide use of BIA methods and their extension to assess body composition, 
our study has important implications for evaluating CVD and metabolic risks in high-risk subjects, 
such as those with MetS. 
5. Conclusions 
In conclusion, BF% and FMI had a moderate discriminatory power in the identification of MetS in 
Colombian university students. Apart from the differences between our cut-off points and those 
reported in other research in geographically different populations, this study reports the first cutoff 
points for identification of MetS by BF% and FMI in Colombian young adults. We demonstrated that 
a BF% ≥ 38.9% in women and ≥25.5% in men, and an FMI ≥11.8 kg/m2 in women and ≥ 6.9 kg/m2 
in men, are thresholds that could be used to predict Colombian young adults at high risk of MetS. 
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Chapter 3: Muscle strength cut-offs for the detection of Metabolic Syndrome in a 
nonrepresentative sample of collegiate students from Colombia. 
 
1. Introduction 
Muscular weakness, as determined with the use of a handgrip dynamometer, is recognized as a marker 
of health risk, similar to that observed for conventional risk factors. [1-3] López-Martínez et al. [3] 
demonstrated that muscle strength is negatively associated with metabolic syndrome (MetS) in young 
adults. Additionally, in a prospective study (follow-up in young adulthood for 20 years), Fraser et al. 
[4] showed that those in the lowest third tertile of strength were independently associated with adult 
MetS. Similarly, our group [5,6] and other investigators [7-9] have shown an independent and inverse 
association between low strength and cardiometabolic risk clustering among adolescents and adults. 
The contribution of muscular weakness to the progression of sedentary behavior with aging and/or 
cardiometabolic risk factors (e.g., obesity, MetS, insulin resistance) is equally unequivocal, and recent 
national effort to identify cut-offs or thresholds for clinically relevant weakness among young people 
[10] will help clinicians screen individuals at greatest risk. [11,12]. 
Senechal et al. [11] determined low muscle strength cut-offs for the prediction of MetS among 
middle-aged and older males using a composite score of normalized strength from chest press and leg 
press from a sample of 5685 men aged<50 years and 1541 men aged ≥ 50 years. However, at this 
time, thresholds derived from handgrip muscle strength, a clinically relevant strength measure, among 
Latin-American college students remains to be determined. Moreover, even though there is scientific 
evidence regarding the role of muscle strength preservation for prevention against cardiometabolic 
risk in several populations, no studies have stablished the minimum strength capacity associated with 
the risk of MetS among Latin-American college students. Clinically relevant handgrip strength cut-
off for detecting MetS have been stablished for youths [6], adults [11], and older adults [7,8]. 
However, Leong et al. [13] reported considerable heterogeneity in median handgrip strength among 
125,456 healthy adults aged 35-70 years from 21 countries in the Prospective Urban Rural 
Epidemiology study. This finding is important because it has been reported that handgrip strength is 
predictive of mortality and cardiovascular disease (CVD) independently of country income [14]. 
Therefore, from a public health perspective, the inclusion of handgrip strength measures in health 
surveillance system is clearly justifiable. For example, moderate weight gain from early to middle 
adulthood is associated with significantly increased risk of major chronic diseases and mortality. [2] 
Therefore, young adults may also be a good population for monitoring fitness, identifying risk factors, 
and offering interventions among those at high cardiometabolic risk. For that, cut-offs to determine 
young adults at cardiometabolic risk are required and to be used later to promote muscular strength 
and to lower CVD risk in later life. 
Thus, our study aimed to determine cut-offs of grip strength for the detection of MetS in a large 
collegiate student population from Colombia. Such evidence could serve as proof of a concept for the 
development of broad normative reference test standards for clinical, academic, and community 
settings. 
2. Methods 
2.1 Participants and study design 
Data were from a cross-sectional component of the FUPRECOL (in Spanish, Asociación de la Fuerza 
Prensil con Manifestaciones Tempranas de Riesgo Cardiovascular en Adultos Colombianos) study 
conducted during the 2014-2017 academic years. We recently published a complete description of 
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the FUPRECOL study design, methods, and primary outcomes for our current cohort. [9] A 
convenience sample comprised 1795 volunteers (61.4% female, aged=20.68 ± 3.10 years, mean ± 
SD) between ages 18 and 30 years of low to middle socioeconomic status, which was evaluated in 
accordance with the following Colombian government classification: stratum 1-2= low, stratum 3-4= 
middle, and stratum 5-6= high). The sample comprised students enrolled in public or private 
universities from 3 distinct areas of Colombia: the capital district of Bogota (Cundinamarca), Tunja 
(Boyacá), and Santiago de Cali (Valle del Cauca). 
Exclusion criteria included medical or clinical diagnosis of a major system disease, including 
malignant conditions such as cancer, type 1 or 2 diabetes, high blood pressure, and hypothyroidism 
or hyperthyroidism; a history of drug or alcohol abuse; regular use of multivitamins; chronic 
inflammatory conditions including rheumatoid arthritis, systemic lupus erythematosus, and multiple 
sclerosis; infectious conditions; or a body mass index (BMI) ≥ 35 kg/m2. Volunteers were not 
compensated for their participation. Informed consent was obtained from each participant. All 
participants provided written consent, and each study was approved by the local authorized 
institutional review boards (Bogota UMB Code N° 01-1802-2013, UR Code N° CEI-ABN026-
000010; Cali UNIAJC Code N° 111-01.01.48/16; Tunja Code N° RECT 60) and complied with the 
Declaration of Helsinki (World Medical Association for Human Subjects). The students who agreed 
to participate and who had signed the informed consent form were given appointments for the 
procedures described in the following. 
2.2 Physical examination 
Subjects were screened for inclusion in the study via personal interviews, Interview questions 
included queries about health status, medical history, CVD risk factors, and lifestyle. After 
completing another general information questionnaire, participants were instructed to wear shorts and 
t-shirts to the physical examination. They were also required to remove all jewelry and metal objects. 
Once the subjects were barefoot and, in their underwear, their body weight (kg) was measured using 
an electric scale (Tanita model BC-418, Tanita Corp., Tokyo Japan) with a range of 0-200 kg and 
with an accuracy within 100 g. Height was measured with a portable stadiometer with a precision of 
0.1 mm and a range of 0.2.50 m (Seca 274, Vogel and Halke, Hamburg, Germany). BMI was 
calculated by using the following formula: body mass (kg)/ height (m2). BMI status was evaluated 
according to the World Health Organization criteria.[15] The waist circumference (WC) was 
measured in cm as the narrowest point between the lower costal border and the iliac crest. When this 
point was not evident, it was measured at the midpoint between the last rib and the iliac crest, using 
a meta tape measure (Lufkin W606PM; Cooper Tools, Parsippany, NJ, USA). The evaluation process 
was carried out by a team of professionals (4 physical therapy professors) with extensive experience 
in anthropometric measurement. Measurements for 2% of the sample was carried out twice to ensure 
quality of measures. The technical error of measurement (TEM) values were <2% for all 
anthropometric variables. 
Body fat percentage (BF%) and fat mass index (FMI) were determined for bioelectrical impedance 
analysis (BIA) by a tetrapolar whole-body impedance (Tanita Model BC-418; Tanita Corp.,). For the 
calculation of intra-and inter-observer TEM, at least 50 subjects needed to be measured (30 males, 
20 females, aged 22.3 ± 2.1 years). The Tanita Model BC-418 is a reliable system that has good 
agreement with laboratory-based methods of assessment (hydrostatic weighing: r= 0.81, p<0.05; 
error of 1.68 BF% or DXA: r=0.87, p< 0.001) [16,17] The corresponding intraobserver technical 
error (% relatability) of the measurements was 95%. A detailed description of the BIA technique can 
be found elsewhere. [18] 
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Before testing, participants were required to adhere to the BIA manufacturer’s instructions 
(http://www.tanita.com/es/bc-418/), including no to (i) eat or drink within 4 h of the test; (ii) consume 
caffeine or alcohol within 12 h of the test; (iii) take diuretics within 7 days of the test; (iv) do physical 
exercise within 12 h of the test, and (v) urinate within 30 min of the test. FMI was calculated by 
dividing each subject´s fat mass (kg) by the square of his or her height (m)2, as described previously. 
[19] 
2.3 Muscular strength 
Handgrip strength was assessed using an adjustable digital handgrip dynamometer (T-18 TKK 
SMEDLY III; Takei Scientific Instruments Co., Ltd., Niigata, Japan). Participants watched a brief 
demonstration of the technique and were given verbal instructions on how to perform the test. The 
dynamometer was adjusted according to the subjects´ hand size based on a predetermined protocol. 
[20] The best score for each hand was recorded in kg. The handgrip strength was calculated as the 
average of the left and right hand. Because there is substantial covariance between strength and both 
physical function and chronic health is directly mediated by the proportion of strength relative to 
body mass, handgrip strength was a normalized grip strength (NGS) per body mass-for instance, 
handgrip strength (kg)/body mass (kg). The reproducibility of our data was R= 0.96. Intra-rater 
reliability was assessed by determining the intra-class correlation coefficient (0.98, 95% confidence 
interval (CI): 0.97-0.99, n=20, median age= 22.88 ± 1.41 years, 66.2 ± 5.41 kg, 1.75 ± 0.1 m, 24.91 
± 3.12 kg/m2) 
2.4 MetS diagnosis 
After the subjects had fasted for 10-12 h, blood samples were obtained from capillary sampling from 
6:00-10:00 a.m. Participants were asked not to engage in prolonged exercise in the 24 h prior to 
testing. The biochemical profile included the following: (i) high-density lipoprotein cholesterol 
(HDL-C), (ii) triglycerides, (iii) low-density lipoprotein cholesterol (LDL-C), (iv) total cholesterol, 
and (v) glucose fasting by enzymatic colorimetric methods. Inter-assay reproducibility (coeffient of 
variation) was determined from 80 replicate analyses of 8 plasma pools over a period of 15 days. The 
percentages obtained were 2.6% (triglycerides), 2.0% (total cholesterol), 3.2% (HDL-C), 3.6% (LDL-
C), and 1.5% (fasting glucose) 
Blood pressure was taken on the left arm at the heart level with the automatic device Omron M6 
Comfort (Omron Healthcare Europe B.V., Hoofddorp, The Netherlands) while the participants were 
sitting still. The blood pressure monitor cuff was placed 2-3 finger- widths above the bend of the arm, 
and a 2-min pause was allowed between the first and the second measurement with a standard cuff 
for an arm circumference of 22-32 cm. The mean arterial pressure (MAP) was calculated using the 
following formula: MAP= (systolic blood pressure + (2 x diastolic blood pressure))/3. 
Participants were considered to have diagnoses of the MetS if they had ≥ 3 of the following: (i) 
abdominal obesity (WC ≥ 80 cm in females and WC ≥ 90 cm in males), (ii) hypertriglyceridemia 
(≥150 g/dL), (iii) low HDL-C (<50 mg/dL in females and <40 mg/dL in males), (iv) high blood 
pressure (systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg) or MAP ≥ 
100 mmHg, and (v) high fasting glucose (≥100 mg/dL). MetS was defined in accordance with the 
updated harmonized criteria of the International Diabetes Federation (IDF). [21] 
We calculated a composite MetS score that reflects a continuous score of the 5 MetS risk factors. The 
MetS score was calculated from the individual subjects´ data, based on the IDF [21], and the standard 
deviations were calculated using data from the entire subject cohort at baseline. The equation used 
was MetS score=((HDL-C: male ≤40 mg/dL or female ≤ 50 mg/dL)/SD: female=1.04 or male = -
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0.19) + ((triglycerides (TG): 150mg/dL)/SD: female= 0.99 or male=0.97)+((fasting glucose: 100 
mg/dL)/SD: female= 0.98 or male=1.02)+((WC: male≥94 cm or female ≥ 80 cm)/SD: female=0.99 
or male=0.94)+((MAP: 100 mmHg)/SD: female= 0.88 or male= 1.07). The mean of this continuously 
distributed MetS score was therefore 0 by definition. 
2.5 Lifestyle covariates 
A standardized questionnaire, the “FANTASTIC” lifestyle (family, physical activity (PA), nutrition, 
tobacco toxins, alcohol, sleep/stress, personality type, insight, and career), was used to collect 
comprehensive information about substance use via a personal interview with participants. Alcohol 
consumption and smoking status were defined as subjects who had consumed any alcoholic beverage 
≥1 time per week and those who had smoked ≥10 cigarettes per week for at least 6 months, 
respectively, as previously described by Ramírez-Vélez et al. [22] Participants who exercised ≥3 
times a week for >30 min were categorized as “physically active”, and those who exercised <3 times 
a week were considered “physically inactive. [22] 
2.6 Statistical analysis 
Descriptive characteristics are provided as means, SDs, and is percentages. Histograms and Q-Q plots 
were used to verify the normality of the selected variables. Independent 2-tailed t tests for continuous 
variables and X2 tests for categorical variables were used to examine sex differences or the MetS 
group. Analysis of covariance adjusted for age, tobacco, alcohol, and PA levels (owing to the 
relationship with MetS) was used to determine the main effects for NGS (weak, intermediate, and 
strong) and anthropometrics, blood pressure, metabolic biomarkers, and muscle strength outcomes. 
We calculated standard indices, including sensitivity, specificity, area under the curve (AUC), and 
receiver operating characteristic (ROC) curve analysis, to establish weak, intermediate, and strong 
handgrip cut-off scores for subjects (male and female). Such cut-off could be used to predict MetS 
according to the IDF criteria. Sensitivity was defined as the probability of classifying correctly those 
college students presenting MetS (true positives), whereas specificity was defined as the probability 
of classifying correctly those participants presenting non-MetS (true negatives). The shortest distance 
is the ROC curve was calculated using the function √(1-sensitivity[2])+(1-specificity[2] by 
maximizing the Youden index. The positive likelihood ratio (LR(+)) and the negative likelihood ratio 
(LR(-)) were used to analyze the potential diagnostic accuracy of the NGS to discriminate among 
weak, intermediate, and strong for MetS. Locally weighted scatterplot smoothing curves were used 
to illustrate the shape of the relationship between the NGS and MetS score. Conditional inference tree 
analyses were used as an alternative method for determining weak, intermediate, and strong risk 
thresholds of normalized strength for detection of the high-risk cardiometabolic phenotype, as 
described previously [23]. Data were analyzed with SPSS version 24.0 for windows (IBM Corp., 
Armonk, NY, USA.) and freely available statistical software R version 3.2.3 (RStudio Team, Boston, 
MA, USA). A p value<0.05 denoted statistical significance. 
3. Results
The 1795 volunteers included 1103 females (61.4%). Their mean age was 20.68 ± 3.10 years. Overall,
males had greater body weight, WC, blood pressure, high triglycerides, and PA levels than females
(p ≤ 0.001), whereas females had lower handgrip and NGS (p ≤ 0.001). The prevalence of overweight
and obesity was 21.31% and 5.53% in females, respectively (p ≤ 0.001) (Table 5).
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Table 5. Characteristics among a sample of college students from Colombia (mean ± SD, n=1795). 
Characteristics Male  (n=692) 
Female 
(n=1103) p 
Anthropometric    
Age (year) 20.51 ± 3.22 20.59 ± 2.99 0.097 
Weight (kg) 68.91 ± 12.22 58.79 ± 10.36 <0.001 
Height (cm) 172.30 ± 6.65 159.09 ± 5.86 <0.001 
WC (cm) 78.23 ± 9.32 71.53 ± 8.02 <0.001 
High WC n (%) 75 (10.84) 151 (13.69) 0.069 
BMI (kg/m2) 23.17 ± 3.60 23.21 ± 3.77 0.089 
Body fat (%) 15.61 ± 6.54 27.03 ± 7.26 0.002 
FMI (kg/m2) 3.81 ± 2.24 6.50 ± 2.75 < 0.001 
Body mass index status, n (%) 
Underweight 38 (5,49) 72 (6.52) < 0.001 
Normal weight 477 (68.93) 735 (66.64) < 0.001 
Overweight 144 (20.81) 235 (21.31) < 0.001 
Obese 33 (4.77) 61 (5.53) < 0.001 
Blood pressure    
Systolic (mmHg) 120.28 ± 12.97 111.29 ± 11.15 < 0.001 
Diastolic (mmHg) 74.19 ± 11.45 71.74 ± 9.35 < 0.001 
MAP (mmHg) 97.23 ± 10.90 91.51 ± 8.92 < 0.001 
Hypertension, n (%) 282 (40.75) 187 (16.95) < 0.001 
Cardiometabolic parameters 
Total cholesterol (mg/dL) 132.75 ± 30.23 146.39 ± 33.33 0.081 
High total cholesterol, n (%) 21 (3.03) 62 (5.62) 0.007 
Triglycerides (mg/dL) 93.74 ± 48.54 88.50 ± 45.34 0.017 
High triglycerides, n (%) 54 (7.80) 127 (11.51) <0.001 
LDL-C (mg/dL) 81.07 ± 26.09 87.92 ± 26.15 0.386 
High LDL-C, n (%) 272 (39.31) 638 (61.92) <0.001 
HDL-C (mg/dL) 39.55 ± 10.67 43.97 ± 12,80 <0.001 
Low HDL-C, n (%) 383 (55.35) 798 (72.35) < 0.001 
Glucose (mg/dL) 84.81 ± 11.99 86.05 ± 11.57 0.010 
High glucose, n (%) 61 (8.82) 90 (8.16) 0.629 
MetS score -3.85 ± 2.95 -3.94 ± 2.66 0.008 
MetS, n (%) 84 (12.14) 82 (7.43) 0.001 
Lifestyle, n (%)    
Tobacco (≥10 cigarettes per week) 199 (28.76) 210 (19.04) 0.548 
Alcohol (≥1 time per week) 378 (54.62) 430 (38.98) 0.451 
Physical activity levels (≥150 min per week) 243 (35.12) 222 (20.13) 0.001 
Muscular strength 
Handgrip (kg) 39.42 ± 7.14 24.07 ± 4.95 < 0.001 
NGS* 0.58 ± 0.11 0.42 ± 0.09 < 0.001 
*NGS measured as handgrip strength (kg)/ body mass (kg). 
Notes: values are presented as mean ± SD unless otherwise noted.  
Abbreviations: BMI= body mass index; FMI= fat mass index; HDL-C= high-density lipoprotein cholesterol; MAP= 
mean arterial pressure; MetS= metabolic syndrome; NGS= normalized grip strength; WC=waist circumference. 
 
In males, the prevalence of overweight and obesity was 20.81% and 4.77%, respectively (p< 0.001). 
It was observed that 40.75% of males had high blood pressure. Total cholesterol, and LDL-C levels 
were significantly higher in females than in males (p< 0.05). 
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Table 6 depicts ROC curve analysis for the diagnostic performance NGS in identifying weak, 
intermediate, and strong risk of MetS. Since multiple levels of risk were desired, the selection of the 
resulting cut-off values was based on multiple combinations of sensitivity and specificity. In males, 
NGS values for weak, intermediate, and strong were < 0.466, 0.466-0.615, and >0.615, respectively 
(Table 6) 
Table 6. Parameters of the ROC curves analysis for the diagnostic performance of NGS identifying 
weak, intermediate, and strong risk of MetS according to the IDF criteria in males and females. 
Parameters Weak Intermediate Strong 
Male 
AUC 0.720 0.740 - 
95%CI 0.679-0.802 0.679-0.802 - 
p <0.001 <0.001 - 
Cut-off <0.466 0.466-0.615 >0.615 
Sensitivity (%) 89.0 86.9 84.3 
Specificity (%) 57.8 56.8 58.7 
LR (+) 2.11 2.10 2.04 
LR (-) 0.19 0.23 0.26 
Percentile ≤14 15-62 ≥63 
Female 
AUC 0.725 0.728 - 
95%CI 0.670-0.780 0.660-0.777 - 
p <0.001 <0.001 - 
Cut-off <0.332 0.332-0.437 >0.437 
Sensitivity (%) 84.9 85.0 86.6 
Specificity (%) 58.5 58.3 57.9 
LR (+) 2.04 2.02 2.05 
LR (-) 0.25 0.24 0.23 
Percentile ≤17 18-60 ≥61 
Notes: NGS is measured as grip strength (kg)/body mass (kg). 
Abbreviations: AUC= area under the curve; CI= confidence interval; IDF= International Diabetes 
Federation; LR (+) = positive likelihood ratio; LR (-) = negative likelihood ratio; MetS= metabolic 
syndrome; NGS= normalized grip strength; ROG= receiver operating characteristic curve. 
 
Mean difference in anthropometrics, cardiometabolic risk, and muscle strength parameters according 
to NGS categories are shown in Table 7. In males and females, analysis of variance adjusted for age, 
tobacco, alcohol, and PA levels showed that there were differences in body weight, FMI, and muscle 
strength (all p<0.05). 
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Table 7. Sex threshold for weak, intermediate, and strong NGS with anthropometric, blood pressure, metabolic biomarkers, and muscle strength. 
Variables 
Male (n= 692) Female (n=1103) 
Weak 
 (n=101) 
Intermediate 
(n=326) 
Strong 
(n=265) F P n
2
p 
Weak  
(n=188) 
Intermediate 
(n=466) 
Strong 
(n=265) F P n
2
p 
Anthropometric 
Weight (kg) 80.0 ± 15.8 70.6 ± 11.2 63.5 ± 8.6 91.53 <0.001 0.241 67.5 ± 13.5 59.6 ± 10.1 52.5 ± 6.3 116.01 <0.001 0.227 
WC (cm) 87.6 ± 12.7 79.5 ± 8.6 74.3 ± 6.0 100.45 <0.001 0.231 77.0 ± 9.0 72.1 ± 7.3 67.0 ± 5.5 98.05 <0.001 0.199 
Body fat (%) 22.2 ± 7.9 16.6 ± 5.7 12.9 ± 4.5 109.76 <0.001 0.247 32.5 ± 7.2 28.1 ± 6.9 22.5 5.9 112.58 <0.001 0.223 
FMI (kg/m2) 6.3 ± 3.4 4.1 ± 1.9 2.8 ± 1.2 117.16 <0.001 0.259 8.9 ± 3.4 6.8 ± 2.6 4.9 ± 1.8 128.13 <0.001 0.241 
Blood pressure (mmHg) 
Systolic 123.9 ±13.8 122.9±12.3 119.4 ± 11.0 12.66 < 0.001 0.136 
111.7 ± 
10.4 111.4 ± 11.4 
110.4 ± 
10.7 1.46 0.232 0.004 
Diastolic 78.6 ± 10.1 76.4 ± 11.0 72.9 ± 9.6 8.83 < 0.001 0.026 73.3 ± 9.3 71.7 ± 10.1 72.2 ± 9.8 1.91 0.147 0.005 
MAP 101.3 ± 10.3 99.6 ± 10.3 96.1 ± 9.3 13.98 < 0.001 0.040 92.5 ± 8.6 91.5 ± 9.3 91.3 ± 8.7 1.42 0.240 0.004 
Cardiometabolic biomarkers 
Total cholesterol 
(mg/dL) 133.4 ± 27.6 142.3 ± 29.8 
140.6 ± 
26.1 3.24 0.039 0.010 
150.0 ± 
32.3 148.5 ± 28.6 
148.3 ± 
28.5 0.02 0.978 0.001 
Triglycerides 
(mg/dL) 113.6 ± 54.6 103.9 ± 47.2 95.3 ± 40.8 9.83 <0.001 0.029 98.5 ± 42.9 94.0 ± 37.7 86.8 ± 34.9 6.65 0.001 0.017 
HDL-C (mg/dL) 38.1 ± 10.2 39.9 ± 10.6 41.5 ± 9.5 4.84 0.008 0.014 38.0 ± 11.7 41.9 ± 11.7 45.2 ± 12.4 15.63 <0.001 0.039 
LDL-C (mg/dL) 74.0 ± 23.0 82.7 ± 27.0 81.5 ± 25.3 4.09 0.017 0.016 93.2 ± 27.6 88.4± 25.3 85.9 ± 22.9 1.87 0.155 0.006 
Glucose (mg/dL) 87.4 ± 11.5 85.5 ± 11.7 82.8 ± 12.1 5.76 0.003 0.017 89.1 ± 8.6 87.6 ± 11.3 85.2 ± 12.5 6.09 0.002 0.017 
MetS score -1.742 ± 
3.160 
-3.252 ± 
2.762 
-4.684 ± 
2.369 51.60 <0.001 0.135 
-2.191± 
2.689 -3.437± 2.525 
-4.729 ± 
2.125 54.01 <0.001 0.125 
Muscle strength 
Handgrip (kg) 32.0 ± 6.1 38.4 ± 5.9 43.7 ± 6.4 135.94 <0.001 0.288 19.7 ± 3.8 23.1 ± 3.9 26.5 ± 3.7 161.13 <0.001 0.125 
NGS* 0.403 ± 0.052* 0.546 ± 0.042 
0.691 ± 
0.069 132.83 < 0.001 0.764 
0.294 ± 
0.032 0.388 ± 0.028 
0.507 ± 
0.054 109.09 <0.001 0.771 
*NGS is measured as handgrip strength (kg)/body mass (kg). F values and partial eta-squared (n2p) calculated from analysis of variance adjusted for age, 
tobacco, alcohol, and physical activity levels. 
Notes: values are presented as mean ± SD unless otherwise noted. 
Abbreviations: FMI= fat mass index; HDL-C= high- density lipoprotein cholesterol; LDL-C= low- density lipoprotein cholesterol; MAP= mean arterial 
pressure; MetS= metabolic syndrome, NGS= normalized grip strength; WC= waist circumference. 
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Conditional inference trees predicting probability of the high-risk cardiometabolic phenotype (MetS 
according to the IDF criteria) confirmed different low strength thresholds between males and females. 
Figure 3 provides results for the primary definition. The first cut-off point identified in males was 
based on having NGS <0.466 vs. ≥ 0.466. within the group of subjects with NGS ≥0.466, a second 
cut-off point was identified as an NGS >0.615. Among the weakest males (NGS<0.466), 34.6% had 
MetS, as compared with 10.7% among males with intermediate NGS (0.466-0.615), and only 4.9% 
among males with the highest NGS (>0.615). Among females, the first identified cut-off point was 
based on having an NGS ≥0.332 vs. <0.332. Within the group of subjects with an NGS < 0.332, a 
second cut-off point was identified as an NGS ≥ 0.332. Among the weakest females (NGS <0.332), 
18.0% had MetS as compared with 7.9% among females with intermediate NGS (0.332-0.437) and 
only 2.4% among females with the highest NGS (>0.437). 
 
Figure 12. Conditional inference trees for NGS, as predictors in identifying risk of MetS 
according to the IDF criteria in males and females. 
NGS is measured as grip strength (kg/body mass (kg). IDF= International Diabetes Federation, MetS= 
metabolic syndrome, NGS= normalized grip strength. 
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Figure 4 provides plots of the association between NGS and MetS score for males and females, 
inspection of the locally weighted scatterplot smoothing curves provides evidence of a well-defined 
threshold effect of low strength on the MetS score as continuous outcome. 
 
Figure 13. Scatterplots with overlaid locally weighted scatterplot smoothing curves to depict the 
shape of the association between the NGS and MetS score by sex. 
NGS is measured as grip strength (kg)/body mass (kg). MetS= metabolic syndrome; NGS= normalized grip 
strength. 
 
4. Discussion 
This is one of the first studies to identify sex-specific cut-off for NGS to detect a high-risk 
cardiometabolic phenotype among a large population of college students. The role of muscular 
strength has been increasingly recognized in the prevention of chronic disease in adult population. 
[1-3] Evidence suggests that muscle mass and strength decrease progressively after the age of 20 
years, [24] whereas in old age, some grip strength and hip strength declines by an average of 1.10 kg 
per year and 1.31 kg per year, respectively. [25] Therefore, young adulthood seems to be crucial time 
frame for monitoring and intervening to reduce the risk of weakness and cardiometabolic disease. 
Few studies have proposed cut-offs for low muscular strength among adults for screening 
cardiometabolic risk; however, this has yet to receive adequate attention in young adult populations, 
and information is scarce. Most studies have analyzed the older adult population. For example, Lee 
et al. [26] demonstrated that cardiometabolic risk was 54% lower for individuals with relative 
handgrip strength (absolute handgrip strength divided by BMI) in the 75th percentile compared with 
the 25th percentile. In addition, Duchowny et al. [27] established cut-off points for muscle weakness 
assessed as handgrip strength in a nationally representative sample by race and sex among older 
American adults. Senechal et al. [11] determined low muscle strength cut-off points for the prediction 
MetS using a composite score of normalized strength from the chest press and leg press. Among 
middle-aged adults, Strand et al. [28] revealed an association between handgrip strength and all-cause 
mortality and cardiovascular mortality, confirming the role of handgrip strength as a mortality 
predictor [29]. Finally, among young adults, Wilkerson et al. [30] investigated 62 collegiate football 
players (mean age 19.9 years) and found that low leg muscle strength was associated with an 
increased likelihood of MetS. 
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In line with studies mentioned earlier, our study revealed cut-offs for NGS by sex and identified 3 
cardiometabolic risk categories (“high”, “intermediate”, and “low”). The ROC curves generated for 
this study showed acceptable AUCs and 95%CI limits, suggesting that the resultant cut-offs were not 
owing to chance (both AUC ≥ 0.72). Specifically, among males in the highest strength category, only 
4.9% had the MetS phenotype, as compared with 10.7% among males with intermediate strength and 
34.6% among males with low strength. Among the females in the highest category, only 2.4% had 
the MetS phenotype, as compared with 7.9% among females with intermediate strength and 18% 
among those with low strength. The identification of the 3 categories of cardiometabolic risk 
coincides with the findings of Peterson et al. [31] who determined by sex the distribution of high 
cardiometabolic risk according to the cut-off points: weak, intermediate, and strong. These cut-off 
points were obtained from a similar size sample but not related to the age range. The cut-off points 
are lower than those identified in our study. 
However, the AUCs observed for this threshold were 0.72-0.74 for males and 0.72 for females, 
whereas in the study performed by Senechal et al. [11] the AUCs were 0.65 for males and 0.81 for 
females. The lower sensitivity and specificity reported in our study might be related to differences in 
age (20-50 years vs. 18-30 years), sample size of the populations studied (1795 vs 5685), and the 
methods used to assess muscle strength (handgrip vs. leg and bench press), as well as the use of a 
composite measure of MetS. Thus, our findings reinforce the concept that muscle strength may be an 
important modifiable lifestyle factor for CVD risk assessment in the same way that physical 
inactivity, body composition, and healthy dietary patterns are important. 
Our findings therefore support previous results demonstrating that low muscle strength is associated 
with MetS. These findings coincide with Sasaki et al. [32] in which for each 5 kg increase grip 
strength, the number of deaths caused by heart disease and stroke diminishes significantly. A plausible 
explanation for the role of muscle strength in MetS prevalence may be through the metabolic and 
structural changes that improve muscle insulin sensitivity and glycemic control [33]. As demonstrated 
by Wu et al. [34] in a recent meta-analysis, there is a 63% higher risk of premature mortality owing 
to CVD among adults with low handgrip muscle strength. 
The strengths of this study include the large sample size and a commonly used and feasible test for 
assessing muscle strength. However, there are some limitations that need to be highlighted. First, 
owing to the cross-sectional nature of the study design, we were unable to draw causal relationships. 
Thus, we were unable to deduce whether low NGS leads to increased risk of MetS, or conversely 
whether poor cardiometabolic profiles lead to declines in muscle strength. Future longitudinal studies 
are needed to better understand how declines in muscle strength contribute to health risks in college-
aged adults. Second, the ROC curve analysis does not enable adjustments for potential confounders 
within the model, and data were not adjusted prior the ROC curve analysis. Finally, we only analyzed 
relatively healthy individuals; therefore, the generalization of our results is limited to healthy younger 
adults. Our study suggests that NGS could be used as a complementary tool that may help clinicians 
and practitioners screen for high cardiometabolic risk. 
5. Conclusion 
In summary, our sex-specific NGS cut-offs could be incorporated into a clinical setting for identifying 
college students at high cardiometabolic disease risk and used as a target for strength training 
programs designed to reduce the risk of MetS. Longitudinal studies are necessary to determine of 
increasing handgrip strength reduces the likelihood of MetS. 
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Chapter 4: Ideal Cardiovascular Health, handgrip strength, and muscle mass among 
college students: The FUPRECOL Adults Study 
1. Introduction
With the rising rates of noncommunicable diseases over the past 30 years, a growing number of adults
are exhibiting cardiometabolic risk factors, including hypertension, dyslipidemia, and dysglycemia
[25]. Decreased physical activity (PA) and sedentary behavior-combined with poor dietary habits
have been implicated as potential contributing factors in the noncommunicable disease crisis [27]. In
Colombia, the number of patients with cardiovascular risk factors has increased rapidly because of
longer lifespan, the aging of the population, and lifestyle changes. During the period from 1998 to
2011, 21-25% of total deaths were due to cardiovascular disease (CVD) [5]. The crude mortality rate
varied from 93.5 to 108.8 per 100,000 habitants, whereas the age adjusted mortality rate varied from
108.6 to 95.5 deaths per 100,000 [23].
Assessments of CVD risk in college students aged 18-24 years show an alarmingly high prevalence 
of abnormal risk facto profiles [6]. Approximately 33% of young adults are overweight [4], and this 
excess weight leads to dyslipemia and increases the risk of metabolic syndrome [22] and CVD [24]. 
Early detection and intervention are critical because 80% of CVD events are preventable through diet 
and life-style [36]. In response to the increasing burden of noncommunicable diseases, including 
CVD, the American Heart Association (AHA) established the 2020 strategic Impact Goals to define 
the concept of Ideal Cardiovascular Health (CVH) and the metrics needed to monitor it across 
populations [17]. The 7 metrics for ideal CVH in adults (age ≥ 20 years) comprise 4 health behaviors 
(current smoking, body mass index [BMI], physical activity and healthy diet score] and 3 
physiological health factors (total cholesterol, blood pressure, and fasting plasma glucose levels). The 
few studies that have analyzed this ideal CVH in young adults suggest a direct association with 
markers related to future cardiovascular events [30], such a carotid intima media thickness [26] of 
left ventricular structure and function later in life [7]. 
Although there is scientific evidence regarding the role of muscle strength preservation in preventing 
cardiometabolic risk and mortality in several populations [9], to the best of our knowledge, only one 
study has analyzed the relationship between ideal CVH and muscle strength in children and 
adolescents from Colombia, and it showed a positive association between the two [31]. Poor diet, 
obesity and physical inactivity have been shown to be the leading CVD risk factors in Colombian 
adults and another Latin American countries [34], raising concerns about whether an increased risk 
of these conditions also affects cardiometabolic status. These changes, in addition to the adoption of 
a Western lifestyle and diet, have led to an increase in the prevalence of overweight and obesity 
among Colombians, particularly among university students [8]. 
In addition, the prevalence of ideal CVH has not been examined in college students in any Latin 
American population. It is very important to identify the risk factors and to take steps to control 
noncommunicable diseases in Colombia. Therefore, the objective of this study was to investigate the 
relationship between handgrip strength, muscle mass, and Ideal CVH among college students. It was 
hypothesized that higher scores on 7 metrics for ideal CVH, indicating better CVH, are associated 
with higher levels of handgrip strength and muscle mass in Colombian college students. 
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2. Methods 
2.1 Experimental approach to the problem 
This was a secondary analysis of cross-sectional of data from the Association of the Prehensile Force 
with Early Manifestations of Cardiovascular Risk in Young Colombian Adults (FUPRECOL). Adults 
study, which investigated the association between muscular strength and metabolic risk factors in 
Colombian collegiate students. 
2.2 Subjects 
The students were enrolled in public or private universities from 3 district areas of Colombia: the 
capital district of Bogotá (Cundinamarca), Tunja (Boyacá) and Santiago de Cali (Valle del Cauca). 
We recently published a complete description of the FUPRECOL Adults study´s design and methods 
and the primary outcomes for our current cohort [29]. The original sample consisted of adults (male: 
n=707; female: n=1,131). Of this group, 1,835 collegiate students (61,4% of women) had valid data 
for body composition and all the components of the cardiometabolic variables. There were no 
differences in the study´s key characteristics (ie., age, sex distribution, BMI, and ideal CVH 
components) between the current study sample and the original FUPRECOL Adults sample (n=1,838, 
all p >0.100).  
Exclusion criteria included the following: medical or clinical diagnosis of a major systemic disease, 
including malignant conditions such as cancer, type 1 or 2 diabetes, high blood pressure, 
hypothyroidism, or hyperthyroidism; regular use of multivitamins; chronic inflammatory conditions, 
including rheumatoid arthritis, systemic lupus erythematosus, and multiple sclerosis, and infectious 
conditions. The volunteers received no compensation for their participation. All participants provided 
written consent, and each study was approved by the University of Rosario Review Board (Bogotá 
UMB Code N° 01-1802-2013, UR code N° CEI-ABN026-000010; Cali UNIAJC Code N° 111-
02.01.48/16; Tunja Code N° RECT 60) and complied with the Declaration of Helsinki (World Medial 
Association for Human Subjects) 
2.3 Procedures 
Clinical Examination. Clinical examinations were performed between January 25, 2015, and March 
30, 2017, by trained personnel and followed standardized routines described in detail elsewhere [29]. 
Briefly, body mass and muscle mass were measured using tetrapolar whole body impedance (Tanita 
Model Tanita BC 420 MA® and SC-331S®; Tanita, Tokyo, Japan). A detailed description of the 
bioelectrical impedance analysis (BIA) technique can be found in a previous study [32]. Muscle mass 
was normalized as muscle mass per body mass, i.e., muscle mass in kg/body mass in kg. In a study 
to validate 2 portable BIA devices for body composition assessment, multiple regression analyses 
showed clinically acceptable agreement between the Tanita BC 420 MA® and SC-331S® device and 
magnetic resonance imaging for visceral adipose tissue and fat mass measurements (R2>0.70, r>0.84) 
[38]. The corresponding intraobserver technical error (% reliability) of the measurements was 95%. 
Before testing, participants were required to adhere to these BIA manufacturer´s instructions, 
including not to (http://www.tanita.com/es/bc-418/): (a) eat or drink within 4 hours of the test; (b) 
consume caffeine or alcohol within 12 hours of the test; (c) take diuretics within 7 days of the test; 
(d) do physical exercise within 12 hours of the test; and (e) urinate within 30 minutes of the test. 
Waist circumference (WC) (cm) was measured at the uppermost border of the iliac crest around the 
abdomen. When this point was not evident, WC was measured at the midpoint between the last rib 
and the iliac crest using a metal tape measure (Lufkin W606PM®, Allers Parsippany, NJ, USA) in 
accordance with the International Society for the Advancement of Kinanthropometry guidelines [21]. 
The evaluation process was performed by a team of professionals (4 physical therapy professors) with 
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extensive experience in anthropometric measurement. Two percent of the sample was measured twice 
to ensure the quality of the measurements. The technical error of measurement values were less than 
2% for all anthropometric variables. 
We used a handgrip strength test (T.K.K. 5401-5001, Grip-A; Takei Scientific Instrument, Tokio, 
Japan), adjusted for each participant by sex and hand size as PA “proxy”. The participants were 
instructed to stand with their arms completely extended, squeezing and to gradually and continuously 
squeeze the handgrip as hard as they could for at least 2 seconds. The test was performed twice, 
alternating hands between tests. A 90-second rest period was provided between trials. The best score 
for each hand was recorded in kilograms [32]. The handgrip score (kg) was calculated as the average 
of the left and right hands and then expressed per kilogram of body mass. The reproducibility of our 
data was R=0.96. Intrarater reliability was assessed by determining the intraclass correlation 
coefficient (0.98, confidence interval [CI] 95% 0.97-0.99, n=20, median age= 22.8 ± 1.4 years, 66,2 
± 5.4 kg, 1.67 ± 0.1 m, 24.9 ± 3.1 kg/m2). As there is substantial covariance between strength capacity 
and body mass and the link between strength and both physical function and chronic health is directly 
mediated by the proportion of strength relative to body mass, handgrip strength was normalized as 
grip strength (NGS) per body mass, i.e., handgrip strength in kg/body mass in kg[1]. In male, unfit 
and fit NGS values at these points were <0.47 and >0.48, respectively [10]. These cutoff points have 
been associated with the detection of metabolic syndrome in Colombian collegiate students. 
Ideal Cardiovascular Health Behaviors. A standardized survey, the “FANTASTIC” lifestyle 
questionnaire (family, PA, nutrition, tobacco toxins, alcohol, sleep/stress, personality type, insight, 
and career), was used to collect comprehensive information about substance use through personal 
interviews with the participants [28]. The physically active category was defined as ≥ 150 minutes of 
moderated activity per week [11]. Data on smoking were collected through self-reported 
FANTASTIC questionnaire (number of cigarettes smoked per day). Ideal smoking status was 
determined as nonsmoker or quit smoking >12 months ago. The accuracy of the information about 
lifestyle covariables obtained from the FANTASTIC questionnaire has been validated with different 
cross-sectional studies and is described in detail elsewhere [28]. 
Body mass index was calculated as (body mass/height2) and was classified using the World Health 
Organization (WHO) criteria (normal: 18.5-24.9 kg/m2; overweight: 25.0-29.9 kg/m2; and obese: 
≥30kg/m2) [40] 
Dietary intake was measured using the test of Adherence to Mediterranean Died (KIDMED) [35]. 
This scale comprises 16 items with an affirmative or negative response; for example: “consumes fish 
regularly (at least 2-3 times per week)”, which are related to patterns associated with the 
Mediterranean diet. Twelve of these items have positive connotations (+1) while the other four have 
negative values (-1). The final score ranges from -4 to +12. The total score ranges from -4 to +12. 
The total score was divided into two categories of Mediterranean diet quality: ≤ 7 points= poor diet 
quality and ≥ 8 points= good diet quality (optimal Mediterranean diet style). Participants who had ≥ 
8 points were categorized as having an ideal healthy diet, whereas those with 7 point or less were 
classified as having a non-ideal diet. This instrument has a reliability of Cronbach´s alpha=0.86. 
Cardiovascular Health Risk Factors. For blood measurements the participants were asked to arrive 
in a fasting state; abstain from exercise training, caffeine, nicotine, and alcohol 12 hours before the 
clinical examination; and continue their regular medication routines. Capillary blood samples (40 µL) 
were collected for determining serum biochemical parameters, including fasting glucose and total 
cholesterol, using portable Cardiocheck equipment (Mexglobal SA, Parsippany, NJ, USA). 
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Blood pressure was measured with an automatic monitor (Omrom HEM 705 CP; Health-care Co, 
Kyoto, Japan) following the recommendations of the European Heart Society (Each participant sat 
quietly with legs uncrossed for 5-10 minutes before blood pressure measurement with the arm 
supported at the level of the heart). 
American Heart Association Criteria. The AHA guidelines [17] were used to determine the CVH 
profile based on the 7 metrics using the cutoff points for adults, with the participants receiving 1 point 
for the presence of each ideal metric. The ideal behaviors defined by the AHA are as follows: BMI 
<25kg/m2, physically active status (≥150 minutes of moderate activity per week), nonsmoking status 
(either never having smoked or having quit smoking >12 months ago), and a dietary pattern that 
promotes ideal CVH (≥8 points= good diet quality optimal Mediterranean diet style). The factors 
were classified as an untreated systolic blood pressure <120 mmHg and diastolic blood pressure <80 
mm Hg, untreated total cholesterol ≤200mg/dL, and untreated fasting blood glucose <100 mg/dL. 
2.4 Statistical Analyses 
Descriptive statistics were computed and summarized; continuous variables are reported using mean 
values and SDs, and categorical variables are reported using proportions (%). The t-test was used to 
compare unadjusted means, and the chi-square test (x2) was used to explore sex group differences. 
The associations among NGS, adjusted muscle mass, and ideal CVH metrics and between ideal CVH 
behaviors and each factor separately were assessed using analysis of covariance. Analyses were 
conducted for men and women separately and adjusted by age, university center, and alcohol use. 
Alcohol use was defined as the consumption of any alcoholic beverage 1 to 9 times per week for at 
least 6 months. Finally using a logistic regression, ideal CVH metrics were examined as a continuous 
variable, considering the odds ratio (OR) per 1-metric increase in the overall profile to compare the 
prevalence of low NGS and low medium adjusted muscle mass. The data were analyzed using SPSS-
IBM (software, v.22.0, SPSS, Inc., Chicago, IL, USA) and a value of p≤0.05 was considered 
statistically significant. 
3. Results 
The 1,835 participants included 1,128 females (61.4%), and the mean age was 20.56 (2.03) years. 
Male had lower body mass, height, muscle mass, muscle mass adjusted, blood pressure, handgrip, 
and NGS levels than female (p<0.001), and female had higher glucose and total cholesterol than male 
(p<0.001; Table 1) 
Table 8. Characteristics of Colombian collegiate students (mean ± SD or frequencies), by sex 
 Female (n=1,128) Male (n= 707) p Value* 
Age (y) 20.59 ± 2.09 20.51 ± 20.1 0.624 
Body mass (kg) 58.79 ± 10.36 68.91 ± 12.23 <0.001 
Height (cm) 159.10 ± 5.86 172.30 ± 6.66 <0.001 
Body mass index (kg/m2) 23.21 ± 3.78 23.17 ± 3.60 0.810 
Muscle mass (kg) 40.14 ± 3.38 55.08 ± 6.57 <0.001 
Muscle mass/body mass 0.69 ± 0.07 0.80 ± 0.08 <0.001 
Systolic blood pressure (mmHg) 111.29 ± 11.16 120.28 ± 12.97 <0.001 
Diastolic blood pressure (mmHg) 71.74 ± 9.35 74.20 ± 11.45 <0.001 
Glucose (mg/dL) 86.05 ± 11.58 84.81 ± 11.99 0.030 
Total cholesterol (mg/dL) 146.39 ± 33.34 132.75 ± 30.24 <0.001 
Alcohol (≥ 1 times per week), n (%) 404 (47.7) 317 (45.2) 0.318 
Muscular strength 
Handgrip strength (kg) 24.16 ± 4.75 39.42 ± 7.15 <0.001 
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Normalized grip strength (NGS) 0.41 ± 0.09 0.58 ± 0.11 <0.001 
Goal/ metric 
Not currently smoking, n (%) 596 (73.4) 485 (70.5) 0.212 
Body mass index <25kg/m2, n (%) 827 (73.4) 526 (74.5) 0.616 
Physically active, n (%) 231 (27.2) 251 (35.9) <0.001 
Healthy diet, n (%) 64 (7.5) 45 (6.4) 0.398 
Total cholesterol <200 mg/dL, n (%) 1,056 (94.5) 676 (97.0) 0.012 
Fasting glucose <100 mg/ dL, n (%) 1,022 (91.6) 633 (90.9) 0.644 
Optimal blood pressure, n (%) 937 (83.4) 416 (59.0) <0.001 
*t-test or X2 test was applied to compare unadjusted means by sex (p<0.001) 
 
 
Higher NGS and adjusted muscle mass levels were associated with a higher number of ideal CVH 
metrics in both sexes (p for trend <0.001; Figure 5) 
 
Figure 14. Association between normalized grip strength in college students. 
(A) Female and (B) male. We collapsed 0 with 1 and 6 with 7 ideal metrics due to relatively few youths who 
had 0 (0.1% of total cohort), 1 (0.4% of total cohort), or 6 (12% of total cohort) and 7 (1% of total cohort) 
ideal CVH metrics. Normalized grip strength (measured as grip strength in kg/body mass). CVH= 
cardiovascular health.  
In addition, higher NGS and adjusted muscle mass levels were associated with a higher number of 
ideal health behaviors (p for trend <0.001 in both male and female) and with a higher number of ideal 
health factors (p for trend <0.001 in both male and female; Figures 6 and 7). 
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Figure 15. Association between normalized grip strength and adjusted muscle mass across ideal 
CVH behaviors in college students.  
(A) Female and (B) male. Normalized grip strength (measured as grip strength in kg/body mass in kg). 
Adjusted muscle mass (muscle mass in kg/body mass in kg). Ideal CVH behaviors (smoking, body mass index, 
physical activity and Mediterranean diet adherence). CVH= cardiovascular health. 
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Figure 16. Association between normalized grip strength and adjusted muscle mass across ideal 
CVH factors in college students.  
A) Female and B) male. Normalized grip strength (measured as grip strength in kg/body mass in kg). 
Adjusted muscle mass (muscle mass in kg/body mass in kg). Ideal CVH factors (total cholesterol, blood 
pressure, and plasma glucose). CVH= cardiovascular health. 
Finally, for the total ideal CVH metrics on a continuous scale from 0 (all 7 poor) to 7 (all 7 ideal), a 
1-metric increase was associated with reduced odds of weak NGS (male, OR=0.667 95% CI, 0.544-
0.819, female, OR= 0.639 95% CI, 0.522-0.782) and low-medium muscle mass (male, OR=0.719 
95% CI, 0.588-0.879, female, OR= 0.656 95% CI, 0.540-0796) (all p<0.001). 
4. Discussion and conclusion 
The findings of this study indicate that in Colombian college students, both handgrip strength and 
muscle mass are positively associated with the ideal CVH metrics determined by the AHA. These 
results are insightful considering the large reduction in overall fitness and PA levels observed in Latin 
American populations in recent decades [13,15]. However, similar to larger studies, we found that 
handgrip strength may be an underappreciated, modifiable determinant of cardiometabolic risk 
factors in adults [3]. 
Although there are very few studies on this topic, Ramírez-Vélez et al. [31] showed that greater 
handgrip strength was associated with a higher number of ideal CVH metrics in a young population, 
which, together with our results, seems to suggest that muscular strength should be considered a 
hallmark for meeting ideal CVH metrics. Along this line, previous studies have shown the relationship 
between the individual components of ideal CVH and handgrip strength in young adults. Regarding 
the ideal CVH factors that were analyzed, previous studies provide evidence that muscular strength 
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is protective against cardiometabolic risk factors [10]. For example, Magnussen et al. [19] reported 
that the negative association between muscle strength and cardiometabolic risk factors is independent 
of cardiorespiratory fitness or adiposity level. In addition, López-Martínez et al. [18] demonstrated 
that in college students, muscle strength is negatively associated with metabolic risk and its individual 
components. Also, the PURE study suggests that muscle strength is a risk factor for incident CVD 
and can predict the risk of death in people who develop either CVD or non-CVD in people of diverse 
economic and sociocultural backgrounds, including Latin American population [15]. 
A recent prospective study of 7,418 adults (46±9.5 years old) suggested that engaging in resistance 
exercise, even for less than 1 hour per week, is associated with a lower risk of developing metabolic 
syndrome, independent of whether the participant engages in aerobic exercise [2]. These results seem 
to suggest the need to promote increased muscle strength in adults to better manage cardiometabolic 
risk factors. In this sense, muscle strength training should be considered in the management of 
cardiometabolic risk factors because studies show that exercise training that aims to increase muscle 
strength in adults is associated with significantly improved cardiometabolic health [16] and muscle 
mass [39]. 
Regarding health behaviors, there is a well-established link between PA, healthy diet, muscular 
strength [14], and muscle mass [37]. Regular PA is a cornerstone strategy for managing 
cardiometabolic risk factors. As a consequence, agencies such as the American College of Sports 
Medicine recommend that adults aged between 18 and 64 years perform activities that increase bone 
and muscle strength, which includes resistance training, 2-3 days per week [11]. Another recent study 
of university student shows that the Mediterranean diet and PA are related to healthy body 
composition parameters in young adults [37]. In addition, a longitudinal study indicates that smoking 
is inversely related to muscle strength in healthy adults [12]. This may be because circulating cigarette 
smoke constituents seem to play an important role in the underlying molecular mechanisms of muscle 
damage, such as reduced oxygen delivery and impaired mitochondrial function [33]. 
The findings of this study are limited by the cross-sectional design; therefore, the direction of 
causality cannot be determined. In addition, ideal health behaviors were measured using a self-
administered questionnaire, and so, some of the questions may have been misinterpreted deliberately 
or unintentionally by some of the college students. Finally, the categorization of the ideal CVH 
metrics relies on the use of binary variables and on the assumption that all risk factors and behaviors 
contained in this concept contribute equally to the final score. 
5. Practical applications 
This study shows for the first time the benefit of higher ideal CVH metrics for muscular strength and 
muscle mass in Colombian collegiate students. Therefore, to reduce the possible future public health 
burden of muscular weakness, physical educators, researchers, trainers, fitness professionals, physical 
therapists, and coaches need to encourage the public to optimize lifestyle-related risk factors during 
the young adult stage. 
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Chapter 5: General Discussion  
Detection of Metabolic Syndrome by body composition and muscular strength screening tools 
(Study I-II) 
 
MetS is defined as a cluster of interconnected factors (central obesity, elevated blood pressure, 
impaired glucose tolerance and atherogenic dyslipidaemia) that increase the risk of coronary heart 
disease, stroke and type 2 diabetes; it has been related to insulin resistance, obesity and muscular 
weakness, independent of age and body size [1-5]. These are considered the result of behavioural 
factors like physical inactivity and excess food fat intake [1,3]. In this sense, there is growing evidence 
that highlights different measures of central body obesity (such as waist circumference-WC, waist-
hip ratio-WHR, body mass index-BMI) and muscular strength (MS- such as normalised handgrip 
strength- NGS) as being strongly related to MetS risk [4,6-8].  
In clinical practice, the bioelectrical impedance analysis (BIA) is the most frequently used method to 
assess body composition and calculate BF%, due to its simplicity, low cost and highest correlation 
with gold standards such as dual-energy X-ray absorptiometry (DXA) or computed tomography (CT) 
[9]. According to this context, one of the studies that composes this thesis, proposed body fat 
percentage (BF%) and fat mass index (FMI), based on BIA, as screening tools which can estimate 
the fat mass and body adiposity dysfunction associated with MetS. This is because of the strongest 
relation with the components of MetS (mean arterial pressure, glucose, HDL-C, triglycerides, total 
cholesterol and waist circumference, p<0.05 for all). The results are similar to those presented by 
Knowles et al. [10], who found correlations between WC, BMI, WHR, Waist height ratio, and 
Visceral adiposity index (VAI) with MetS components (p<0.001). 
In this sense, it was found that BF% and FMI had a moderate discriminatory power in the 
identification of MetS for both sexes in Colombian young adults, according to the Receiver Operating 
Characteristic (ROC) analysis (BF%: Area Under the Curve - AUC=0.835, % sensitivity=96.1, % 
specificity= 57.5 for men; AUC= 0.887, % sensitivity=97.4, % specificity= 55.9 for women, both 
p<0.001; FMI: AUC=0.838, % sensitivity=95.8, % specificity= 56.2 for men; AUC= 0.889, % 
sensitivity= 97.6, % specificity=56.9 for women, both p<0.001). When these results are compared 
with similar studies carried out among adults, some discrepancies were found for BF%, which showed 
limited effectiveness for predicting MetS compared to other body composition indexes; this could be 
explained by the heterogeneity of the populations. [11,12]. Besides, other researchers such Peltz et 
al. [13] determined the accuracy of FMI as a convenient tool for assessing obesity compared with 
BF%, using BIA as the reference method; they found a correlation coefficient of 0.976 in men and 
0.992 in women (both p<0.001). On the other hand, the results of our study about the FMI cut-offs 
(≥ 6.9 kg/m2 in men and ≥ 11.8 kg/m2 in women), was similar to those presented by Schutz et al. [14], 
who defined the overfat status when FMI is greater than 8.2 kg/m2 in men and 11.8 kg/m2, which 
contribute to the development of a set of recommended ranges to predict MetS. 
As an approximate physiological mechanism explanation of our results, the determination of BF% 
and FMI as measures of the distribution of fatty adipose tissue are highlighted, which is considered 
one of the predominant underlying risk factors of the appearance of MetS, as a result of behavioural 
factors like physical inactivity and excess food fat intake, which generate excess energy that is stored 
as subcutaneous or visceral fat [1,3]. The visceral adipose tissue, specifically constituted by white 
adipose tissue, is metabolically active and secretes dozens of hormones, free fatty acids (FFA), 
adipocytokines and inflammatory factors (TNF-α, interleukin 6, angiotensinogen, PAI-1, and resistin) 
[15,16,17,]. In this sense, the of fat accumulation generates a destructive effect on glucose 
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metabolism, like insulin resistance and pancreatic beta cell dysfunction; this is defined as lipotoxicity, 
and is characterised by impaired glucose oxidation and glycogen synthesis and decreased glucose 
transport-phosphorylation as a result of the fat accumulation of intracellular toxic metabolites of FFA 
as triacylglycerol (TAG) [1,18,19].  
Other measures related to MetS risk include MS from the HGS, which is recognised as a simple 
inexpensive measure of overall MS and useful prognostic indicator of mortality; when corrected for 
body mass, it is associated with a higher prevalence of MetS in adults, independent of age and body 
size, and is considered to reflect muscle mass as an important health indicator [4, 5]. In this sense, the 
second study that composes this thesis proposed NGS cut-off for the detection of MetS in a collegiate 
student population from Colombia, taking into account that this is one of the first studies to identify 
sex specific cut-offs in this population. 
This study proposes three cardiometabolic risk categories for NGS by sex, catalogued as weak 
(<0.466 for men and <0.332 for women, p<0.001 for both), intermediate (0.466-0.615 for men and 
0.0332-0.437 for women, p<0.001 for both) and strong (>0.615 for men and >0.437 for women); the 
AUC was shown to be acceptable (>0.72, % sensitivity > 84.0, % specificity > 56.0, p<0.001) for 
men and women. Therefore, when comparing the MetS phenotype by cut-off for NGS, it was found 
that, among males in the highest strength category, 4.9% had MetS, in the intermediate strength 
category 10.7% and in the low strength category 34.6% had MetS. In women in the highest category, 
only 2.4% had the MetS phenotype, compared with 7.9% and 18% among females with intermediate 
and low strength, respectively.  
Different studies showed similar results, like that of Senechal et al. [20], whose objective was to 
identify a threshold of muscle strength (using normalised strength from the chest press and leg press) 
associated with MetS in 5685 men aged <50 years and 1541 men aged >50 years; low MS was 
established as the lowest age-specific 20th percentile and high MS was above 20th percentile. The 
study found that in men aged <50 years, the threshold of MS associated with MetS was 2.57 kg, with 
the odds of MetS in the first group being 2.20 (95%CI: 1.89-2.54) higher in those with low MS, 
independent of age, smoking, and alcohol intake. Likewise, Lee et al. [21] demonstrated that 
individuals with relative handgrip strength (absolute hand-grip strength divided by BMI), in the 75th 
percentile compared with the 25th percentile, had a 54% lower cardiometabolic risk.  
In this sense, Peterson, et al. [22] established the importance of MS measured as NHS due its 
association with cardiometabolic disease and physical disabilities in middle-age to older men and 
women; for the loss of every 0.05 kg of MS, the odds of diabetes in American adults increased by 
49%, the odds of hyperglycaemia by 46%, the odds of hypertriglyceridemia by 15%, the odds of low 
HDL-cholesterol by 22%, the odds of hypertension by 19%, and the odds of disability status by 36% 
(all p<0.01). Similar works were presented by Ramírez-Vélez et al. [23], who determined the 
association between the new ratio of NHS and increased visceral fat level mass (MVF), and the 
prevalence of MetS and Ideal CVH; they found that subjects with lower MVF ratio (Q1) showed 
worse CVH metrics (accomplishment 0-2 metrics) and a higher prevalence of MetS (32.2%, 
p<0.0001) in young Colombian adults.  
Therefore, these findings allowed different strategies to be determined, like resistance training, as 
part of the physical activity recommendations for the primary and secondary prevention of MetS and 
associated chronic diseases in adults; this was due to the role of skeletal muscle in the metabolism of 
glucose and triglycerides [24,25]. Several studies have elucidated the health impact of physical 
activity and exercise to increase mitochondrial oxidative capacity and skeletal muscle capillarisation 
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and generate anti-inflammatory effects which contribute to improved insulin signalling, glucose 
uptake and metabolic flexibility [26]. The interventional study by Tomeleri et al. [27] has shown that 
12 weeks of resistance training reduces MetS components (glucose: -20.4%, waist circumference: -
1.5% and systolic blood pressure: -6.2%, all p<0.05) and inflammatory biomarkers (CRP: -28.6%, 
TNF-α: -21.6%, all p<0.05), and generates different body composition and physical fitness levels, 
like reduced body fat (-6.0%, p<0.01), increased skeletal muscle mass (+6.1 kg, p<0.01) and MS 
(+14.0, p <0.001) in older women.  
However, due to the cross-sectional nature of the study design, it was not possible to determine causal 
relationships, suggesting that future longitudinal studies are needed to better understand the 
physiological mechanism that explains how body fat contributes to health risks in college-aged adults. 
Cardiovascular Health and muscular strength (Study III) 
 
With the rising rates of deaths from CVD, which is considered the number one cause of death globally 
[28, 29], Cardiovascular health (CVH) has been considered the highest strategic impact goal, with 
focus on reducing cardiac heart disease and stroke death rates and the prevalence of risk factors by 
20%, through the adoption of seven metrics comprise four healthy behaviours (abstinence from 
smoking, ideal body mass index [BMI], physical activity at goal and consumption of a healthy diet 
that promotes CVH) and three physiological health factors (untreated total cholesterol <200mg/dL, 
untreated blood pressure <120/<80 mm Hg, and absence of T2DM) [30].  
In this sense, several studies have established that young adults who reach middle age with some 
health behaviours and factors (cholesterol, blood pressure and no cigarette consumption), have a 
lower risk of developing CVD and greater longevity; this highlights the importance of identifying 
and treating CVD risk factors at an early age [31-33]. The results may be supported by the systematic 
review and meta-analysis by Ramirez-Vélez et al. [34], which established that the incidence of CVD 
was lower (HR=0.28, 95%CI: 0.23-0.33, p<0.001, I2=72.0%) in individuals who had an ideal CVH 
profile (achieve 5-7 metrics) compared with individuals with a poor ideal CVH profile (meeting only 
1-2 metrics). 
On the other hand, the role of physical fitness as one of the strongest predictors of individual future 
health status is well established, and is characterised by the ability to perform daily activities with 
vigour. These daily activities can be performed through capacities that are associated with a low risk 
of the development of chronic diseases and premature death, especially cardiorespiratory fitness and 
MS, and specifically, as mentioned above, because MS is considered as an indicator for preventing 
cardiometabolic risk and mortality in several populations, thus highlighting its importance [24, 
35,36].  
In this sense, the third study that composed this thesis had the purpose of investigating the relationship 
between MS (determined as handgrip strength), muscle mass, and ideal CVH among Colombian 
College students, taking into account that only one study has analysed this relationship in the 
Colombian population, specifically in children and adolescents [37] 
The findings of this study indicate that, in Colombian college students, MS and muscle mass are 
positively associated with ideal CVH metrics, which are similar to the results presented by Ramirez-
Vélez et al. [37]. In the same line, different studies such the PURE study, suggest that MS is a risk 
factor for incident CVD and is catalogued as a predictive tool to identify the risk of death in people 
who develop CVD [35]. In this sense, the protective effect of muscle strength training on improved 
health parameters such as cardiometabolic health and muscle mass is well established, and can be 
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explained by the role of muscle as an endocrine organ [38-40]. The muscle has anti-inflammatory 
properties for the release of cytokines such IL-6, IL-1ra and IL-10, which together help with the 
reduction of FFA, suppress TNF-α expression, down-regulate TLR 4 expression and reduce the 
activation of NF-kB signalling and cytokine production; consequently, this improves glucose 
homeostasis and lipolysis during exercise [27, 41-44].  
Besides, the link between physical activity, a healthy diet, and muscular strength on CVH is well-
established, due the beneficial effect on vascular function; this implicates the increase in shear stress 
on the vascular lumen, generating the activation of acetylcholine (Ach) signalling and phospholipase 
activity in endothelial cells, due to an increase in intracellularly released Ca2, prostaglandin I2 (PGI2), 
and the relaxation of smooth muscle cells by the cyclic adenosine monophosphate (cAMP) action. 
Also, phosphoinositide 3-kinase (PI3K) is activated for the vascular endothelial growth factor 
receptor 2 (VEGFR2) activity, which induces phosphorylated protein kinase B (AKT)-mediated nitric 
oxide synthase endothelium (eNOS) phosphorylation, leading to the increased production of NO [45]. 
However, the findings of this study are limited by the cross-sectional nature of the study design, which 
means that the causality direction cannot be determined. 
Reference 
[1] Samson SL, Garber AJ. Metabolic Syndrome. Endocrinol Metab Clin North Am. 2014;43(1):1-
23. Doi: 10.1016/j.ecl.2013.09.009.
[2] Alshehri AM. Metabolic Syndrome and cardiovascular risk. J Family Community Med.
2010;17(2):73-78.
[3] O´Neill S, O´Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its
associated pathologies. Obes Rev. 2015;16(1):1-12. Doi: 10.1111/obr.12229.
[4] Jurca R, Lamonte MJ, Barlow CE, Kampert JB, Church TS, Blair SN. Association of muscular
strength with incidence of metabolic syndrome in men. Med Sci Sports Exerc. 2005;37(11):1849-55.
Doi: 10.1249/01.mss.0000175865.17614.74
[5] Byeon JY, Lee MK, Yu MS, Kang MJ, Lee DH, Kim KC, et al. Lower Relative Handgrip Strength
is Significantly Associated with a higher prevalence of the Metabolic Syndrome in Adults. Metab
Syndr Relat Disord. 2019;17(5):280-288. Doi: 10.1089/met.2018.0111.
[6] González-Muniesa P, Martínez-González MA, Hu EB, Després JP, Matsuzawa Y, Loos RJF,
Moreno LA, Bray GA, Martínez JA. Obesity. Nat Rev Dis Prim 2017;3:17034
[7] Bener A, Yousafzai MT, Darwish S, Al-HAmaq AO, Nasralla EA, Abdul-Ghani M. Obesity index
that better predict metabolic syndrome: Body mass index, waist circumference, waist hip ratio, or
waist height ratio. J Obes 2013;2013:269038
[8] López-Martínez S, Sánchez-López M, Solera-Martínez M, Arias-Palencia N, Fuentes-Chacón
RM, Martínez-Vizcaíno V. Physical activity, fitness, and metabolic syndrome in Young adults. Int J
Sport Nut Exerc Metab 2013;23:312-21.
[9] Xu L, Cheng X Wang J, Cao Q, Sato T, Wang M, Zhao X, Liang W. Comparisons of body-
composition prediction accuracy: a study of 2 biolectric impedance consumer devices in healthy
Chinese persons using DXA and MRI as criteria methods. J Clin Densitom 2011;14:458-464.
84 
 
[10] Knowles KM, Paiva LL, Sanchez SE, Revilla L, Lopez T, Yasuda MB, Yanez ND, Gelaye B, 
Williams MA. Waist circumference, body mass index, and other measures of adiposity in predicting 
cardiovascular disease risk factors among Peruvian adults. Int J Hypertens 2011;2011:1-10. 
[11] Mohammadreza B, Farzad H, Davoud K, Fereidoun AF. Prognostic significance of the complex 
“Visceral Adiposity Index” vs. simple anthropometric measures: Tehran lipid and glucose study. 
Cardiovasc Diabetol 2012;11:20. 
[12] Mousa U, Kut A, Bozkus Y, Cicek Demir C, Anil C, Bascil Tutuncu N. Performance of 
abdominal bioelectrical impedance analysis and comparison with other known parameters in 
predicting the metabolic syndrome. Exp Clin Endocrinol Diabetes 2013, 121, 391-396. 
[13] Peltz G, Aguirre MT, Sanderson M, Fadden MK. The role of fat mass index in determining 
obesity. Am J Hum Biol 2010; 22: 639-647. 
[14] Schutz Y, Kyle U, Pichard C. Fat-free mass index and fat mass index percentiles in Caucasions 
aged 18-98 years. Int J Obes 2002;26:953-960. 
[15] Saklayen MG. The Global Epidemic of the Metabolic Syndrome. Curr Hypertens Rep. 
2018;20(2):12. Doi: 10.1007/s11906-018-0812-z. 
[16] Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 
2004;89(6):2548-56. Doi: 10.1210/jc.2004-0395. 
[17] Carobbio S, Pellegrinelli V, Vidal-Puig A. Adipose tissue function and expandability as 
determinants of lipotoxicity and the Metabolic Syndrome. Adv Exp Med Biol. 2017;960:161-196. 
Doi: 10.1007/978-3-319-48382-5_7. 
[18] Yazici D, Sezer H. Insuline resistance, Obesity and Lipotoxicity. Adv Exp Med 
Biol.2017;960:277-304. Doi: 10.1007/978-3-319-48382-5_12. 
[19] Van Pelt DW, Newsom SA, Schenk S, Horowitz JF. Relatively low endogenous fatty acid 
mobilization and uptake helps preserve insulin sensitivity in obese women. Int J Obes. (Lond). 
2015;39(1):149-55. Doi: 10.1038/ijo.2014.70. 
[20] Senechal M, McGavock JM, Church TS, Lee DC, Earnest CP, Sui X, et al. Cut points of muscle 
strength associated with metabolic syndrome in men. Med Sci Sports Exerc 2014;46:1475-81. 
[21] Lee WJ, Peng LN, Chiou ST, Chen LK. Relative handgrip strength is a simple indicator of 
cardiometabolic risk among middle-aged and older people: a nationwide population-based study in 
Taiwan. PLoS One 2016;11:e0160876. Doi:10.1371/journal.pone.0160876. 
[22] Peterson MD, Duchowny K, Meng Q, Wang Y, Chen X, Zhao Y. Low Normalized Grip Strength 
is a Biomarker for Cardiometabolic Disease and Physical Disabilities Among U.S. and Chinese 
Adults.  J Gerontol A Biol Sci Med Sci. 2017;72(11):1525-1531. Doi:10.1093/Gerona/glx031. 
[23] Ramírez-Vélez R, Correa-Rodríguez M, Izquierdo M, Schmidt-RioValle J, González-Jiménez 
E. Muscle fitness to visceral fat ratio, metabolic syndrome and ideal cardiovascular health metrics. 
Nutrients. 2018;11(1). Pii.E24. Dooi: 10.3390/nu11010024. 
[24] Artero EG, Lee DC, Lavie CJ, España-Romero V, Sui X, Chruch TS, Blair SN. Effects of 
muscular strength on cardiovascular risk factors and prognosis. J Cardiopulm Rehabil Prev. 
2012;32(6):351-8. Doi: 10.1097/HCR.0013e3182642688. 
85 
 
[25] Stump CS, Henriksen EJ, Wei Y, Sowers JR. The metabolic syndrome: a role of skeletal muscle 
metabolism. Ann Med. 2006;38(6):389-402. Doi: 10.1080/07853890600888413. 
[26] Wijndaele K, Duvigneaud N, Matton L, Duquet W, Thomis M, Beunen G, et al. Muscular 
strength, aerobic fitness, and metabolic syndrome risk in Flemish adults. Med Sci Sports Exerc. 
2007:39(2):233-40. Doi: 10.1249/01.mss.0000247003.32589.ag 
[27] Tomeleri CM, Souza MF, Burini RC, Cavaglieri CR, Ribeiro AS, Antunes M, et al. Resistance 
training reduces metabolic syndrome and inflammatory markers in older women: A randomized 
controlled trial.  J Diabetes. 2018;10(4):328-337. Doi: 10.1111/1753-0407.12614. 
[28] World Health Organization. Cardiovascular disease. [internet]. 2017 [cited 2019 Jun]. Available 
from: https://www.who.int/cardiovascular_diseases/about_cvd/en/ 
[29] Joseph P, Leong D, McKee M, Anand SS, Schwalm JD, Teo K, et al. Reducing the Global 
Burden of Cardiovascular Disease, Part 1: The Epidemiology and Risk Factors. Circ Res. 2017; 
121:677-694. DOI: 10.1161/CIRCRESAHA.117.308903.  
[30] Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, et al. Defining 
and setting national goals for cardiovascular health promotion and disease reduction: the American 
Heart Association´s strategic Impact Goal through 2020 and beyond. Circulation. 2010;121(4):586-
613. Doi:10.1161/CIRCULATIONAHA.109.192703. 
[31] Stamler J, Stamler R, Neaton JD, Wentworth D, Daviglus ML, Garside D, et al. Low Risk-Factor 
Profile and Long-term Cardiovascular and Noncardiovascular Mortality and Life Expectancy: 
Findings for 5 Large Cohorts of Young Adult and Middle-Aged Men and Women. JAMA 
1999;282(21):2012-8. 
[32] Casagrande SS, Menke A, Cowie CC. Cardiovascular Risk Factors of Adults Age 20-49 Years 
in the United States, 1971-2012: A series of Cross-Sectional Studies. PloS One.2016;11(8): 
e0161770. Doi: 10.1371/journal.pone.0161770. 
[33] Bucholz EM, Gooding HC, de Ferranti SD. Awareness of Cardiovascular Risk Factors in U.S. 
Young Adults Aged 18-39 Years. Am J Prev Med. 2018;54(4):e67-77. 
[34] Ramírez-Vélez R, Saavedra JM, Lobelo F, Celis-Morales CA, Pozo-Cruz BD, García-Hermoso 
A. Ideal Cardiovascular Health and Incident Cardiovascular Disease Among Adults: A Systematic 
Review and Meta-analysis. Mayo Clin Proc. 2018;93(11):1589-1599. Doi: 
10.1016/j.mayocp.2018.05.035. 
[35] Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. 
Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) 
study. Lancet. 2015;386(9990):266-73. Doi: 10.1016/S014-6736(14)62000-6. 
[36] García-Hermoso A, Cavero-Redondo I, Ramírez-Vélez R, Ruiz JR, Ortega FB, Lee D-C, et al. 
Muscular Strength as a Predictor of All-Cause Mortality in an Apparently Healthy Population: A 
Systematic Review and Meta-Analysis of Data from Approximately 2 Million Men and Women. Arch 
Phys Med Rehabil. octubre de 2018;99(10):2100-2113.e5. 
[37] Ramírez-Vélez R, Tordecilla-Sanders A, Correa-Bautista JE, Peterson MD, and Garcia-
Hermoso, A. Handgrip strength and ideal cardiovascular health among Colombian children and 
adolescents. J Pediatr 2016; 179: 82–89.e81. 
86 
 
[38] Phillips SA, Mahmoud AM, Brown MD, Haus JM. Exercise interventions and peripheral arterial 
function: implications for cardiometabolic disease. Prog Cardiovasc Dis. 2015;57(5):521-34. Doi: 
10.1016/j.pcad.2014.12.005. 
[39] Lin X, Zhang X, Guo J, Roberts CK, McKenzie S, Wu WC, et al. Effects of Exercise Training 
on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A systematic Review and 
Meta- Analysis of Randomized Controlled Trials. J Am Heart Assoc. 2015;4(7). Pii: e002014. Doi: 
10.1161/JAHA.115.002014. 
[40] Terzis G, Georgiadis G, Stratakos G, Vogiatzis I, Kavouras S, Manta P, et al. Resistance 
exercise-induced increase in muscle mass correlates with p70S6 kinase phosphorylation in human 
subjects. Eur J Appl Physiol 2008; 102: 145–152. 
[41] Rada I, Deldioque L, Francaux M, Zbinden-Foncea H. Toll like receptor expresión induced by 
exercise in obesity and metabolic syndrome: a systemic review. Exerc Immunol Rev. 2018;24:60-71. 
[42] Pedersen BK. Exercise-induced myokines and their role in chronic diseases. Brain Behav Immun. 
2011;25(5):811-6. Doi: 10.1016/j.bbi.2011.02.010.  
[43] Pedersen BK, Fischer CP. Physiological roles of muscle-derived interleukin-6 in response to 
exercise. Curr OPin Clin Nutr Metab Care. 2007;10(3):265-71. Doi: 
10.1097/MCO.0b013e3280ebb5b3. 
[44] Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-
6. Physiol Rev. 2008;88(4):1379-406. Doi: 10.1152/physrev.90100.2007. 
[45] Fernandes T, Gomes-Gatto CV, Pereira NP, Alayafi YR, das Neves VJ, Oliveira EM. NO 
signaling in the Cardiovascular System and Exercise. Adv Exp Med Biol.2017;1000:211-245. Doi: 
10.1007/978-981-10-4304-8_13. 
 
 
 
 
 
 
 
 
 
 
 
  
87 
 
Chapter 6: Conclusions, practical applications and future perspectives 
 
Study 1 (chapter 2) 
Conclusion 1: In the first study, it can be conclude that BF% and FMI had a moderate 
discriminatory power in the identification of MetS in Colombian university students and is 
demonstrated that a BF% ≥ 38.9% in women and ≥25.5% in men, and an FMI ≥11.8 kg/m2 in women 
and ≥ 6.9 kg/m2 in men, are thresholds that could be used to predict Colombian young adults at high 
risk of MetS. This study reports the first cutoff points for identification of MetS by BF% and FMI in 
Colombian young adults.  
Practical application 1: This study demonstrates the discriminatory capability of the BF% 
and FMI in the detection of MetS in University students, which highlight the important implications 
for evaluating CVD and MetS risks factors.  
Future perspective 1: Longitudinal studies are required to elucidate the mechanisms 
responsable that explain how body fat contribute to health risks in college-aged adults. 
 
Study 2 (chapter 3) 
Conclusion 2: In summary, the sex-specific NGS cut-offs could be incorporated into a 
clinical setting for identifying college students at high cardiometabolic disease risk and used as a 
target for strength training programs designed to reduce the risk of MetS. Longitudinal studies are 
necessary to determine of increasing handgrip strength reduces the likelihood of MetS. 
Practical application 2: This study demonstrates the discriminatory capability of the NGS 
in the detection of MetS in University students, which highlight the important implications for 
evaluating CVD and MetS risks factors. 
Future perspective 2: Longitudinal studies are required to elucidate the mechanisms 
responsible that explain how Muscular strength contribute to the detection of MetS in college-aged 
adults. 
 
Study 3 (chapter 4) 
Conclusion 3: The findings of this study indicate that NGS and muscular strength are 
positively associated with ideal CVH metrics in Colombian collegiate students. The categorization of 
the ideal CVH metrics relies on the assumption that all risk factors and behaviors contained in this 
concept contribute equally to the final score. 
Practical application 3: This study suggest the importance to generate preventive strategies 
to reduce the future public health burden associated to muscular weakness, and should be focused on 
the lifestyle-related risk factors during the young adult stage. 
Future perspective 3: Longitudinal studies are required to elucidate the mechanisms 
responsible that explain how Muscular strength is associated to the lifestyle-related health factors in 
college-aged adults. 
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Conclusiones generales 
 
Estudio 1 (Capítulo 2)  
Conclusión 1: En este primer estudio, se puede concluir que el porcentaje de tejido graso 
(BF%- Siglas en inglés Body fat percentage) y el índice de masa grasa (FMI- Siglas en inglés Fat 
mass index) tuvo moderado poder discriminatorio en la identificación de Síndrome metabólico 
(MetS- Siglas en inglés Metabolic Syndrome) en estudiantes universitarios de Colombia y se 
demuestra que un BF% ≥ 38.9% en mujeres y ≥25.5% en hombres, y un FMI ≥11.8 kg/m2 en mujeres 
y ≥ 6.9 kg/m2 en hombres, son umbrales que podrían usarse para predecir adultos jóvenes 
Colombianos con alto riesgo de síndrome metabólico. Este estudio reporta los primeros puntos de 
corte para identificar el síndrome metabólico a través del BF% y FMI en adultos jóvenes 
Colombianos. 
Aplicaciones prácticas 1: Este estudio demuestra la capacidad discriminatoria del BF% y el 
FMI en la detección de MetS en estudiantes universitarios, lo que destaca las importantes 
implicaciones para evaluar los factores de riesgo de las Enfermedades cardiovasculares (CVD-Siglas 
en inglés Cardiovascular Disease) y el síndrome metabólico. 
Perspectivas futuras 1: Se requieren de estudios longitudinales que diluciden los 
mecanismos responsables de explicar cómo la masa grasa contribuye al riesgo en la salud de adultos 
universitarios. 
Estudio 2 (Capítulo 3) 
Conclusión 2: En resumen, los puntos de corte de fuerza prensil ajustada (NGS- siglas en 
inglés Normalized handgrip strength) específicos por sexo, podrían incorporarse en un entorno 
clínico para identificar a estudiantes universitarios con alto riesgo de enfermedad cardiometabólica y 
utilizarse como objetivo para programas de entrenamiento de fuerza diseñados para reducir el riesgo 
de síndrome metabólico. Estudios longitudinales son necesarios para determinar como el aumento de 
la fuerza prensil reduce la probabilidad de aparición de síndrome metabólico. 
Aplicaciones prácticas 2: Este estudio demuestra la capacidad discriminatoria de la NGS en 
la detección de síndrome metabólico en estudiantes universitarios, lo que destaca las importantes 
aplicaciones para evaluar los factores de riesgo de las Enfermedades cardiovasculares y el síndrome 
metabólico. 
Perspectivas futuras 2: Se requieren de estudios longitudinales que diluciden los 
mecanismos responsables de explicar cómo la fuerza muscular contribuye en la detección de 
Síndrome metabólico   en adultos universitarios. 
Estudio 3 (Capítulo 4) 
Conclusión 3: Los hallazgos de este estudio indican que la NGS y la fuerza muscular se 
asocian positivamente con las métricas ideales de salud cardiovascular en estudiantes universitarios 
de Colombia. La categorización de las métricas ideales de salud cardiovascular se basa en el supuesto 
de que todos los factores de riesgo y comportamiento que componen este concepto, contribuyen 
equitativamente a la puntuación final. 
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Aplicaciones prácticas 3: Este estudio sugiere la importancia de generar estrategias 
preventivas para reducir futura carga de salud pública asociada con la debilidad muscular se debe 
centrar en los factores de riesgo relacionados con el estilo de vida durante la edad adulta. 
Perspectivas futuras 3: Se requieren de estudios longitudinales que diluciden los 
mecanismos responsables de explicar cómo la fuerza muscular se asocia con factores de salud 
relacionados con el estilo de vida en adultos universitarios. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
Chapter 7: Relevant Papers 
 
nutrients
Article
Percentage of Body Fat and Fat Mass Index
as a Screening Tool for Metabolic Syndrome
Prediction in Colombian University Students
Robinson Ramírez-Vélez 1,* ID , Jorge Enrique Correa-Bautista 1 ID ,
Alejandra Sanders-Tordecilla 1, Mónica Liliana Ojeda-Pardo 2, Elisa Andrea Cobo-Mejía 2,
Rocío del Pilar Castellanos-Vega 2, Antonio García-Hermoso 3 ID , Emilio González-Jiménez 4,5 ID ,
Jacqueline Schmidt-RioValle 4,5 and Katherine González-Ruíz 6
1 Centro de Estudios para la Medición de la Actividad Física CEMA, Escuela de Medicina y Ciencias de la
Salud, Universidad del Rosario, Bogotá DC 111221, Colombia; jorge.correa@urosario.edu.co (J.E.C.-B.);
alesanders_0615@hotmail.com (A.S.-T.)
2 Grupo CORPS, Universidad de Boyacá, Facultad de Ciencias de la Salud, Boyacá 150003, Colombia;
mlojeda@uniboyaca.edu.co (M.L.O.-P.); eacobo@uniboyaca.edu.co (E.A.C.-M.);
dpcastellanos@uniboyaca.edu.co (R.d.P.C.-V.)
3 Laboratorio de Ciencias de la Actividad Física, el Deporte y la Salud, Facultad de Ciencias Médicas,
Universidad de Santiago de Chile, USACH, Santiago 7500618, Chile; antonio.garcia.h@usach.cl
4 Departamento de Enfermería, Facultad de Ciencias de la Salud, Avda. De la Ilustración, 60,
University of Granada, 18016 Granada, Spain; emigoji@ugr.es (E.G.-J.); jschmidt@ugr.es (J.S.-R.)
5 Grupo CTS-436, Adscrito al Centro de Investigación Mente, Cerebro y Comportamiento (CIMCYC),
University of Granada, 18071 Granada, Spain
6 Grupo de Ejercicio Físico y Deportes, Vicerrectoría de Investigaciones, Universidad Manuela Beltrán,
Bogotá DC 110231, Colombia; katherine.gonzalez@docentes.umb.edu.co
* Correspondence: robin640@hotmail.com or robinson.ramirez@urosario.edu.co;
Tel.: +57-1-297-0200 (ext. 3428)
Received: 26 June 2017; Accepted: 11 September 2017; Published: 13 September 2017
Abstract: High body fat is related to metabolic syndrome (MetS) in all ethnic groups. Based on
the International Diabetes Federation (IDF) definition of MetS, the aim of this study was to
explore thresholds of body fat percentage (BF%) and fat mass index (FMI) for the prediction
of MetS among Colombian University students. A cross-sectional study was conducted on
1687 volunteers (63.4% women, mean age = 20.6 years). Weight, waist circumference, serum lipids
indices, blood pressure, and fasting plasma glucose were measured. Body composition was
measured by bioelectrical impedance analysis (BIA) and FMI was calculated. MetS was defined as
including more than or equal to three of the metabolic abnormalities according to the IDF definition.
Receiver operating curve (ROC) analysis was used to determine optimal cut-off points for BF% and
FMI in relation to the area under the curve (AUC), sensitivity, and specificity in both sexes. The overall
prevalence of MetS was found to be 7.7%, higher in men than women (11.1% vs. 5.3%; p < 0.001).
BF% and FMI were positively correlated to MetS components (p < 0.05). ROC analysis indicated
that BF% and FMI can be used with moderate accuracy to identify MetS in university-aged students.
BF% and FMI thresholds of 25.55% and 6.97 kg/m2 in men, and 38.95% and 11.86 kg/m2 in women,
were found to be indicative of high MetS risk. Based on the IDF criteria, both indexes’ thresholds
seem to be good tools to identify university students with unfavorable metabolic profiles.
Keywords: obesity; adiposity; fat mass; metabolic syndrome
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1. Introduction
With increasing prevalence worldwide, obesity has become a significant public health issue [1].
Obesity has been linked to a number of cardiovascular disease (CVD) risk factors including metabolic
syndrome (MetS) [2]. In Colombia, it is estimated that over 50% of adults are overweight or obese and
the obesity epidemic has been associated with obesogenic factors, such as an intake of energy-dense
diets, a sedentary lifestyle, and low levels of physical activity [3,4] .
In this context, there is growing evidence that suggests that the way in which fat is distributed
contributes different effects on the cardiometabolic risk associated with obesity [3–5]. In addition,
measures of central body obesity, such as waist circumference and waist–hip ratio, have been
suggested as being more strongly related to MetS risk compared to body mass index (BMI) [4,5].
Aside from age or sex, excess body fat is the strongest determinant of an individual’s risk of developing
MetS [6], and several epidemiological studies have found an association between fat distribution and
metabolic risk factors, including high blood pressure, dysglycemia, dyslipidemia, and subsequent risk
of MetS [4,5].
Although BMI is the most frequently used method to assess the level of obesity [7], BMI does not
differentiate between body lean mass and body fat mass; that is, a person can have a high BMI but still
have a low fat mass and vice versa [8,9]. In addition, the ongoing uncertainty as to which measure
of body fat is most important at gauging an individual’s risk [6], particularly with respect to MetS,
may also contribute to the lack of their use and monitoring in clinical practice.
In this sense, Computed Tomography (CT) or dual-energy X-ray absorptiometry (DXA),
continue to be the gold standard for evaluating the distribution of body fat [10]. Nevertheless,
the high cost and low availability have made it difficult to use in large population studies. Evidently,
this factor limits the possible screening of MetS in high-risk populations, especially in developing
countries such as Colombia [2,11]. Recently, more research has examined the potential role of body
composition measurements in health monitoring [12,13]. Bioelectrical impedance analysis (BIA) is the
method that is most frequently used to assess body composition and calculate BF% in clinical practice,
given its accuracy, simplicity, low cost, and excellent correlation with DXA, CT, or magnetic resonance
imaging (MRI) [14,15].
Alternative simple and inexpensive approaches for assessing body adiposity have been suggested.
A recent study highlighted the usefulness of the fat mass index (FMI), measured as kg/m2,
as an indicator of the function of adipose tissue as a surrogate marker of cardiovascular risk in young
adults [16]. However, BF% and FFM are known to change with height, weight, sex, and age. Along this
line, VanItallie et al. [16] proposed an FMI that considers an individual’s height. FMI, like BMI
except that it uses a two-compartment model, merits reappraisal and appears to be of interest in the
classification of overweight, obese, and underweight patients [17]. Previous research has evaluated
the applicability of FMI in the prediction of MetS and has highlighted its close relation with the
components of MetS [17]. However, only a few studies have focused on the differential impacts
adiposity levels [18–24] in young adults when examining the link between fat and the risk of MetS.
Understanding the specific fat distribution associated with MetS risk is important to improve
the interventions that are currently more focused on overall weight loss [5,6]. Our study proposes
a gender-specific fat index based on BIA as a way of estimating the fat mass and body adiposity
dysfunction associated with MetS. Apart from the study of Liu et al. [17], this is the first study in
Colombian young adults (university students) to investigate the association between fat mass by BIA
and MetS components. Based on the IDF definition of MetS [2], the aim of the study was to explore
thresholds of BF% and FMI for the prediction of MetS among Colombian university students.
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2. Methods
2.1. Study Design and Sample Population
During the 2014–2017 academic years, we reviewed a cross-sectional component of the FUPRECOL
study that investigated the association between muscular strength and metabolic risk factors in
Colombian collegiate students. The FUPRECOL study aimed to establish the general prevalence
of cardiovascular risk factors, including anthropometric and metabolic markers, in the study
population and to examine the relationships between physical fitness levels, body composition,
and cardiometabolic risk factors. We recently published a complete description of the FUPRECOL
study design, methods, and primary outcomes for our current cohort [2]. The sample consisted
of adults (men: n = 707; women: n = 1128). We removed cases due to missing (n = 37, 2.0%) or
erroneous data entry (n = 83, 4.5%) and those which had neither age nor a valid date of birth recorded
(n = 28, 1.5%), limiting the analytical sample to 1687 volunteers, which was 63.4% women and
a mean age of 20.6 years. The subjects, whose ages ranged from 18 to 35 years, were all of low to
middle socioeconomic status (SISBEN levels: 1–4 on a scale of 1–6 as defined by “The System of
Identifying Potential Beneficiaries of Social Programs”, called SISBEN). The system takes into account
sociodemographic characteristics including family composition, employment status, family income,
and educational level; living conditions, including construction type and materials; and access to
public utilities, which involves sewers, electricity, potable water, and garbage collection. They were
enrolled in public or private universities in the capital district of Bogota, Boyacá, and Cali, Colombia.
Exclusion criteria included the following: medical or clinical diagnosis of a major systemic
disease including malignant conditions such as cancer, type 1 or 2 diabetes, high blood pressure,
hypothyroidism or hyperthyroidism; a history of drug or alcohol abuse; regular use of multivitamins;
chronic inflammatory conditions including rheumatoid arthritis, systemic lupus erythematosus,
multiple sclerosis; infectious conditions; and a BMI ≥ 35 kg/m2. Volunteers received no compensation
for their participation.
2.2. Data Collection
Subjects were screened for inclusion in the study via personal interviews. Interview questions
collected consisted of health status, medical history, CVD risk factors, and lifestyle. After completing
another general information questionnaire, participants were instructed to wear shorts and a T-shirt
to the physical exam. They were also required to remove all worn jewelry and metal objects.
Once the subjects were barefoot and in their underwear, their body weight (kg) was measured using
an electric scale (Model Tanita® BC-418®, Tokyo, Japan) with a range of 0–200 kg and with an accuracy
of within 100 g. Height was measured with a portable stadiometer with a precision of 0.1 cm and a range
of 0–2.5 m (Seca® 274, Hamburg, Germany). BMI was calculated by using the formula proposed by
Quetelet where BMI = body mass (kg)/height (m2). Body mass index status was evaluated according to
the World Health Organization (WHO) criteria [24]. The waist circumference (WC) (cm) was measured
as the narrowest point between the lower costal border and the iliac crest. When this point was not
evident, it was measured at the midpoint between the last rib and the iliac crest, using a metal tape
measure (Lufkin W606PM®, Parsippany, NJ, USA), in accordance with the International Society for
the Advancement of Kinanthropometry guidelines [25]. The evaluation process was carried out by
a team of professionals (four physical therapy professors) with extensive experience in anthropometric
measurement. Two percent of the sample was measured twice in order to ensure quality of measures.
The technical error of measurement (TEM) values was less than 2% for all anthropometric variables.
BF% and FMI were determined for BIA by a tetrapolar whole body impedance (Tanita Model
BC-418®, Tokyo, Japan). A detailed description of the BIA technique can be found in a previous
study [2]. For the calculation of intra–inter observer TEM, at least 50 subjects needed to be measured
(30 men, 20 women, aged 22.3 ± 2.1 years). The corresponding intra-observer technical error
(% reliability) of the measurements was 95%. FMI was then calculated by dividing each subject’s fat
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mass (kg) by the square of his or her height (m), as previously described [17]. In a sub-sample (48 adults,
54% women, range mean age = 20 to 40 years old), we verified the validity of BIA for predicting BF%
in Colombian adults using DXA as a reference. Our analysis showed a strong agreement between
the two methods, as reflected in the range of BF% (Lin’s concordance correlation coefficient = 0.943
(95% CI = 0.775 to 0.950, p = 0.041) and bias −0.6 (SD 2.2; 95% CI = −5.0 to 3.7). In line with our
findings, a previously study has shown a high correlation between fat mass determined by BIA and
that obtained by a CT scan and DXA [14,15,26]. Thus, these results show that BIA and DXA are
comparable methods for measuring body composition with lower/higher body fat percentages.
2.3. Metabolic Syndrome Diagnosis
After the subjects had fasted for 10–12 h, blood samples were obtained from capillary sampling
between 6:00 a.m. and 9:00 a.m. Participants were asked not to engage in prolonged exercise in the 24 h
prior to testing. The biochemical profile included the following: (i) high-density lipoprotein cholesterol
(HDL-C); (ii) triglycerides; (iii) low-density lipoprotein cholesterol (LDL-C); (iv) total cholesterol;
(v) glucose fasting by enzymatic colorimetric methods (CardioChek PA®, Polymer Technology Systems,
PTS, Indianapolis, IN, USA). The inter-assay reproducibility (coefficient of variation) was determined
from 16 replicate analyses of 8 capillary blood pools over a period of 15 days. The percentages obtained
were 2.6% for triglycerides, 2.0% for total cholesterol, 3.2% for HDL-C, 3.6% for LDL-C, and 1.5% for
fasting glucose.
Blood pressure was taken on the left arm at the heart level with an automatic device Omron M6
Comfort (Omron® Healthcare Europe B.V., Hoofddorp, The Netherlands) while the participants were
sitting still. The blood pressure monitor cuff was placed two to three finger-widths above the bend
of the arm and a two-minute pause was allowed between the first and second measurements with
a standard cuff for an arm circumference of 22–32 cm.
MetS was defined in accordance with the updated harmonized criteria of the IDF [2]. Participants
were considered to have MetS if they showed three or more of the following: (1) abdominal obesity for
individuals (WC ≥ 80 cm in women and ≥ 90 cm in men) [27]; (2) hypertriglyceridemia (≥150 g/dL);
(3) low HDL-C (<50 mg/dL in women and <40 mg/dL in men); (4) high blood pressure (systolic blood
pressure≥ 130 mmHg or diastolic blood pressure≥ 85 mmHg); (5) high fasting glucose (≥100 mg/dL).
2.4. Lifestyle Co-Variables
A standardized questionnaire, FANTASTIC lifestyle, was used to collect comprehensive
information about substance use via a personal interview with participants [28]. Alcohol consumption
and smoking status were defined as subjects who had consumed any alcoholic beverage ≥1 times
per week, and those who had smoked ≥10 cigarettes per week, for at least six months, as previously
described by Ramírez-Vélez et al. [28]. Participants who exercised three or more times a week
for >30 min were categorized as physically active (PA), and those who exercised less than three
times a week were considered insufficiently physically active. The accuracy of information about
lifestyle co-variables obtained from the FANTASTIC questionnaire has been validated by different
cross-sectional studies and described in detail elsewhere [28,29].
2.5. Ethics Statement
Informed consent was obtained from each participant. The protocol was based on the Helsinki
Declaration Accord (World Medical Association for Human Subjects). Moreover, ethical approval was
obtained from the Universidad Manuela Beltrán (UMB N◦ 01-1802-2013).
2.6. Statistical Analysis
Participants’ characteristics obtained were given as mean values and standard deviation (SD).
Histograms and Q–Q plots were used to verify the normality of the selected variables. Independent
two-tailed t-tests for continuous variables, and chi-square (χ2) tests for categorical variables, were used
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to examine sex differences or MetS grouping. The relationships between BF%, FMI, and MetS
components were tested by means of partial correlation coefficients. This analysis was adjusted by age,
sex, tobacco, and alcohol consumption, and PA levels. To predict MetS with BF% and FMI, we used area
under the curve (AUC), ranging between 0 and 1 (a worthless and a perfect test, respectively), which is
a global indicator of diagnostic performance, and represents the ability of the test to correctly classify
participants with high risk MetS by p-values < 0.01 and an AUC > 0.80. The positive likelihood ratio
LR (+) and the negative likelihood ratio LR (−) were also determined. Cutoff points were chosen based
on the highest Youden index, i.e., the point on the receiver operating characteristic curve (ROC) that is
farthest from the line of equality [30]. Data analysis was performed using the Statistical Package for the
Social Sciences for Windows SPSS, version 21.0 (SPSS Inc., Chicago, IL, USA). Statistical significance
was set at p < 0.05.
3. Results
3.1. Descriptive Characteristics
Descriptive characteristics of the participants are presented in Table 1. The final sample had
a mean age of 20.6 years (SD 3.0; range 19–24 years), with 63.4% of participants being women. Women
were found to have significantly lower height, WC, blood pressure, triglycerides, and PA than men
(p < 0.05). The prevalence of MetS was higher in men than in women at 11.2% vs. 5.3% (p < 0.001).
Table 1. Characteristics among a sample of college students from Colombia (mean (SD) or frequency (%)).
Characteristic Men (n = 617) Women (n = 1070) p-Value
Anthropometric
Age (years) 20.6 (2.2) 20.6 (2.0) 0.843
Weight (kg) 58.9 (10.0) 69.9 (12.4) <0.001
Height (cm) 159.8 (6.1) 172.5 (6.7) <0.001
WC (cm) 78.4 (9.5) 71.5 (7.9) <0.001
BMI (kg/m2) 23.2 (3.7) 23.2 (3.7) 0.356
Body fat (%) 15.7 (6.7) 27.0 (7.2) 0.028
FMI 3.9 (2.3) 6.5 (2.7) <0.001
Body mass index status n (%) *
Underweight 34 (5.5) 71 (6.7)
<0.001
Normal weight 425 (68.8) 725 (57.8)
Overweight 128 (20.8) 220 (20.5)
Obese 31 (5.0) 54 (5.0)
Blood pressure
Systolic blood pressure (mmHg) 120.83 (13.0) 111.28 (11.1) <0.001
Diastolic blood pressure (mmHg) 74.83 (11.4) 71.78 (9.3) <0.001
Mean arterial pressure (mmHg) 97.83 (10.8) 91.53 (8.9) <0.001
Metabolic biomarkers
Total cholesterol (mg/dL) 132.26 (30.8) 146.27 (33.3) 0.212
Triglycerides (mg/dL) 93.01 (48.7) 88.10 (43.7) 0.011
LDL-C (mg/dL) 38.92 (10.4) 43.98 (12.8) <0.001
HDL-C (mg/dL) 81.89 (26.5) 87.85 (26.2) 0.589
Glucose (mg/dL) 84.36 (12.2) 85.99 (11.6) 0.002
Metabolic Syndrome n (%) *
Yes 73 (11.2) 59 (5.3) 0.001
Life-style n (%) *
Tobacco (≥10 cigarettes per week) 183 (29.7) 213 (19.9) 0.289
Alcohol (≥1 times per week) 294 (47.6) 381 (35.6) 0.358
PA (three or more times a week for >30 min) 213 (34.5) 228 (21.3) 0.011
Continuous variables are reported as mean values (standard deviations) and categorical variables are reported
as numbers and percentages in brackets. Significant between-sex differences (t-tests or * chi-square test χ2).
WC: waist circumference; BMI: body mass index; FMI: fat mass index; LDL-C: low-density lipoprotein cholesterol;
HDL-C: high-density lipoprotein cholesterol; PA: physical activity.
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At least one MetS component was found in 818 participants (48.5%), two MetS components were
present in 341 participants (20.2%), three MetS components were found in 126 participants (7.7%),
and four or more components of MetS were present in 80 participants (4.7%) (Figure 1).Nutrients 2017, 9, 1009 6 of 13 
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3.2. Clinical Characteristics and Distribution by etS Status
Independent of sex, participants with MetS had significantly higher weight, body ass index, WC,
BF%, FMI, and total cholesterol and triglyceride levels (p < 0.01) (Table 2). Furthermore, participants
without MetS were more active (34.5% vs. 17.8% for men, and 21.1% vs. 6.8% for women, p < 0.01).
Table 2. The descriptiv characteristics of participants with and without tS in both sexes.
Variable
Men (n = 617) Women (n = 1070)
MetS
(n = 73)
Non-MetS
(n = 544) p Value
MetS
(n = 59)
Non-MetS
(n = 1011) p Value
Anthropometric
Age (years) 21.7 (3.4) 20.4 (3.1) 0.229 22.3 (3.8) 20.5 (2.8) <0.001
Weight (kg) 80.8 (15.8) 67.3 (10.7) <0.001 76.4 (13.8) 57.4 (8.8) <0.001
Height (cm) 172.7 (7.5) 172.1 (6.6) 0.129 161.1 (5.6) 158.9 (5.8) 0.902
WC (cm) 89.5 (11.6) 76.7 ( .0) <0.001 84.9 (8.8) 70.5 (7.1) 0.145
BMI (kg/m2) 27.0 (4.7) 22.6 (3. ) <0.001 29.3 (4.7) 22.7 (3.3) <0.001
Body fat (%) 23.5 (7.5) 14.5 (5.7) 0.005 37.3 (6.0) 26.2 (6.8) <0.001
FMI (kg/m2) 6.6 (3.1) 3.4 (1.8) <0.001 11.2 (3.4) 6.1 (2.4) <0.001
Body mass index status n (%) *
Underweight 4 (0.6) 30 (5.0)
<0.001
0.0 ( .0) 71 (6.6)
<0.001
Normal weight 16 (2.6) 408 (66.1) 8 (0.8) 717 (67.0)
Overweight 37 (6.0) 91 (14.8) 23 (2.1) 197 (18.4)
Obese 16 (2.6) 15 (2.4) 28 (2.6) 26 (2.4)
Blood pressure
Systolic blood pressure (mmHg) 131.01 (11.96) 119.36 (12.44) 0.461 123.50 (11.03) 110.33 (10.64) 0.809
Diastolic blood pressure (mmHg) 83.60 (10.75) 73.48 (10.07) 0.160 81.61 (13.82) 71.10 (8.60) 0.237
Mean blood pressure (mmHg) 107.30 (10.20) 96.42 (10.07) 0.176 102.55 (9.16) 90.71 (8.36) 0.518
Metabolic biomark rs
Total cholesterol (mg/dL) 146.01 (39.6) 130.27 (29.1) <0.001 153.39 (33.7) 145.74 (33.3) 0.955
Triglyceride (mg/dL) 163.03 (75.9) 83.04 (33.7) <0.001 139.83 (66.6) 84.90 (40.2) <0.001
HDL-C (mg/dL) 31.27 (5.9) 40.06 (10.5) <0.001 36.51 (9.0) 44.52 (12.9) 0.002
LDL-C (mg/dL) 86.01 (30.8) 81.31 (26.0) 0.077 89.61 (28.4) 87.57 (26.1) 0.571
Glucose (mg/dL) 92.44 (13.8) 83.14 (11.6) 0.063 92.58 (14.4) 85.49 (11.3) 0.142
Life-style n (%) *
Tobacco (≥10 cigarettes per week) 19 (26.0) 155 (28.5) 0.769 5 (8.5) 198 (19.6) 0.088
Alcohol (≥1 times per week) 36 (49.3) 294 (54.0) 0.563 22 (37.3) 394 (38.7) 0.378
PA (three or more times a week for >30 min) 13 (17.81) 188 (34.5) 0.005 4 (6.8) 213 (21.0) 0.018
Continuous variables are reported as mean values (standard deviations) and categorical variables are reported as
numbers (percentages). Significant between-sex differences (t-tests or * chi-square test χ2). WC: waist circumference;
BMI: body mass index; FMI: fat mass index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density
lipoprotein cholesterol; PA: physical activity. The mean blood pressure was calculated using the following formula:
(systolic blood pressure + (2 × diastolic blood pressure))/3.
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Table 3 shows the partial correlation between BF%, FMI, and MetS components. Overall, BF% and
FMI were weakly positively correlated with all MetS parameters (all p < 0.05), except HDL, which was
negatively correlated.
Table 3. Results of the partial correlation analysis between body fat percentage (BF%), fat mass index
(FMI), and MetS components.
Variable Glucose(mg/dL)
HDL-C
(mg/dL)
Triglycerides
(mg/dL)
Total Cholesterol
(mg/dL)
MAP
(mmHg) WC (cm)
FMI
(kg/m2)
Body fat (%) 0.188 * −0.239 ** 0.230 ** 0.279 ** 0.276 ** 0.827 ** 0.960 **
FMI (kg/m2) 0.113 ** −0.256 ** 0.230 ** 0.162 * 0.272 ** 0.860 ** 1
WC (cm) 0.106 * −0.219 0.248 0.858 ** 0.271 ** 1
Mean blood pressure (mmHg) 0.004 −0.022 ** 0.179 ** 0.259 ** 1
Total cholesterol (mg/dL) −0.008 −0.341 ** 0.241 ** 1
Triglycerides (mg/dL) 0.125 ** −0.170 ** 1
HDL-C (mg/dL) −0.158 ** 1
Glucose (mg/dL) 1
Analysis adjusted by co-variables: age, sex, tobacco, alcohol, and physical activity. * p < 0.05; ** p < 0.01. WC: waist
circumference; FMI: fat mass index; HDL-C: high-density lipoprotein cholesterol; MAP: mean arterial pressure.
The mean blood pressure was calculated using the following formula: (systolic blood pressure + (2 × diastolic blood
pressure))/3.
3.3. Optimal Cut-Off Value in the Screening of MetS
The ROC analysis showed that BF% and FMI parameters could be used to detect MetS according
to the IDF criteria among Colombian university students (Table 4; Figure 2). Since multiple levels of
risk were desired, the selection of the resulting cut-off values was based on multiple combinations
of sensitivity and specificity. The focus was on higher sensitivity for the BF% and FMI thresholds in
an effort to identify the majority of cases of MetS according to the IDF criteria. In men, the cut-off point
value of 25.5% for BF% provided a sensitivity of 96.1%, an LR (+) value of 2.3, a specificity of 57.5%,
and an LR (−) value of 0.06. For FMI, the cut-off value of 6.9 kg/m2 provided a sensitivity of 95.8%,
an LR (+) value of 2.2, a specificity of 56.2%, and an LR (−) value of 0.07. With respect to BF% among
the women in the study population, the cut-off point value of 38.9% provided a sensitivity of 97.4%,
an LR (+) value of 2.2, a specificity of 55.9%, and an LR (−) value of 0.04. The ROC curve for FMI was
also obtained, using a cut-off value of 11.8 kg/m2, a sensitivity of 97.6%, an LR (+) of 2.2, a specificity
of 56.9%, and an LR (−) of 0.04.
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Table 4. Parameters of the ROC curves analysis for the diagnostic performance of body fat percentage
(BF%) and fat mass index (kg/m2) in identifying high risk of MetS according to the IDF criteria in men
and women.
Parameter BF% FMI
High risk of MetS
Men
AUC 0.835 0.838
95% CI 0.779–0.891 0.779–0.892
p value <0.001 <0.001
Cut-off 25.5 6.9
Sensitivity (%) 96.1 95.8
Specificity (%) 57.5 56.2
LR (+) 2.3 2.2
LR (−) 0.06 0.07
Women
AUC 0.887 0.889
95% CI 0.842–0.932 0.844–0.933
p value <0.001 <0.001
Cut-off 38.9 11.8
Sensitivity (%) 97.4 97.6
Specificity (%) 55.9 56.9
LR (+) 2.2 2.2
LR (−) 0.04 0.04
AUC: area under the curve; CI: confidence interval; LR (+): positive likelihood ratio; LR (−): negative likelihood ratio.
4. Discussion
In our study, we found that the MetS prevalence was higher in men than in women (11.2% vs. 5.3%;
p < 0.001), which is an intermediate value compared to those reported in local and international studies,
ranging from 2 to 13% [31–33], that BF% and FMI were positively correlated to MetS components
(p < 0.05), and that the ROC analysis showed that both the BF% and FMI had a moderate discriminatory
power in the identification of MetS among Colombian university students.
The higher prevalence of MetS, at 11.2%, seen in male subjects in our results does not coincide
with Ruano-Nieto et al. [34] who found that the estimated prevalence of MetS was 8.4% for women
and 6.1% for men in a population of Ecuadorian university students. The overall prevalence of MetS in
our study, at 7.7%, was also greater than that in other Latin American countries such as Chile at 4.9%
and Argentina at 4.1% [35,36]. Clearly, the prevalence of MetS could differ between studies depending
on the MetS cluster used, the design method, and the target population. In this study, we used the IDF
and AHA/NHLBI [2] joint statement, as it was an international attempt to harmonize the definition of
MetS; central obesity is not an obligatory component of this definition and it is ethnic-specific.
Of those components, abdominal obesity, the most prevalent manifestation of MetS, is a marker
of dysfunctional adipose tissue, and is of central importance in clinical diagnosis [37–41]. Our results
show correlation between BF%, FMI, and all of the cardiometabolic biomarkers analyzed, including
mean arterial pressure, glucose, HDL-C, LDL-C, triglycerides, and total cholesterol (<0.05 for all).
These findings agree with Knowles et al. [19], who studied a population of young Peruvian adults and
found significant correlations between the fat parameters and the above-mentioned cardiometabolic
biomarkers. Blood lipid disorders and adipose tissue are the key etiologic defects that define MetS;
we found all fat indices used in this study were associated with BF%. In contrast, other researchers
such as Schuster et al. [40], who studied a sample of 444 young adults in Brazil, only found correlations
between the BF% and glucose, HDL-C, and triglycerides. Our result may be different due to degree
and the prevalence varying on the basis of ethnicity, genetic susceptibility, lifestyle, and geographic
location. In addition, our results showed lower values of weight, height, and WC in women compared
to men. This aligns with Liu et al. [17], who studied a population of 1698 adults in China. In all
likelihood, these differences in body composition were due to sexual dimorphism [31] and diet [34].
Sex-specific hormones are another possible explanation. For example, the triglyceride levels and blood
pressure were also lower among women in comparison to men. In this context, much of the risk of
MetS associated with sex can be explained by the change in steroid hormone levels and the metabolism
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of carbohydrates and lipids [39]. An increase in total fat and the distribution of central fat, resulting
from alterations in biomarker-disease, such as fasting glucose, triglycerides, and ferritin, which are
mediators of MetS, has been reported in female Hispanic/Latino adults [40]. This coincides with
previous research, in which this finding was correlated with lower cardiovascular morbidity and
dysfunctional adipose tissue in women [39,41]. Furthermore, the observation of ongoing changes
in body composition by sex and its relationship with obesity has demonstrated that obesity affects
individuals no matter their muscle mass, fat mass, height, and weight [41].
The AUC values for the MetS ROC analyses, at 0.835 for men and 0.838 for women, indicate that
BF% has moderate diagnostic capabilities to identify subjects with MetS (≥3 risk factors). Interestingly,
when considering MetS in our study, FMI showed the greatest AUC to predict MetS risk in women
compared to men. Results show that metabolic disorders are present in young adult independent of
age, smoking, physical activity, or fitness levels [42]. There is a growing interest in suggesting cut-off
points for body fat levels for the early detection of CVD risk. Future longitudinal studies should be
carried out to understand the role of different levels of adiposity on CVD risk stratification within
a college population.
In contrast, another study carried out by Mohammadreza et al. [43] among Iranian adults found
that BF% was not as effective a parameter for predicting MetS as other anthropometric indexes such
as BMI, waist-to-height ratio, and waist-to-hip ratio. In this same line, Mousa et al. [44] studied
a population of young adults and found that the predictive power of BF% and BMI for screening
MetS was limited. This discrepancy in results could be explained by the heterogeneity of the sample
populations. Consequently, the applicability and usefulness of BF% and FMI in the prediction of MetS
require further studies of different populations and ethnic groups. These results are partially consistent
with previous studies that showed BF% was positively correlated with single metabolic risk factors,
such as BMI and triglycerides, and negatively correlated with HDL cholesterol in men, but not in
women [45,46].
To our knowledge, few studies have explored the use of FMI as a proxy of obesity. In a study of
538 Mexican American college students (373 women and 165 men), the validity of FMI and BMI against
BF% with BIA as the reference method was evaluated [47]. Correlations between FMI and BF% resulted
in correlation coefficients of 0.976 in men (p < 0.001) and 0.992 in women (p < 0.001). However, similar
to our findings, the correlations between FMI and PBF were higher (r = 0.960, p < 0.01). In a study of
2986 healthy white men and 2649 white women, age 15 to 98 years in Switzerland, the mean FMI in
the overall age group was 4.9 (1.8) kg/m2 in men and 6.6 (2.4) kg/m2 in women [48], compared to our
results, of 6.6 (3.1) kg/m2 in men and 11.2 (3.4) kg/m2 in women without MetS. This difference can be
explained by the fact that FMI cutoffs in the Swiss group were derived from BMI and not from MetS
cutoffs. On the other hand, in the Peltz et al. study [47], the median FMI in the overall age group was
7.3 (interquartile range 4.5) kg/m2 in men and 9.0 (interquartile range 5.9) kg/m2 in women. Our FMI
means fell within the lower range of the Mexican American normal FMI ranges in both men and women.
This was expected, as South Americans have a lower percentage of body fat across all age groups when
compared to non-Hispanic whites, Mexican Americans, and non-Hispanic blacks [49]. In a subsequent
study from the same group (5635 apparently healthy adults from a mixed non-randomly selected
Caucasian population) in Switzerland, obesity was defined as an FMI greater than 8.2 kg/m2 in men
and 11.8 kg/m2 in women [50], which are similar than our FMI cutoffs of ≥6.9 kg/m2 in men and
≥11.8 kg/m2 in women in our study. These findings, although limited, show an interesting agreement
with our results, which collectively contribute to the concept of developing one set of recommended
ranges that are not affected by height.
Our results have public health and clinical implications as college populations have been reported
as a period in life when several behavioral and metabolic changes occur. These changes, in addition
to the adoption of a Western lifestyle and diet, have led to a rise in the prevalence of overweight
and obese Colombians, particularly among university students [32,51]. Further studies are needed to
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identify clinical characteristics in young adults that could be used in screening tests to predict MetS
risk in adulthood.
The principal limitation of this study was the use of cross-sectional data. Furthermore, it is also
true that the hydration status of the participants could have modified the results of the BF% measured
with BIA. Most BIA prediction equations assume that the fat mass and fat-free mass consist of 73%
water [52]. These major limitations of the BIA method remain unresolved. Secondly, the assessment of
other biomarkers, such as insulin, adiponectin, and c-reactive protein levels, which could have shown
additional information about prognostic assessment, was not performed. These and other questions
deserve further investigation by future well-designed longitudinal studies.
The main strength of our study is the fact that our study compared the predictive power of both
BF% and FMI while providing cutoff values for the prediction of MetS in university students from
Colombia. Considering the wide use of BIA methods and their extension to assess body composition,
our study has important implications for evaluating CVD and metabolic risks in high-risk subjects,
such as those with MetS.
5. Conclusions
In conclusion, BF% and FMI had a moderate discriminatory power in the identification of MetS
in Colombian university students. Apart from the differences between our cut-off points and those
reported in other research in geographically different populations, this study reports the first cutoff
points for identification of MetS by BF% and FMI in Colombian young adults. We demonstrated that
a BF% ≥38.9% in women and ≥25.5% in men, and an FMI ≥11.8 kg/m2 in women and ≥6.9 kg/m2 in
men, are thresholds that could be used to predict Colombian young adults at high risk of MetS.
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Abstract
Background: Evidence shows an association between grip strength and health; however, grip strength cut-offs for the detection of metabolic syn-
drome (MetS) in Latin American populations are scarce. The purpose of this study was to determine cut-offs of normalized grip strength (NGS)
for the detection of MetS in a large nonrepresentative sample of a collegiate student population from Colombia.
Methods: A total of 1795 volunteers (61.4% female, age = 20.68 § 3.10 years, mean § SD), ranging between 18 and 30 years of age partici-
pated in the study. Strength was estimated using a handheld dynamometer and normalized to body mass (handgrip strength (kg)/body mass
(kg)). Anthropometrics, serum lipids indices, blood pressure, and fasting plasma glucose were measured. Body composition was measured by
bioelectrical impedance analysis. MetS was defined as including 3 of the 5 metabolic abnormalities according to the International Diabetes
Federation definition. A metabolic risk score was computed from the following components: waist circumference, triglycerides, high-density
lipoprotein cholesterol, glucose, and systolic and diastolic blood pressure.
Results: Receiver operating curve analysis showed significant discriminatory accuracy of NGS in identifying the thresholds and risk categories.
Lower strength was associated with increased prevalence of MetS. In males, weak, intermediate, and strong NGS values at these points were
<0.466, 0.4660.615, >0.615, respectively. In females, these cut-off points were <0.332, 0.3320.437, >0.437, respectively.
Conclusion: Our sex-specific cut-offs of NGS could be incorporated into a clinical setting for identifying college students at cardiometabolic dis-
ease risk.
 2018 Published by Elsevier B.V. on behalf of Shanghai University of Sport. This is an open access article under the CC BY-NC-ND license.
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Cardiometabolic risk; Muscular fitness; Receiver operating characteristic curve; Thresholds
1. Introduction
Muscular weakness, as determined with the use of a hand-
grip dynamometer, is recognized as a marker of health risk,
similar to that observed for conventional risk factors.13
Lopez-Martınez et al.3 demonstrated that muscle strength is
negatively associated with metabolic syndrome (MetS) in
young adults. Additionally, in a prospective study (follow-up
in young adulthood for 20 years), Fraser et al.4 showed that
those in the lowest third tertile of strength were independently
associated with adult MetS. Similarly, our group5,6 and other
investigators79 have shown an independent and inverse asso-
ciation between low strength and cardiometabolic risk cluster-
ing among adolescents and adults. The contribution of
muscular weakness to the progression of sedentary behavior
with aging and/or cardiometabolic risk factors (e.g., obesity,
MetS, insulin resistance) is equally unequivocal, and recent
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national efforts to identify cut-offs or thresholds for clinically
relevant weakness among young people10 will help clinicians
screen individuals at greatest risk.11,12
Senechal et al.11 determined low muscle strength cut-offs
for the prediction of MetS among middle-aged and older males
using a composite score of normalized strength from chest
press and leg press from a sample of 5685 men aged <50 years
and 1541 men aged  50 years. However, at this time, thresh-
olds derived from handgrip muscle strength, a clinically rele-
vant strength measure, among Latin-American college
students remains to be determined. Moreover, even though
there is scientific evidence regarding the role of muscle
strength preservation for prevention against cardiometabolic
risk in several populations, no studies have established the
minimum strength capacity associated with the risk of MetS
among Latin-American college students. Clinically relevant
handgrip strength cut-offs for detecting MetS have been estab-
lished for youths,6 adults,11 and older adults.7,8
However, Leong et al.13 reported considerable heterogene-
ity in median handgrip strength among 125,462 healthy adults
aged 3570 years from 21 countries in the Prospective Urban
Rural Epidemiology study. This finding is important because
it has been reported that handgrip strength is predictive of
mortality and cardiovascular disease (CVD) independently of
country income.14 Therefore, from a public health perspective,
the inclusion of handgrip strength measures in health surveil-
lance systems is clearly justifiable. For example, moderate
weight gain from early to middle adulthood is associated with
significantly increased risk of major chronic diseases and mor-
tality.2 Therefore, young adults may also be a good population
for monitoring fitness, identifying risk factors, and offering
interventions among those at high cardiometabolic risk. For
that, cut-offs to determine young adults at caridiometabolic
risk are required and to be used later to promote muscular
strength and to lower CVD risk in later life.
Thus, our study aimed to determine cut-offs of grip strength
for the detection of MetS in a large collegiate student popula-
tion from Colombia. Such evidence could serve as proof of a
concept for the development of broad normative reference test
standards for clinical, academic, and community settings.
2. Methods
2.1. Participants and study design
Data were from a cross-sectional component of the
FUPRECOL (in Spanish, Asociacion de la Fuerza Prensil
con Manifestaciones Tempranas de Riesgo Cardiovascular
en Adultos Colombianos) study conducted during the
20142017 academic years. We recently published a com-
plete description of the FUPRECOL study design, methods,
and primary outcomes for our current cohort.9 A convenience
sample comprised 1795 volunteers (61.4% female, age =
20.68 § 3.10 years, mean § SD) between ages 18 and 30
years of low to middle socioeconomic status, which was eval-
uated in accordance with the following Colombian govern-
ment classification: stratum 12 = low, stratum 34 =
middle, and stratum 56 = high). The sample comprised
students enrolled in public or private universities from 3 dis-
tinct areas of Colombia: the capital district of Bogota (Cundi-
namarca), Tunja (Boyaca), and Santiago de Cali (Valle del
Cauca).
Exclusion criteria included medical or clinical diagnosis of
a major systemic disease, including malignant conditions such
as cancer, type 1 or 2 diabetes, high blood pressure, and hypo-
thyroidism or hyperthyroidism; a history of drug or alcohol
abuse; regular use of multivitamins; chronic inflammatory
conditions including rheumatoid arthritis, systemic lupus
erythematosus, and multiple sclerosis; infectious conditions;
or a body mass index (BMI)  35 kg/m2. Volunteers were not
compensated for their participation. Informed consent was
obtained from each participant. All participants provided
written consent, and each study was approved by the local
authorized institutional review boards (Bogota UMB Code N˚
01-1802-2013, UR Code N˚CEI-ABN026-000010; Cali
UNIAJC Code N˚ 111-02.01.48/16; Tunja Code N˚ RECT 60)
and complied with the Declaration of Helsinki (World Medical
Association for Human Subjects). The students who agreed to
participate and who had signed the informed consent form
were given appointments for the procedures described in the
following.
2.2. Physical examination
Subjects were screened for inclusion in the study via per-
sonal interviews. Interview questions included queries about
health status, medical history, CVD risk factors, and lifestyle.
After completing another general information questionnaire,
participants were instructed to wear shorts and t-shirts to the
physical examination. They were also required to remove all
jewelry and metal objects. Once the subjects were barefoot
and in their underwear, their body weight (kg) was measured
using an electric scale (Tanita Model BC-418, Tanita Corp.,
Tokyo, Japan) with a range of 0200 kg and with an accuracy
within 100 g. Height was measured with a portable stadiome-
ter with a precision of 0.1 mm and a range of 02.50 m
(Seca 274, Vogel and Halke, Hamburg, Germany). BMI was
calculated by using the following formula: body mass (kg)/
height (m2). BMI status was evaluated according to the World
Health Organization criteria.15 The waist circumference (WC)
was measured in cm as the narrowest point between the lower
costal border and the iliac crest. When this point was not evi-
dent, it was measured at the midpoint between the last rib and
the iliac crest, using a metal tape measure (Lufkin W606PM;
Cooper Tools, Parsippany, NJ, USA). The evaluation process
was carried out by a team of professionals (4 physical therapy
professors) with extensive experience in anthropometric mea-
surement. Measurements for 2% of the sample was carried out
twice to ensure quality of measures. The technical error of
measurement (TEM) values were <2% for all anthropometric
variables.
Body fat percentage (BF%) and fat mass index (FMI) were
determined for bioelectrical impedance analysis (BIA) by a
tetrapolar whole-body impedance (Tanita Model BC-418;
Tanita Corp.,). For the calculation of intra- and inter-observer
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TEM, at least 50 subjects needed to be measured (30 males, 20
females, aged 22.3 § 2.1 years). The Tanita Model BC-418 is
a reliable system that has good agreement with laboratory-
based methods of assessment (hydrostatic weighing: r = 0.81,
p < 0.05; error of 1.68 BF% or DXA: r = 0.87,
p < 0.001).16,17 The corresponding intraobserver technical
error (% reliability) of the measurements was 95%. A detailed
description of the BIA technique can be found elsewhere.18
Before testing, participants were required to adhere to the BIA
manufacturer’s instructions (http://www.tanita.com/es/bc-418/),
including not to (i) eat or drink within 4 h of the test; (ii)
consume caffeine or alcohol within 12 h of the test; (iii) take
diuretics within 7 days of the test; (iv) do physical exercise
within 12 h of the test, and (v) urinate within 30 min of the test.
FMI was calculated by dividing each subject’s fat mass (kg) by
the square of his or her height (m)2, as described previously.19
2.3. Muscular strength
Handgrip strength was assessed using an adjustable digital
handgrip dynamometer (T-18 TKK SMEDLY III; Takei Sci-
entific Instruments Co., Ltd., Niigata, Japan). Participants
watched a brief demonstration of the technique and were given
verbal instructions on how to perform the test. The dynamom-
eter was adjusted according to the subjects’ hand size based on
a predetermined protocol.20 The best score for each hand was
recorded in kg. The handgrip strength was calculated as the
average of the left and right hand. Because there is substantial
covariance between strength capacity and body mass, and
because the link between strength and both physical function
and chronic health is directly mediated by the proportion of
strength relative to body mass, handgrip strength was a nor-
malized grip strength (NGS) per body mass—for instance,
handgrip strength (kg)/body mass (kg). The reproducibility of
our data was R = 0.96. Intra-rater reliability was assessed by
determining the intra-class correlation coefficient (0.98, 95%
confidence interval (CI): 0.970.99, n = 20, median
age = 22.88 § 1.41 years, 66.2 § 5.41 kg, 1.75 § 0.1 m,
24.91 § 3.12 kg/m2).
2.4. MetS diagnosis
After the subjects had fasted for 1012 h, blood samples
were obtained from capillary sampling from 6:0010:00 a.m.
Participants were asked not to engage in prolonged exercise in
the 24 h prior to testing. The biochemical profile included the
following: (i) high-density lipoprotein cholesterol (HDL-C),
(ii) triglycerides, (iii) low-density lipoprotein cholesterol
(LDL-C), (iv) total cholesterol, and (v) glucose fasting by
enzymatic colorimetric methods. Inter-assay reproducibility
(coefficient of variation) was determined from 80 replicate
analyses of 8 plasma pools over a period of 15 days. The per-
centages obtained were 2.6% (triglycerides), 2.0% (total cho-
lesterol), 3.2% (HDL-C), 3.6% (LDL-C), and 1.5% (fasting
glucose).
Blood pressure was taken on the left arm at the heart level
with the automatic device Omron M6 Comfort (Omron
Healthcare Europe B.V., Hoofddorp, The Netherlands) while
the participants were sitting still. The blood pressure monitor
cuff was placed 23 finger-widths above the bend of the arm,
and a 2-min pause was allowed between the first and the sec-
ond measurement with a standard cuff for an arm circumfer-
ence of 2232 cm. The mean arterial pressure (MAP) was
calculated using the following formula: MAP = (systolic blood
pressure + (2£ diastolic blood pressure))/3.
Participants were considered to have diagnoses of the MetS
if they had 3 of the following: (i) abdominal obesity (WC 
80 cm in females and WC  90 cm in males), (ii)
Table 1
Characteristics among a sample of college students from Colombia (mean §
SD, n = 1795).
Characteristics Male
(n = 692)
Female
(n = 1103)
p
Anthropometric
Age (year) 20.51§ 3.22 20.59§ 2.99 0.077
Weight (kg) 68.91§ 12.22 58.79§ 10.36 <0.001
Height (cm) 172.30§ 6.65 159.09 § 5.86 <0.001
WC (cm) 78.23§ 9.32 71.53§ 8.02 <0.001
High WC n (%) 75 (10.84) 151 (13.69) 0.069
BMI (kg/m2) 23.17§ 3.60 23.21§ 3.77 0.089
Body fat (%) 15.61§ 6.54 27.03§ 7.26 0.002
FMI (kg/m2) 3.81§ 2.24 6.50 § 2.75 <0.001
Body mass index status, n (%)
Underweight (5.49) 72 (6.52) <0.001
Normal weight 477 (68.93) 735 (66.64) <0.001
Overweight 144 (20.81) 235 (21.31) <0.001
Obese 33 (4.77) 61 (5.53) <0.001
Blood pressure
Systolic (mm Hg) 120.28§ 12.97 111.29 § 11.15 <0.001
Diastolic (mm Hg) 74.19§ 11.45 71.74§ 9.35 <0.001
MAP (mm Hg) 97.23§ 10.90 91.51§ 8.92 <0.001
Hypertension, n (%) 282 (40.75) 187 (16.95) <0.001
Cardiometabolic parameters
Total cholesterol (mg/dL) 132.75§ 30.23 146.39 § 33.33 0.081
High total cholesterol, n (%) 21 (3.03) 62 (5.62) 0.007
Triglycerides (mg/dL) 93.74§ 48.54 88.50§ 45.34 0.017
High triglycerides, n (%) 54 (7.80) 127 (11.51) <0.001
LDL-C (mg/dL) 81.07§ 26.09 87.92§ 26.15 0.386
High LDL-C, n (%) 272 (39.31) 683 (61.92) <0.001
HDL-C (mg/dL) 39.55§ 10.67 43.97§ 12.80 <0.001
Low HDL-C, n (%) 383 (55.35) 798 (72.35) <0.001
Glucose (mg/dL) 84.81§ 11.99 86.05§ 11.57 0.010
High glucose, n (%) 61 (8.82) 90 (8.16) 0.629
MetS score 3.85 § 2.95 3.94 § 2.66 0.008
MetS, n (%) 84 (12.14) 82 (7.43) 0.001
Lifestyle, n (%)
Tobacco (10 cigarettes
per week)
199 (28.76) 210 (19.04) 0.548
Alcohol (1 time per
week)
378 (54.62) 430 (38.98) 0.451
Physical activity levels
(150 min per week)
243 (35.12) 222 (20.13) 0.001
Muscular strength
Handgrip (kg) 39.42§ 7.14 24.07§ 4.95 <0.001
NGSa 0.58 § 0.11 0.42 § 0.09 <0.001
a NGS measured as handgrip strength (kg)/body mass (kg).
Notes: values are presented as mean § SD unless otherwise noted.
Abbrevations: BMI = body mass index; FMI = fat mass index; HDL-C = high-
density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol;
MAP =mean arterial pressure; MetS = metabolic syndrome; NGS = normal-
ized grip strength; WC =waist circumference.
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hypertriglyceridemia (150 g/dL), (iii) low HDL-C (<50
mg/dL in females and <40 mg/dL in males), (iv) high blood
pressure (systolic blood pressure 130 mmHg or diastolic
blood pressure 85 mmHg) or MAP 100 mmHg, and (v)
high fasting glucose (100 mg/dL). MetS was defined in
accordance with the updated harmonized criteria of the Inter-
national Diabetes Federation (IDF).21
We calculated a composite MetS score that reflects a con-
tinuous score of the 5 MetS risk factors. The MetS score was
calculated from the individual subjects’ data, based on the
IDF,21 and the standard deviations were calculated using data
from the entire subject cohort at baseline. The equation used
was MetS score = ((HDL-C: male 40 mg/dL or female 50
mg/dL)/SD: female = 1.04 or male =0.19) + ((triglycerides
(TG): 150 mg/dL)/SD: female = 0.99 or male = 0.97) + ((fast-
ing glucose: 100 mg/dL)/SD: female = 0.98 or
male = 1.02) + ((WC: male 94 cm or female 80 cm)/SD:
female = 0.99 or male = 0.94) + ((MAP: 100 mmHg)/SD:
female = 0.88 or male = 1.07). The mean of this continuously
distributed MetS score was therefore 0 by definition.
2.5. Lifestyle covariates
A standardized questionnaire, the “FANTASTIC” lifestyle
(family, physical activity (PA), nutrition, tobacco toxins, alco-
hol, sleep/stress, personality type, insight, and career), was
used to collect comprehensive information about substance
use via a personal interview with participants. Alcohol con-
sumption and smoking status were defined as subjects who
had consumed any alcoholic beverage 1 time per week and
those who had smoked 10 cigarettes per week for at least
6 months, respectively, as previously described by Ramırez-
Velez et al.22 Participants who exercised 3 times a week for
>30 min were categorized as “physically active”, and those
who exercised <3 times a week were considered “physically
inactive”.22
2.6. Statistical analysis
Descriptive characteristics are provided as means, SDs, and
percentages. Histograms and Q-Q plots were used to verify the
normality of the selected variables. Independent 2-tailed t tests
for continuous variables and x2 tests for categorical variables
were used to examine sex differences or the MetS group. Anal-
ysis of covariance adjusted for age, tobacco, alcohol, and PA
levels (owing to the relationship with MetS) was used to deter-
mine the main effects for NGS (weak, intermediate, and
strong) and anthropometrics, blood pressure, metabolic bio-
markers, and muscle strength outcomes. We calculated
standard indices, including sensitivity, specificity, area
under the curve (AUC), and receiver operating characteris-
tic (ROC) curve analysis, to establish weak, intermediate,
and strong handgrip cut-off scores for subjects (male and
female). Such cut-offs could be used to predict MetS
according to the IDF criteria. Sensitivity was defined as
the probability of classifying correctly those college stu-
dents presenting MetS (true positives), whereas specificity
was defined as the probability of classifying correctly those
participants presenting non-MetS (true negatives). The
shortest distance in the ROC curve was calculated using
the function x(1¡sensitivity2) + (1¡specificity2) by maxi-
mizing the Youden index. The positive likelihood ratio
(LR(+)) and the negative likelihood ratio (LR(¡)) were
used to analyze the potential diagnostic accuracy of the
NGS to discriminate among weak, intermediate, and strong
for MetS. Locally weighted scatterplot smoothing curves
were used to illustrate the shape of the relationship
between the NGS and MetS score. Conditional inference
tree analyses were used as an alternative method for deter-
mining weak, intermediate, and strong risk thresholds of
normalized strength for detection of the high-risk cardio-
metabolic phenotype, as described previously.23 Data were
analyzed with SPSS Version 24.0 for Windows (IBM
Corp., Armonk, NY, USA,) and freely available statistical
software R version 3.2.3 (RStudio Team, Boston, MA,
USA). A p value <0.05 denoted statistical significance.
3. Results
The 1795 volunteers included 1103 females (61.4%). Their
mean age was 20.68 § 3.10 years. Overall, males had greater
body weight, WC, blood pressure, high triglycerides, and PA
levels than females (p  0.001), whereas females had lower
handgrip and NGS (p < 0.001). The prevalence of overweight
and obesity was 21.31% and 5.53% in females, respectively
Table 2
Parameters of the ROC curves analysis for the diagnostic performance of NGS inidentifying weak, intermediate, and strong risk of MetS according to the IDF crite-
ria in males and females.
Parameters AUC 95%CI p Cut-off Sensitivity (%) Specificity (%) LR (+) LR (–) Percentile
Male
Weak 0.720 0.679–0.802 <0.001 <0.466 89.0 57.8 2.11 0.19 ≤14
Intermediate 0.740 0.679–0.802 <0.001 0.466–0.615 86.9 56.8 2.10 0.23 15–62
Strong — — — >0.615 84.3 58.7 2.04 0.26 ≥63
Female
Weak 0.725 0.670–0.780 <0.001 <0.332 84.9 58.5 2.04 0.25 ≤17
Intermediate 0.728 0.660–0.777 <0.001 0.332–0.437 85.0 58.3 2.02 0.24 18–60
Strong — — — >0.437 86.6 57.9 2.05 0.23 ≥61
Notes: NGS is measured as grip strength (kg)/body mass (kg).
Abbreviations: AUC = area under the curve; CI = confidence interval; IDF = International Diabetes Federation; LR(+) = positive likelihood ratio; LR(¡) = negative
likelihood ratio; MetS = metabolic syndrome; NGS = normalized grip strength; ROC = receiver operating characteristic curve.
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(p < 0.001) (Table 1). In males, the prevalence of overweight
and obesity was 20.81% and 4.77%, respectively (p < 0.001).
It was observed that 40.75% of males had high blood pressure.
Total cholesterol, and LDL-C levels were significantly higher
in females than in males (p < 0.05).
Table 2 depicts ROC curve analysis for the diagnostic per-
formance NGS in identifying weak, intermediate, and strong
risk of MetS. Since multiple levels of risk were desired, the
selection of the resulting cut-off values was based on multiple
combinations of sensitivity and specificity. In males, NGS val-
ues for weak, intermediate, and strong were <0.466, 0.466-
0.615, and >0.615, respectively. In females, these cut-offs were
<0.332, 0.332-0.437, and>0.437, respectively (Table 2).
Mean differences in anthropometrics, cardiometabolic risk,
and muscle strength parameters according to NGS categories
are shown in Table 3. In males and females, analysis of
variance adjusted for age, tobacco, alcohol, and PA levels
showed that there were differences in body weight, FMI, and
muscle strength (all p < 0.05).
Conditional inference trees predicting probability of the
high-risk cardiometabolic phenotype (MetS according to the
IDF criteria) confirmed different low strength thresholds
between males and females. Fig. 1 provides results for the pri-
mary definition. The first cut-off point identified in males was
based on having NGS <0.466 vs. 0.466. Within the group of
subjects with NGS 0.466, a second cut-off point was identi-
fied as an NGS <0.615. Among the weakest males (NGS
<0.466), 34.6% had MetS, as compared with 10.7% among
males with intermediate NGS (0.466-0.615), and only 4.9%
among males with the highest NGS (>0.615). Among females,
the first identified cut-off was based on having an NGS 0.332
vs. <0.332. Within the group of subjects with an NGS <0.332,
a second cut-off point was identified as an NGS 0.332.
Among the weakest females (NGS <0.332), 18.0% had MetS,
as compared with 7.9% among females with intermediate
NGS (0.332-0.437) and only 2.4% among females with the
highest NGS (>0.437).
Fig. 2 provides plots of the association between NGS and
MetS score for males and females. Inspection of the locally
weighted scatterplot smoothing curves provides evidence of a
well-defined threshold effect of low strength on the MetS score
as a continuous outcome.
4. Discussion
This is one of the first studies to identify sex-specific cut-
offs for NGS to detect a high-risk cardiometabolic phenotype
among a large population of college students. The role of mus-
cular strength has been increasingly recognized in the preven-
tion of chronic disease in adult populations.13 Evidence
suggests that muscle mass and strength decrease progressively
after the age of 20 years,24 whereas in old age, some grip
strength and hip strength declines by an average of 1.10 kg per
year and 1.31 kg per year, respectively.25 Therefore, young
adulthood seems to be crucial time frame for monitoring and
intervening to reduce the risk of weakness and cardiometa-
bolic disease. T
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Few studies have proposed cut-offs for low muscular
strength among adults for screening cardiometabolic risk;
however, this has yet to receive adequate attention in young
adult populations, and information is scarce. Most studies
have analyzed the older adult population. For example, Lee et
al.26 demonstrated that cardiometabolic risk was 54% lower
for individuals with relative handgrip strength (absolute hand-
grip strength divided by BMI) in the 75th percentile compared
with the 25th percentile. In addition, Duchowny et al.27 estab-
lished cut-off points for muscle weakness assessed as handgrip
strength in a nationally representative sample by race and sex
among older American adults. Senechal et al.11 determined
low muscle strength cut-off points for the prediction MetS
using a composite score of normalized strength from the chest
press and leg press. Among middle-aged adults, Strand et al.28
revealed an association between handgrip strength and all-
cause mortality and cardiovascular mortality, confirming the
role of handgrip strength as a mortality predictor.29 Finally,
among young adults, Wilkerson et al.30 investigated 62 colle-
giate football players (mean age 19.9 years) and found that
low leg muscle strength was associated with an increased like-
lihood of MetS.
In line with studies mentioned earlier, our study revealed
cut-offs for NGS by sex and identified 3 cardiometabolic risk
categories (“high”, “intermediate”, and “low”). The ROC
curves generated for this study showed acceptable AUCs and
95%CI limits, suggesting that the resultant cut-offs were not
owing to chance (both AUC 0.72). Specifically, among
males in the highest strength category, only 4.9% had the
MetS phenotype, as compared with 10.7% among males with
intermediate strength and 34.6% among males with low
strength. Among the females in the highest strength category,
only 2.4% had the MetS phenotype, as compared with 7.9%
among females with intermediate strength and 18% among
those with low strength. The identification of the 3 categories
of cardiometabolic risk coincides with the findings of Peterson
et al.,31 who determined by sex the distribution of high cardio-
metabolic risk according to the cut-off points: weak, interme-
diate, and strong. These cut-off points were obtained from a
similar size sample but not related to the age range. The cut-
off points are lower than those identified in our study.
However, the AUCs observed for this threshold were
0.720.74 for males and 0.72 for females, whereas in the
study performed by Senechal et al.,11 the AUCs were 0.65 for
males and 0.81 for females. The lower sensitivity and specific-
ity reported in our study might be related to differences in age
(2050 years vs. 1830 years), sample size of the popula-
tions studied (1795 vs. 5685), and the methods used to assess
muscle strength (handgrip vs. leg and bench press), as well as
the use of a composite measure of MetS. Thus, our findings
reinforce the concept that muscle strength may be an important
modifiable lifestyle factor for CVD risk assessment in the
same way that physical inactivity, body composition, and
healthy dietary patterns are important.
Our findings therefore support previous results demonstrat-
ing that low muscle strength is associated with MetS. These
findings coincide with Sasaki et al.,32 in which for each 5 kg
increase in grip strength, the number of deaths caused by heart
disease and stroke diminishes significantly. A plausible expla-
nation for the role of muscle strength in MetS prevalence may
be through the metabolic and structural changes that improve
muscle insulin sensitivity and glycemic control.33 As demon-
strated by Wu et al.34 in a recent meta-analysis, there is a 63%
higher risk of premature mortality owing to CVD among
adults with low handgrip muscle strength.
The strengths of this study include the large sample size and
a commonly used and feasible test for assessing muscle
strength. However, there are some limitations that need to be
highlighted. First, owing to the cross-sectional nature of
the study design, we were unable to draw causal relationships.
Thus, we were unable to deduce whether low NGS leads to
increased risk of MetS, or conversely whether poor cardiome-
tabolic profiles lead to declines in muscle strength. Future lon-
gitudinal studies are needed to better understand how declines
in muscle strength contribute to health risks in college-aged
adults. Second, the ROC curve analysis does not enable
Fig. 1. Conditional inference trees for NGS, as predictors in identifying risk
of MetS according to the IDF criteria in males and females. NGS is measured
as grip strength (kg)/body mass (kg). IDF = International Diabetes Federation;
MetS =metabolic syndrome; NGS = normalized grip strength.
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adjustments for potential confounders within the model, and
data were not adjusted prior to ROC curve analysis. Finally,
we only analyzed relatively healthy individuals; therefore, the
generalization of our results is limited to healthy younger
adults. Our study suggests that NGS could be used as a com-
plementary tool that may help clinicians and practitioners
screen for high cardiometabolic risk.
5. Conclusion
In summary, our sex-specific NGS cut-offs could be incor-
porated into a clinical setting for identifying college students
at high cardiometabolic disease risk and used as a target for
strength training programs designed to reduce the risk of
MetS. Longitudinal studies are necessary to determine if
increasing handgrip strength reduces the likelihood of MetS.
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